EPA/600/R-92/080
                                                  September 1993
         Methods for Aquatic
Toxicity Identification Evaluations

    Phase II Toxicity Identification
 Procedures for Samples Exhibiting
      Acute  and Chronic Toxicity
                      by

                  E. J. Durban1
                T. J. Norberg-King1
                 L. P. Burkhard1

              With Contributions from:

                  G. T. Ankley1
                M. T. Lukasewycz2
              M. K. Schubauer-Berigan2
                 J. A. Thompson2

         1U.S. Environmental Protection Agency
       2AScl Corporation - Contract No. 68-CO-0058
             Previous Phase II Methods
        by D. I. Mount and L. Anderson-Carnahan
                EPA-600/3-88/035
       National Effluent Toxicity Assessment Center
              Technical Report 01-93
          Environmental Research Laboratory
          Office of Research and Development
         U.S. Environmental Protection Agency
                Duluth, MN 55804
                                      /~x~y
                                      {§&) Printed on Recycled Paper

-------
                            Disclaimer
       This document has been reviewed in accordance with U.S. Environmental
Protection Agency policy and approved for publication. Mention of trade names or
commercial products does not constitute endorsement or recommendation for use.

-------
                              Foreword
       This document is one in a series of guidance documents intended to assist
dischargers and their consultants in conducting acute or chronic aquatic toxicity
identification evaluations (TIEs). TIEs might be required by state or federal agencies
resulting  from an enforcement action or as a condition of a National Pollutant
Discharge Elimination System  (NPDES)  permit.  The methods described in this
document will also help to determine the adequacy of effluent TIEs when they are
conducted as part of a toxicity reduction evaluation (THE).

       This Phase II document is the second of a three phase series of documents
that provide methods to characterize and identify the cause of toxicity in effluents. The
first phase of the series, Phase  I (EPA, 1991 A; EPA, 1992),  characterizes the
physical/chemical nature of the acute and chronic toxicant(s), thereby simplifying the
analytical work needed to identify the toxicant(s). Phase II provides guidance to
identify the suspect toxicants, and the last phase, Phase III (EPA, 1993A) provides
methods  to confirm that the suspect toxicants are indeed the cause of toxicity. The
recent TIE documents (EPA, 1991 A; EPA, 1992; EPA, 1993A; and this document)
have been produced or revised to include chronic toxicity recommendations and
additional information or experiences we have gained since the original methods were
printed (EPA, 1988A; EPA, 1989A; EPA, 1989B).

       This Phase II document provides identification schemes for non-polar or-
ganic chemicals, ammonia, metals, chlorine, and surfactants that cause either acute
or chronic toxicity. The document is still incomplete in that it does not provide methods
to identify all toxicants, such as polar organic compounds. This Phase II manual also
incorporates chronic and acute toxicity identification techniques into one document.

       While the TIE approach was originally developed for effluents, the methods
and techniques directly  apply to other types of aqueous samples, such as ambient
waters, sediment pore waters, sediment elutriates, and hazardous waste leachates.
These methods are not mandatory protocols but should be used as general guidance
for conducting TIEs.

       The sections of both Phase I documents (EPA, 1991 A; EPA, 1992) which
address health and safety, quality assurance/quality control (QA/QC), facilities and
equipment, dilution  water, testing,  sampling, and  parts of the introduction are
applicable to Phase II. These sections, however, are not repeated in their entirety in
this document.
                                    iii

-------
                               Abstract
       This manual and its companion guidance documents describe a three phase
approach for dischargers to identify the causes of toxicity in municipal and industrial
effluents (Phase I, EPA, 1991 A; EPA, 1992; and Phase III, EPA, 1993A). In 1989, the
document titled Methods for Aquatic Toxicity Identification Evaluations:  Phase II
Toxicity Identification Procedures was published as a guidance document for identi-
fying the cause of toxicity in acutely toxic effluents (EPA, 1989A). This new Phase II
document provides details for more types of samples, tests and test procedures that
can be used to identify the specific chemical(s) responsible for acute or chronic
effluent toxicity when the cause of toxicity is related to non-polar organic compounds,
ammonia, surfactants, chlorine, or metals. Phase I characterization and Phase III
confirmation manuals, the other guidance documents in the three phase TIE ap-
proach, have also been produced or updated to include both chronic toxicity
information and new developments made since the first set of documents were
printed. The TIE approach is applicable to effluents, ambient waters, sediment pore
waters or elutriates, and hazardous waste leachates.
                                   IV

-------
                               Contents
                                                                          Page
Foreword	,	iii
Abstract	iv
Tables	vii
Figures	viii
Abbreviations	:	ix
Acknowledgments	x

1.0 Introduction	1-1
    1.1 General Overview	1-1
    1.2 Biological Testing Considerations	1-2

2.0 Non-polar Organic Compounds	2-1
    2.1 General Overview	2-1
    2.2 Acute Toxicity: Fractionation and Toxicity Testing Procedures	2-2
       2.2.1  Sample Volume	2-3
       2.2.2  Filtration	2-3
       2.2.3  Column Size	2-3
       2.2.4  C18 SPE Column Conditioning	2-4
       2.2.5  Elution Blanks	2-4
       2.2.6  Column Loading with Effluent	2-4
       2.2.7  C18 SPE Column Elution	2-6
       2.2.8  Blank and Effluent Fraction Toxicity Tests	2-6
       2.2.9  SPE Fractions: Concentration and Subsequent Toxicity Testing	2-7
       2.2.10 HPLC Separation	2-9
       2.2.11 HPLC Fraction Toxicity Tests	2-9
       2.2.12 HPLC Fractions: Concentration and Subsequent Toxicity Testing ...2-10
    2.3 Chronic Toxicity: Fractionation and Toxicity Testing Procedures	2-10
       2.3.1  Sample Volume	2-11
       2.3.2  Filtration	2-11
       2.3.3  Column Size	2-12
       2.3.4  C18 SPE Column Conditioning	2-13
       2.3.5  Elution Blanks	2-13
       2.3.6  Column Loading with Effluent	2-14
       2.3.7  C18 SPE Column Elution	2-14
       2.3.8  Blank and Effluent Fraction Toxicity Tests	2-14
       2.3.9  SPE Fractions: Concentration and Subsequent Toxicity Testing	2-15
       2.3.10 HPLC Separation	2-16
       2.3.11 HPLC Fraction Toxicity Tests	2-16
       2.3.12 HPLC Fractions: Concentration and Subsequent Toxicity Testing ...2-17
    2.4 GC/MS Analyses	2-17
    2.5 Identifying Suspect Toxicants	2-18
       2.5.1  Identifying Organophosphate Pesticides	2-19
       2.5.2  Identifying Surfactants	2-19
    2.6 Alternate Fractionation Procedures	2-21
       2.6.1  Modified Elution Method	2-21
       2.6.2  Solvent Exchange,	2-21
       2.6.3  Alternative SPE Sorbents and Techniques	2-22

-------
                         Contents (continued)
3.0 Ammonia	3-1
    3.1 General Overview	3-1
    3.2 Toxicity Testing Concerns	3-2
    3.3 Measuring Ammonia Concentration	3-5
    3.4 Graduated pH Test	3-5
       3.4.1  pH Control: Acid/Base Adjustments	3-5
       3.4.2  pH Control: CO Adjustments	3-6
       3.4.3  pH Control: Buffer pH Adjustments	3-7
    3.5 Zeolite Resin Method	3-8
    3.6 Air-Stripping of Ammonia	3-9

4.0 Metals	4-1
    4.1 General Overview	4-1
    4.2 Analysis of Metals	4-2
       4.2.1  Prioritizing Metals for Analysis	4-2
       4.2.2  Metal Analysis Methods	4-2
       4.2.3  Metal Speciation	4-4
       4.2.4  Identification of Suspect Metal Toxicants	4-4
    4.3 Additional Toxicity Testing Methods	4-5
       4.3.1  EDTA Addition Test	4-5
       4.3.2  Sodium Thiosulfate Addition Test	4-6
       4.3.3  Metal Toxicity Changes with pH	4-6
       4.3.4  Ion-Exchange Test	4-7

5.0 Chlorine	,	5-1
    5.1 General Overview	5-1
    5.2Tracking Toxicity and TRC Levels	 5-1

6.0 Identifying Toxicants Removed by Filtration	6-1
    6.1 General Overview	6-1
    6.2 Filter Extraction	6-1

7.0 References	7-1

8.0 Appendix A	A-1
                                   VI

-------
                                   Tables

Number                                                                   Page
 2-1.   Solid phase extraction (SPE) column fractionation information	2-4
 2-2.   Comparison of toxic units (TUs) in each toxic fraction to TUs of all
          fractions combined and whole effluent	2-7
 2-3.   Information for concentrating SPE and HPLC fractions	2-8
 2-4.   Example HPLC elution gradients for four commonly toxic SPE fractions	2-9
 2-5.   Eluate volumes needed for chronic SPE fraction toxicity tests with
          Ceriodaphnia dubia and Pimephales promelas	2-12
 2-6.   Approximate effluent volumes needed for the chronic non-polar organic
          identification procedures	2-12
 2-7.   Example HPLC elution gradient for SPE fractions from chronically toxic
          effluent samples	'.	2-16
 2-8.   Composition of 11 recommended fractions in modified elution scheme	2-21
 3-1.   Percent un-ionized ammonia in aqueous solutions for selected
          temperatures and pH values	3-2
 3-2.   Calculated un-ionized ammonia LCSOs (mg/l) based on 24-h and
          48-h results of a Ceriodaphnia dubia  toxicity test conducted
          at pH 8.0 and 25°C	3-3
 3-3.   Calculated un-ionized ammonia LCSOs (mg/l) based on 24-h, 48-h,
          72-h, and 96-h results of a fathead minnow (Pimephales promelas)
          toxicity test conducted at pH 8.0 and 25°C	3-4
 3-4.   Un-ionized ammonia toxicity values for species frequently used in
          effluent testing	3-4
 3-5.   Percent un-ionized ammonia in aqueous solutions at 25°C and various
          IDS levels	3-7
 4-1.   Atomic absorption detection limits and concentration ranges	4-3
 4-2.   Estimated instrumental detection limits for ICP-MS and ICP-AES	4-3
 4-3.   Metal LCSOs with respect to test pH	4-6
 A-1.  Effluent volume calculation worksheets	A-2
 A-2,  Effluent volume calculation worksheets (example)	A-6
                                       vii

-------
                                   Figures

Number                                                                    Page
  2-1.  Phase II schematic for the identification of non-polar organic toxicants	2-1
  2-2.  Procedures for eluting the SPE column with a gradient of methanoI/water
       solutions	.....:	2-5
  2-3.  Concentrating effluent on the C18 SPE column	'.	2-5
  2-4.  Procedure to concentrate toxic SPE fractions	2-8
  2-5.  Procedure to fractionate acutely toxic SPE concentrates using HPLC	2-9
  2-6.  Procedure to concentrate toxic HPLC fractions	2-10
                                      VIII

-------
                          Abbreviations


AA       Atomic Absorption
C18       Octadecylcarbon Chain
C8        Octylcarbon Chain
CTAS     Cobalt Thiocyanate Active Substances
DO       Dissolved Oxygen
DOC      Dissolved Organic Carbon
EDTA     Ethylenediamine Tetraacetic Acid
ERL-D    Environmental Research Laboratory-Duluth
GC       Gas Chromatography
GC/MS    Gas Chromatography/Mass Spectrometry
Heppso   N-(2-Hydroxyethyl) Piperazine-N'-2-Hydroxypropane Sulfonic Acid
HPLC     High Performance Liquid Chromatography
ICp       Inhibition Concentration Percentage
ICP-AES  Inductively Coupled Plasma-Atomic Emission Spectroscopy
ICP-MS   Inductively Coupled Plasma-Mass Spectrometry
Kow       Octanol-Water Partition Coefficient
LAS      Linear Alkylbenzene Sulfonate
LC/MS    Liquid Chromatography/Mass Spectrometry
LC        Lethal Concentration
MBAS     Methylene Blue Active Substances
Mes      2-(N-Morpholino) Ethane-Sulfonic Acid
Mops      3-(N-Morpholino) Propane-Sulfonic Acid
NETAC    National Effluent Toxicity Assessment Center
NIST      National Institute of Standards and Technology
NOEC     No Observed Effect Concentration
NPDES    National Pollutant Discharge Elimination System
PBO      Piperonyl Butoxide
Popso     Piperazine-N,N'-bis (2-Hydroxypropane) Sulfonic Acid
QA/QC    Quality Assurance/Quality Control
SPE      Solid Phase Extraction
SS        Suspended Solids
Taps      N-tris-(Hydroxymethyl) Methyl-3-Aminopropane Sulfonic Acid
TDS      Total Dissolved Solids
TIE       Toxicity Identification Evaluation
TOC      Total Organic Carbon
TRE      Toxicity Reduction Evaluation
TU        Toxic Unit
YCT      Yeast-CerophyP-Trout food
                                    ix

-------
                        Acknowledgments
       This document presents additional methods and improvements made to the
procedures of Methods for Aquatic Toxicity Identification Evaluations:  Phase II
Toxicity Identification Procedures (EPA-600/3-88/035) by Donald Mount and Linda
Anderson-Carnahan. This manual reflects new information, techniques, and test
procedures developed by theNational Effluent Toxicity Assessment Center(NETAC)
since the previous Phase II document was printed in 1989. This Phase II document
is based on the efforts of both federal and contract staff of the NETAC group. We
gratefully acknowledge the following individuals' contributions to the research and
development of the methods for this document:  Penny Juenemann and Sharieen
Schm'rtt (federal staff); Joe Amato, Lara Andersen, Steve Baker, Tim Dawson, Joe
Dierkes, Nola Englehorn, Doug Jensen, Correne Jenson, Jim Jenson, Liz Makynen,
Phil Monson, Don Mount, and Greg Peterson (contract staff).

       Through the support of Rick Brandes and Jim Pendergast (EPA, Permits
Division) and Nelson Thomas (ERL-D), the NETAC staff members developed and
revised the TIE series of documents.

-------
                                             Section 1
                                           Introduction
1.1    General Overview

       The major objective of Phase II is to identify the
suspected toxicant(s) in effluent samples using toxicity
identification evaluation (TIE) procedures. Some general
guidance to achieve this goal might be furnished by the
results of acute or chronic Phase I tests (EPA, 1991 A;
EPA,  1992), but for many effluents,  such as those that
contain non-polar organic toxicants, both  separation and
concentration steps will be needed to achieve the stated
objective.  If metals are the suspect toxicants, atomic
absorption (AA) spectrometry should be sensitive enough
to  measure toxic concentrations directly  in the sample,
and the number of metals is small enough that toxicity
can be attributed without separating one from another.
The same principle applies to toxicants such as ammonia
and chlorine; measurements can be made without sepa-
rating or concentrating the effluent. However, if non-polar
organic chemicals  are suspected, separation  is usually
necessary for analytical and toxicological reasons.

       Because there are often many constituents within
the classes of chemicals (e.g., non-polar organics) iden-
tified  in Phase I,  initial  efforts are  most productively
directed towards separating the toxic from the non-toxic
constituents.  With  the  need to identify  the  toxicant(s)
quickly, comes the temptation to analyze too soon. Using
methods such as gas chromatography/mass spectrom-
etry (GC/MS) one can identify many non-polar organics
that are present in the whole  effluent mixture, but the
association of toxicity  with  compound identification  is
very difficult to make for several reasons:

      • There can be hundreds of compounds present in
       the mixture, and to investigate all of them would
       be very time consuming.

      • Toxicity data for many of the chemicals identified
       are usually not available; chronic data are espe-
       cially scarce.

      • Separate constituents are often not commer-
       cially available; therefore, their toxicities cannot
       be measured and compared to effluent toxicity.
      • Interactions (additivity, synergism, antagonism)
       are not known for the given mixtures and one
       must know interactions to apportion toxicity.

       Therefore, it is suggested that the search for a
separation technique to simplify the mixture into toxic and
non-toxic subsamples  be the first priority,  rather than
spending time investigating non-toxic components. If there
is a single suspect toxicant such as ammonia, then sepa-
ration needs are limited largely by the analytical  require-
ments. If the toxicity is caused by one constituent, the
number of other non-toxic constituents is irrelevant when
attributing toxicity. However, Phase I results do not usu-
ally lead to a  single suspect toxicant and, therefore,
separation may be necessary.

       When a method for separating the toxicant(s) is
found, concentration might be an inherent part of the
procedure (as in solvent extraction) which will simplify the
problem of finding a method to concentrate the toxicity. At
each stage of the separation and concentration process,
measurement of toxicity is the best way to evaluate the
success or failure of the manipulations.

       The interpretation of TIE results can be different
than in the classical research approach,  where experi-
ments are designed to either accept or reject a hypoth-
esis.  In  TIE  work, an experiment usually  permits
acceptance but not rejection of the hypothesis. For ex-
ample, if ammonia is  the suspect toxicant,  it  can be
removed using zeolite resin. If the post-zeolite effluent is
still toxic, you  can conclude that there  are additional
toxicants present. If the post-zeolite effluent is not toxic,
you cannot conclude that there are no additional toxicants
because the zeolite might have removed other toxicants
in addition to the ammonia.

       The always present question of whether or not
there is more than  one toxicant immensely complicates
data  interpretation. Phase I  results might  not  give an
indication of multiple toxicants unless the toxicant classes
change over time or from sample to sample. Phase  II
results are often  such that one cannot tell  whether the
situation is one of partial removal of a single toxicant or
                                                     1-1

-------
 toxlctty resulting from multiple toxicants. The issue might
 be resolved when one toxicant is identified and measured
 analytically. Experience shows that the best choice is to
 try to focus on the toxicant that appears easiest to iden-
 tify. Usually that will be a toxicant that can be separated
 from  the  sample (e.g., extracted  or recovered  from a
 sorbent that reduces the toxicity) and for which there is a
 broad spectrum analytical identification method. Above
 all, data should always be interpreted under all probable
 scenarios, i.e., one toxicant, multiple toxicants, and even
 different toxicants from sample to sample.

        Experience gained since the  first Phase II (EPA,
 1989A) document was printed has shown that effluent
 toxicants are not always strictly additive. When they are
 not additive, the toxicant present in the largest number of
 toxic  units (TUs)1 will determine  the toxic units of the
 effluent. Non-additive toxicity will not  be reduced  by ma-
 nipulations that remove toxicants present in fewer TUs
 than the major toxicant. Two or more toxicants might be
 present In approximately equal TUs, however, the ratio of
 TUs might change over different sampling times  so that
 different chemicals determine the toxicity of the effluent.
 These important problems can be dealt with in Phase III
 (EPA, 1993A). In Phase II, the objective is to find which
 toxicants are present in toxic concentrations. However,
 failure of addttivity may confuse Phase  II results. Minor
 toxicants might not be noticed  until the  major one has
 been removed. In addition, additivity cannot be deter-
 mined until at least one toxicant has  been identified.
 Usually Phase II and Phase III merge and overlap, there-
 fore such  concerns regarding non-additivity  must be  in-
 corporated in Phase II, at least in the latter stages.

        As effluent constituents are identified, a  sorting
 process begins in which a decision must be made as to
 whether or not each one  identified  contributes to  the
 toxicity of  the  effluent. Usually, this is based on  the
 estimated concentration and the constituents' toxicities.
 Analytical  error in quantttation might be large (10-fold or
 more) because recoveries and instrument response fac-
 tors probably will not yet have been determined on a
 particular chemical. Uncertainty about toxicological data
 Is caused  by differences in species sensitivity and water
 quality effects, when literature values  are available. Con-
 fidence in an acute toxicity value (LC50) will vary depend-
 ing on the quality of the test, the number of times it was
 repeated, and the completeness by which the results and
 conditions were described. Data on chronic effect levels
 are often scarce and rarely have  tests  been repeated.
 Species sensitivity frequently varies from 100-fold to 1,000-
fold; an error will likely be introduced when the published
TU calculations are described in EPA, 1992. The TUs of whole
 effluent equals 100% divided by the LC50, NOEC, or ICp (IC25.IC50)
 of the effluent The TU of a specific chemical equals the concentration
 of the compounded divided by the effect level of the compound.
toxicity data for species other than the test species are
used. When the uncertainty of the toxicity data is high, a
maximum of 100-fold difference between measured con-
centrations and literature effect would be acceptable to
classify a chemical as a suspect. If one has good data for
the test species being used, then this difference might be
reduced (e.g.,  to  10-fold). Since  these decisions are
always subjective, they will  sometimes be wrong no mat-
ter how carefully they are made. Perhaps most important
is use of an iterative process to make these decisions.
First evaluate candidates that have concentrations higher
than or closest to their chronic or acute effect levels and if
these prove to be negative, then examine those that have
concentrations  below their effect levels. Remember that
the suspected toxicant concentrations at the dilution equal
to the effect level concentration are the important concen-
trations to compare. At some point, a decision must be
made whether the true toxicants have not yet been iden-
tified or measured  and that different sample preparation
or analyses must be used.

        For some  effluents,  Phase I  results  might not
have provided any guidance for selecting the appropriate
Phase II procedures to  follow. Other characterization
steps that might be helpful  are solvent extraction (acidic
or basic), sample evaporation, size exclusion chromatog-
raphy, lyophilization, and vacuum or steam  distillation
(Jop et al., 1991;  Walsh et  al., 1983). We  have little
experience upon which to recommend procedures in
these cases. It  is most important to realize that the more
severe the effluent treatment, the  more likely it is that
toxic artifacts will be created.  These toxic artifacts could
then be confused with effluent toxicity; therefore,  artifac-
tual toxicity must be monitored for each technique by
using blanks.

        Phase  II efforts should  develop  into Phase III
confirmation (EPA, 1989B; EPA, 1993A) as soon as good
evidence is obtained that one or more  candidates are
probable toxicants. The primary product of Phase II is the
chemical identification of the  suspected toxicants to fur-
nish the  basis for Phase III testing. The techniques de-
scribed in this  document are useful for TIE  work with
effluents as well as  ambient waters (Norberg-King et al.,
1991) and sediment pore water or elutriates (EPA, 1991B).

1.2     Biological Testing  Considerations

       The Phase  I characterization documents (EPA,
1991 A; EPA, 1992) provide detailed discussions of vari-
ous issues that  are important in decision making through-
out the TIE. The guidance covers use of various species,
test concentrations,  effluent  sample types,  testing re-
quirements for  quality  assurance (QA),  test endpoints,
frequency of changing the test solutions, and more. All of
these issues will not be discussed at length here and the
user is encouraged to refer to the acute Phase I or the
chronic Phase  I as companion documents for the TIE
process. As the Phase II  identification and  Phase  III
confirmation steps are initiated, QA requirements  should
                                                    1-2

-------
be revisited and the types of tests modified as needed.
Several of these testing concerns are addressed below.

        During  Phase I, the analyst is searching for an
obvious alteration in  effluent toxicity, which  might be
obtained by using modified acute or chronic test methods.
Confirmation testing (Phase III) conducted according to
the standard methodologies will confirm whether the sus-
pect toxicant(s) detected in the characterization and iden-
tification steps (Phases I and II) is the true toxicant.

        In characterizing the toxicity in Phase I, factors
such as time requirements, number of tests and the test
design had to  be considered and weighed against the
type of questions that are  posed. EPA has  published
manuals that describe the acute or chronic test methods
to determine the toxicity of effluent or receiving waters to
freshwater and marine organisms  (EPA, 1991C;  EPA,
1993B; EPA, 1993C), and these tests are typically those
that  indicated  the  presence of toxicity  which the TIE
initiated. Deviations from these standard effluent testing
protocols were  discussed in both the acute Phase I (EPA,
1991 A) and the chronic Phase I (EPA, 1992) manuals.
For either the acute or the chronic Phase  I procedures,
the test volumes, number  of test concentrations, and
number of replicates were ail reduced from the standard
test methods (EPA, 1991C; EPA, 1993B). Additional modi-
fications for the short-term  chronic tests (EPA, 1993B)
including  shorter test  duration and a reduction  in the
frequency of the test solution renewal are suggested.

        Throughout this document the TIE procedures for
acutely toxic samples are based on the following species:
Ceriodaphnia dubia,  Pimephales promelas,  Daphnia magna,
Daphniapulex, Hyalella azteca, and Chironomus tentans. Al-
most all acute tests have been conducted using 10 ml of test
solution in a 1 oz plastic cup (or 30  ml  glass beaker). TIE
procedures with chronically toxic effluents  are based on
tests using either C. dubia or larval fathead  minnows
(P. promelas).  In our laboratory, the chronic tests with C.
dubia generally are conducted using 10 ml of test solution
in 1 oz cups and the chronic tests with fathead minnows
are conducted  using 50 ml of test solution in a 4 oz plastic
cup (10 fish per cup). Use of other species is constrained
only  by availability, size, age, and adaptability to test
conditions, and the threshold levels for additives and
reagents for the other organisms must be determined.

        As soon as good evidence is obtained to impli-
cate a suspect toxicant(s), the procedures for performing
the toxicity tests can be changed.  Therefore in Phase II,
the time  to  modify the -tests from the  way they  were
conducted in Phase I may depend on when the toxicant is
identified,  and  generally there is more flexibility for this in
 Phase II than in  Phase 111. The  quality control  (QC)
measures in Phase I were not very strict because the data
are primarily informative rather than definitive. The iden-
tity of the suspect toxicant(s) furnishes the basis  upon
which  Phase  III testing  will be conducted,  which will
require stricter QC measures.

        Initially, the use of modified protocols in Phase II
may continue; however, once specific toxicant(s) identifica-
tion has been  made,  Phase II  (and Phase  III) testing
conditions should be similar to the methods described in
the protocol that was used to trigger the TIE.  Although a
shortened version of the 7-d C. dubia test (which is referred to
as the 4-d test) may have been used in Phase I, the use of this
test changes in Phase II (and Phase 111). In order to use the 4-d
test in Phases I and II of the TIE, the 4-d test must detect similar
trends of toxicity as the 7-d test does. However, in Phase 111 the
7-d test is required because the toxicity as measured in the 7-d
test (with additional replicates, more test concentrations, addi-
tional volume) was used to detect toxicity for the  permit, and
should be used to confirm the cause of toxicity.  In the early
Phase II chronic toxicity evaluation steps, the qualitative evalu-
ation of toxicity  might be  useful and there is no reason why a
toxicity test could not be terminated sooner than day seven, if
the answer to  a particular question has been found.

        Information obtained from all toxicity tests should
be maximized. For instance, in acute toxicity tests, moni-
toring time to mortality  might be useful. In chronic toxicity
tests, time to young production of the cladocerans or the
lack of food in the stomach of the larval fish might be
useful parameters. Observations such as these made
during a test might be  subtle indications and  quite infor-
mative of small changes in toxicity. For example, if there
is complete mortality on day four of the baseline effluent
test, and in the EDTA addition test (Section 4) the animals
either do not reproduce or grow yet they are alive at day
seven of the exposure, the indication is that  the toxicity
was reduced.  These results suggest that either an addi-
tional toxicant is present or the EDTA concentration was
not sufficient to remove all cationic metal toxicity. These
types of observations in the short-term tests might be just
as useful as reductions in young production or growth.
For evaluating whether any manipulation changed toxic-
ity, the  investigator should not rely only on statistical
evaluations of test endpoints (see below and  Phase I;
EPA,  1992). Some  treatments may have a significant
biological effect that was not detected by the statistical
analysis. Judgement and experience in toxicology should
guide the interpretation.

        In addition,  for  acute  or chronic toxicity tests,
randomization, careful exposure time readings, use of
animals of uniform  narrow-age  groups (i.e.,  C.  dubia
neonates 0-6  h old rather than 0-12 h old) might assist in
detecting smaller differences in tests. For example, in the
chronic C. dubia tests, it is important to use organisms of
known parentage (EPA, 1993B) when the  number of.
replicates  is reduced from ten to five. For C.  dubia, daily
renewals of the test media  (as required  in  the chronic
 manual; EPA,  1993B)  might not be necessary in Phase I
or early Phase H testing as long as the toxicity of the
                                                      1-3

-------
 effluent can be  measured  with one or two renewals.
 However in Phase III, tests must be conducted with daily
 renewal of test solutions similarto the routine biomonitoring


        Although reference toxicant tests are not recom-
 mended for each set of Phase I manipulations, when a
 toxicant has been identified in Phase II and some Phase III
 confirmation tests indicate it is the toxicant, that chemical
 should become the reference toxicant with the species
 used In the TIE. In Phase II, the reference toxicant data
 are useful for identification  interpretation and provide
 Information on the quality  of the  test  organisms and
 general test procedures. Reference toxicant tests should
 be conducted  routinely and control charts  should  be
 generated (EPA,  1991C; EPA, 1993B). If a toxicant has
 not been identified, standard reference toxicants should
 be used, but as soon as a toxicant is  identified, that
 compound should be  used as the reference toxicant for
 the TIE tests.

        The Phase I procedures frequently rely only on
 one test species, but  in Phase III of the TIE the use of
 more than one species is recommended. This will be
 useful In determining whether or not the cause of toxicity
 Is the same for other species of the aquatic community. In
 Phase I, we recommended that the  species that detected
 the toxicity be the first choice as the TIE species.  If an
 alternative species is chosen one must prove in Phases II
 and ill that the species that initially detected the toxicity is
 being  impacted by the same toxicant as the alternate
 species. Both species  need not have the same sensitivity
 to the toxlcant(s), but each species' threshold must be at
 or  below the toxicant concentration(s)  present in the
 effluent. One method of proving that the two species are
 being affected by the same compound(s) is to test several
 samples of the effluent over time with both species. If the
 effluent possesses sufficient variability, and the two spe-
 cies LCSOs or IC25s change in proportion one to another
 as would be expected, the analyst may assume that the
 organisms are reacting to changing  concentrations of the
 same compound. Further proof that the two species are
 responding to the same toxicant should surface during
 Phases II and/or III. If the toxicant  is the same for both
 species, then characterization manipulations  that  alter
toxfcfty to one  species should also alter toxicity to the
second species. The extent to which toxicity is altered for
 each will depend upon the efficiency of the manipulation
to remove toxicity and the organism's sensitivity to the
toxicant. Approaches used in Phase III will confirm whether
the two species are indeed sensitive to the same toxicant
In the effluent. If in Phase III, the organism of choice  is not
responding to the same toxicant  as the species that
triggered the TIE, extensive time and resources might
have been wasted.

       The type of sample to use in the Phase II identifi-
cation stage most often will be similar to those used in
Phase I. The use of multiple (daily samples for acute and
chronic tests  or the minimum of three for chronic tests)
 effluent samples for each chronic test should nor be used
 in the early stages of Phase II (EPA, 1992). The use of
 one grab or composite sample for the Phase II identifica-
 tion procedures is needed until some suspects have been
 identified. For  instance, if several  effluent samples  are
 used for renewals during the chronic Phase I  and/or
 Phase II TIE and the toxicants are different or change in
 their ratios one to another, interpreting the results will be
 difficult.  Indeed, such variability must be identified but it
 should be done after at least one, or preferably most of
 the toxicants are known. The use of one sample is even
 more important in Phase III, (EPA, 1993A) where toxicity
 data are correlated to the measured concentrations in the
 effluent.  If multiple samples are used for one toxicity test,
 this correlation cannot be readily done because the same
 toxicant  may not be present in each sample, it might be
 present in varying concentrations, or other toxicants may
 appear. For the acute TIE, one composite or grab sample
 has  been used for identification and confirmation steps.
 However, since the permit test may require daily samples
 for an acute static renewal or 7-d short-term tests, once
 the toxicant is identified each daily  sample may have to
 be analyzed for that toxicant.

       Sample degradation is a concern that should be
 addressed. The toxicity of the whole  effluent can  be
 monitored by conducting toxicity tests upon sample  ar-
 rival and at periodic intervals throughout the TIE. For
 some types of toxicants degradation or loss  might  be
 expected (i.e., chlorine, see Section 5) but for toxicants
 such as non-polar organic compounds,  this may  not
 readily be known. Since the toxicant identification stage
 might be lengthy, it is important to know that the toxicity
 remains  in the effluent even  at a  lower concentration.
 When a toxicant is identified, further analyses and toxicity
 tests can be conducted on effluent samples and any
 toxicant degradation or loss evaluated.

       As discussed in the Phase I manuals (EPA, 1991 A;
 EPA, 1992) if the level of toxicity for any given effluent has
 been established with  some  degree of certainty from
 previous  tests, it might be adequate to use four effluent
 dilutions  and a control  to follow toxicity changes  of the
 sample to reduce the cost of the tests. As the toxicant is
 identified, test concentrations should be selected to de-
 tect small changes in toxicity. We are assuming  that if
 effluents  have inhibition concentration percentage (ICp)
 (or  no observed  effect concentration (NOEC)) values
 below 10%, the effluent is likely to show acute toxicity and
 if so, an acute TIE approach can be used. If chronic TIE
 work is to be done on  a highly toxic effluent, the same
 recommendations given in the chronic Phase  I manual
 should be followed; that is, use concentrations of 4x, 2x,
 1x and 0.5x the IC25 or IC50 value. For example, if the
 IC25  is 5% effluent, we would  suggest using a test
 concentration range such as 20%,  10%, 5% and 2.5%
 effluent for the  various tests. With chronic toxicity data
where the NOEC is 12% (or the IC25 is 10%), a concen-
tration series such as 6.3%, 12.5%, 25%, and 50% would
 be logical. If closer concentration intervals are desired,
                                                   1-4

-------
using 20% effluent as the high concentration and a dilu-
tion factor of 0.7, the concentrations to test would be 7%,
10%, 14%, and 20%. If the NOEC (from historical data) is
40-50% (or above 50%), then the concentration series to
test might be either 25%, 50%, 75%, and 100% or 40%,
60%, 80%, and 100%. Choice of dilution factor and test
concentration  range  is a matter of judgement and de-
pends on precision required and practicality.

        After conducting Phase I procedures on an efflu-
ent sample, the  amount of  effluent available for subse-
quent identification work can be sufficiently reduced so
that  it may be impractical to try to conduct each step as
described in this manual. This is most likely to be a
concern for the non-polar organic identification techniques
and  other methods that require large volumes of effluent
to identify the toxicant. Therefore, when the volume of an
effluent sample  is limited, it might be possible to track
toxicity through the non-polar identification  steps without
quantifying the amount of toxicity that is being tracked.
Essentially, this  means  that the toxicity tests are done
without dilutions  and the results would indicate only that
toxicity  was present or absent; the  degree of toxicity
present would not be measured. Once a suspect toxicant
is identified,  it is important that the  amount of toxicity
removal is known (through the use of dilutions) because
this  information can be used to correlate a suspect toxi-
cant to the effluent toxicity in the Phase III confirmation.

        If the number of replicates per test  concentration
is reduced, one must assume that precision is sufficient to
decipher changes in toxicity that must be measured. One
problem in using reduced replicates and low numbers of
test  concentrations in chronic tests is that this smaller
data.set is not amenable to  all statistical requirements as
recommended for the short-term tests (EPA, 1989C; see
Section 5.8). Use of more organisms and more replicates
than in the Phase I modified tests might be preferable if
Phase  I and/or  Phase  II data are likely to  be used in
Phase III confirmation (See Sections 2.2 and 2.3).

        For acute toxicity tests, usually the LC50 or EC50
is reported  for the toxicity data (calculated as  recom-
mended in EPA, 1991C). Endpoints for the most com-
monly used freshwater short-term chronic tests are growth,
reproduction, and survival. The no effect level (the NOEC),
and the effect concentration (the lowest observed effect
concentration (LOEC)) are determined using the statisti-
cal approach of hypothesis testing to determine a statisti-
cally significant response  difference between a control
group and a treatment group. The NOEC/LOEC are heavily
affected by choice of test concentrations and test design
(see Phase I; EPA, 1992). The linear interpolation method
(EPA,  1993B)  provides a  point estimate of the effluent
concentration that causes a given percent reduction based
on organism response. To calculate the inhibition concen-
tration percentage (ICp), a computer program (Norberg-
King,  1993; DeGraeve  et al.,  1988; EPA,  1989C)  is
available and the assumptions for the method are not the
same as the test design  requirements for hypothesis-
based analyses. This point estimation method is particu-
larly useful for analyzing the type  of data obtained from
chronic TIE tests using  dilutions  (see Phase  I;  EPA,
1992). Confidence intervals are calculated using a boot-
strap  technique  and might be  useful in  determining if
significant toxicity  alterations  have been observed.  A
significant reduction in toxicity and the precision of refer-
ence toxicant tests must be determined by each labora-
tory for each effluent. The use of the IC50 for Phase I
TIEs might be more useful in correlating the characteriza-
tion test results to  the effluent toxicity than an  IC25.
However, there are situations when an IC50 may not be
able to be estimated while the IC25 can.  Above all, it is
most  important to use a consistent effect level for TIE
toxicity testing (EPA, 1992A; EPA, 1992B). When sub-
stantial toxicity reductions occur in the toxicity tests, it
may not always appear to be a significant reduction when
the IC25s  are  compared. In order to further  evaluate
whether toxicity reductions  occurred, the sample size
(number of replicates, number of concentrations) should
be increased in subsequent testing in an effort to differen-
tiate toxicity responses from the sample size limitations.
The dose response curves should then be compared to
see if responses are similar. Once the toxicant is identi-
fied, the number of replicates should be  increased, the
dilution sequence might be modified  and more dilutions
used  (see Phase III; EPA, 1993A). This should increase
the confidence in the IC25 (or any other ICp value cho-
sen) estimate.
                                                     1-5

-------

-------
                                             Section 2
                                 Non-Polar Organic Compounds
2.1    General Overview
       The procedures described in this section pre-
sume that the results of Phase I tests have implicated
non-polar organic compounds as  the cause of acute or
chronic toxicity.  Results of Phase  I tests that  clearly
implicate a non-polar organic toxicant typically are (1) all
toxicity is removed by the C18 Solid  Phase Extraction
(SPE) column and (2) toxicity was observed in the  metha-
nol eluatetest (see Section 8.6, EPA, 1991 A; and Section
6.7, EPA, 1992). In some instances, toxicity might not be
removed completely by the SPE column,  but  sufficient
toxicity is recovered in the methanol eluate to suggest a
non-polar organic  toxicant is present. While  toxicants
other than non-polar  organic compounds  might  be  re-
moved by the column (e.g., metals), the elution for such
toxicants is unlikely to be similar to that of the non-polar
organic compounds. However, there is also the possibility
that  non-polar toxicants such as  surfactants will be  re-
moved by the column and not recovered in the  methanol
eluate. The goal in this section is to separate the non-
polar organic toxicants from the many non-toxic compo-
nents of the sample to simplify the analytical work needed
to identify the toxicant.

        This section  provides the general background
information on non-polar organic  compounds along with
methods for concentrating and separating the toxicants
for samples with acute and/or chronic toxicity. While the
method  provides  a  stepwise procedure,  there  are  in-
stances where the investigator may have  to modify the
approach to achieve the best results.

        Also provided in this section are procedures that
might prove helpful in less common situations. Metabolic
blockers can  be  used to reduce or  eliminate  certain
organophosphate compounds from exhibiting their toxic-
ity (Section 2.5.1). In the  instance  when  toxicity is  not
recovered in the methanol eluate and toxicity is  not evi-
dent in the post-column effluent, alternate SPE elution
procedures might be needed (Section 2.6).

        A flow  diagram of the general procedures  fol-
 lowed in identifying non-polar organic toxicants is shown
 in Figure 2-1. In this procedure, the C18 SPE column is
 used to extract  non-polar organic compounds from efflu-
 ent  samples. These compounds are then  selectively
                   Effluent Sample



                         Toxicity Test



                 SPE Fractionation



                         Toxicity Tests


                         r
        Concentrate and Combine Toxic SPE Fractions
                          Toxicity Tests
                          GO/MS Analysis (optional)
                 HPLC Fractionation
                          Toxicity Tests
        Concentrate and Combine Toxic HPLC Fractions
                          Toxicity Tests
                          GO/MS Analysis
                  GC/MS Identification
          Compare Concentrations to Toxicity Values
Figure 2-1.  Phase II schematic for the identification of non-polar
          organic toxicants.
                                                     2-1

-------
 stripped off the column by eluting the C18 sorbent with
 solvent/water mixtures that are increasingly less polar. As
 a  series,  the  "fractions" resulting  from  column elution
 contain analytes that are decreasingly polar and decreas-
 ingly water soluble. Each fraction is then tested for toxic-
 Hy. The fractions that exhibit toxicity are concentrated,
 and chromatographed using reversed phase High Perfor-
 mance Liquid Chromatography  (HPLC). The resulting
 HPLC fractions are collected and tested for toxicity. The
 toxic HPLC fractions are concentrated into methanol by
 using another CJ8 SPE column. The concentrates are
 toxicity tested as before and analyzed using gas chroma-
 tography/mass spectrometry (GC/MS). Those constitu-
 ents that are Identified by GC/MS are roughly quantitated,
 by assuming that the identified constituents and the inter-
 nal standard have the same response factor, and the
 estimated  concentrations are compared to available tox-
 fcity values for each chemical. If this process reveals
 strong suspect toxicants, mass balance  testing (Phase
 III; EPA, 1993A) could be started to determine whether
 additional toxfcants are present. If no suspect toxicants
 are identified by GC/MS, a longer analysis time on the
 HPLC might  help the  identification by  increasing the
 separation between toxic and non-toxic components, es-
 pecially if  there  are many constituents  present. Also,
 additional constituents might be identified by  increasing
 the concentration factor by using larger effluent samples.
 At  some point, the probability that the toxicants are not
 chromatographing on the gaschromatograph or the mass
 spectrometer is not detecting the toxicants must be con-
 sidered if no suspect toxicants are identified. Use of other
 types of mass spectrometry, such as liquid chromatogra-
 phy/mass spectrometry  (LC/MS)  or direct probe  mass
 spectrometry may be useful. Some effluents might re-
 quire the SPE fractionation of several different samples
 before good suspect toxicants are found (Burkhard et al.,
 1991; Lukasewycz and Durhan, 1992).

        The sorbents that we recommend  for use in SPE
 and HPLC  columns are chemically identical. The column
 packing is composed of silica gel which has been reacted
 with octadecyl silane to produce a covalent bonded phase
 one layer thick. The mechanism of  extraction with  C
 sorbents is relatively simple. Extraction of effluent com-
 pounds occurs because the C1S sorbent competes for the
 non-polar compounds more strongly than the surrounding
 water molecules of the  effluent.  Sorption of  non-polar
 organlcs is  also influenced by ionic strength, pH, and total
 organic carbon (TOC) levels. The same compounds  will
 partition on both SPE and HPLC columns and the order of
 elution of chemicals will be approximately the same. The
 major difference between the SPE and HPLC columns is
the amount of resolution achieved. The particle size em-
ployed In HPLC columns is smaller, providing a greater
surface area and better component resolution. Despite
less resolution, SPE  columns have the  advantage of
possessing  a higher loading capacity  in  general than
HPLC columns. The SPE column could be  considered as
a preparatory column for sample cleanup while the HPLC
column gives far more refined and controlled separation
of sample constituents.
         To elute non-polar organic toxicants extracted by
 the C18 SPE column, the sorbed compounds must have a
 higher affinity for the eluting solvent than for the octadecyl
 functional group (C18). Choosing  a solvent for elution  is
 complicated because the toxicants'  identities are not
 known,  in general, the solvent should be less polar than
 water and more polar than the  C18 functional group. The
 degree of solvent strength required to elute the toxicants
 is also unknown. Since methanol is less polar than water,
 has a very low toxicity (EPA,  1991 A; EPA, 1992) and
 elutes chemicals from CL sorbents, it has been a good
 solvent choice for most TIE purposes to date.

         During sequential column elutions with succes-
 sively increasing methanol in water concentrations, the
 relatively hydrophilic, polar compounds are eluted first,
 and the  more hydrophobic  non-polar compounds  are
 eluted last. Given the strength of methanol as a solvent
 for non-polar compounds, it is possible that very hydro-
 phobic (octanol water partition coefficient (log  K  ) >4)
 effluent  compounds will not be eluted from the c"" sor-
 bent. If toxicity caused by  a very hydrophobic compound
 is extracted by the SPE column but not eluted by metha-
 nol, less polar solvents might be used to elute the SPE
 column (Section 2.6.1).

        Once toxicity is found in  one or  more C18 SPE
 effluent fractions, the toxic fractions can be concentrated,
 then fractionated using HPLC. HPLC separation is used
 to reduce the number of non-polar organic chemicals
 associated with the toxicant(s) and to simplify analytical
 identification. The toxic HPLC fractions are concentrated
 and then analyzed by GC/MS. The estimated concentra-
 tions of constituents in the  final concentrate (based on an
 internal  standard)  are then  compared to their toxicity
 values to decide which may be sufficiently high in concen-
 tration to cause toxicity. If none are found, higher concen-
 tration factors, other analytical  methods  (e.g., LC/MS),
 and better separation are recommended.

        Fractionation and  toxicity testing procedures for
 non-polar organic toxicants causing either acute or chronic
 toxicity are presented in different sections of this chapter.
 The acute toxicity (Section 2.2) and chronic toxicity (Sec-
 tion 2.3)  sections, have similar outlines and were written
 so either section could be  used independently. As a
 result,  some details that apply to both acute and chronic
 toxicity are repeated. After using Section  2.2 or Section
 2.3 the investigator should then follow the identification
 techniques described in Sections 2.4 and  2.5. Additional
 identification techniques are included  in Sections 2.5.1
 and 2.5.2, and alternate fractionation methods are found
 in Section 2.6.


 2.2    Acute Toxicity: Fractionation and
       Toxicity Testing Procedures
       In the initial stages of Phase II, toxicity tests may
 be conducted on C18 SPE effluent fractions  and blank
fractions  to detect the presence of toxicants and not to
 quantify the magnitude of the toxicity in each. As in the
toxicity tests conducted during Phase I, careful measure-
                                                   2-2

-------
ment of test solution water chemistry parameters is not
required, and duplicate exposures are not needed during
initial stages of Phase II. The major purpose of this step is
to assess whether or not acute toxicity is present in the
effluent fractions  and the blank fractions. However, as
suspect toxicants  are identified, quantitative toxicity mea-
surements will be needed to compare with the analytical
measurements. If Phase  II data will be used to correlate
effluent toxicity to toxicant  concentrations  (Phase III),
then more replicates per concentration, randomization of
test concentrations, careful observation of organism ex-
posure times, and organisms of approximately the same
age should  be used (Section 1.2). Also, the amount of
eluate that is collected from the SPE fractionation, SPE
concentration, and the amount of eluate used for testing
and GC/MS  analysis should be measured at all steps.
The volume of eluate must be measured to determine the
actual toxicity concentration  in each step of the proce-
dure. If it is expected that the Phase II data will be needed
later, it is prudent to measure the degree of toxicity in the
eight SPE effluent fractions at the onset of testing. We
rarely see blank fraction toxicity; therefore, there is little
need to evaluate the toxicity of the blank fractions with
dilutions.

2.2.1  Sample Volume
        The volume of effluent  needed depends on its
toxicity,  the toxicity of the chemicals causing  effluent
toxicity, and the sensitivity of the analytical method. Since
only the first of these will usually be known when Phase  II
begins, trial and error will dictate volume size. For acutely
toxic effluents with LC50 values in the range of 25-100%,
2,000 ml have usually been adequate to perform one
complete Phase  II procedure, i.e., C18 SPE and HPLC
fractionations, and GC/MS identification. Examples of the
variables that should be considered when deciding what
volume of effluent to fractionate are provided in Appendix
 A, Tables A-1 and A-2.

 2.2.2   Filtration
         For acute tests, glass fiber filter(s) (1 u.m nominal
 pore size) should be prepared as described in Section 8
 of Phase I (EPA,  1991 A).  Both 45  mm  and 90  mm
 diameter filters have been used routinely, the 90 mm filter
 allows about four times more effluent to be passed over
 the filter than one 45 mm filter. All filters and glassware
 should first be pre-rinsed with pH 3 high purity water (e.g.,
 Milli-Q® Water System, Millipore Co.,  Bedford,  MA) to
 remove  any metal residues followed by  a high purity
 water rinse which is discarded. The filter should then be
 rinsed with 200 ml of dilution water (rather than with high
 purity water) and a sample collected after most of the
 volume has been filtered, to provide  the filter toxicity
 blank. In subsequent steps, a dilution water column blank
 will be  collected after passing the filtered dilution water
 through the SPE column. The same type of dilution water
 should be used for the filter blank as for the column blank
 (Section 2.2.4). Usually, a reconstituted water is used for
 these procedures (EPA, 1991C).
       The volume of effluent that can be passed through
a single filter is sample specific. If more than one filter is
needed (as is often the case) a single filter blank can be
prepared by stacking three to  eight pre-rinsed filters in
one filter holder, followed by a dilution water rinse. The
filters are then separated and used one at a time to filter
the effluent sample.  If samples  are high in suspended
solids additional pre-filtration may be needed. Centrifuga-
tion may also be useful for reducing solids in the sample.
The decision to use a vacuum or a pressure system for
filtering should have been made during the filtration tests
of Phase I. If a volatile chemical is indicated in Phase I,
pressure filtration should be used.

        Filtration equipment should be thoroughly cleaned
before use to  prevent  any toxicity  carry-over or particle
buildup from previous samples. We have found that glass
vacuum filtering  apparatus with stainless steel filter sup-
ports (for samples without  pH adjustments), or plastic
pressure filtering devices are the most useful.  We have
also found that if removable glass frits are used, they can
be rigorously cleaned  with aqua  regia for 20-40  min
followed by rinsing  with copious  amounts of water to
remove residual effluent particles,  since glass frits may
act as a filter. The removable stainless steel filter sup-
ports do not require as rigorous cleaning as fritted glass-
ware, and therefore are a good substitute.

        A portion of the filtered sample must be reserved
for toxicity testing while the rest is used for C18 extraction.
 If the filtration toxicity blank exhibits  slight or complete
toxicity, but the post C18 SPE column effluent is not toxic
 (and effluent toxicity was  unchanged  after filtration), the
 blank toxicity can be ignored since the effluent toxicity
was removed (see Phase I). However, as the  identifica-
tion process continues, the  blank toxicity will have to be
 eliminated, or it could lead to a misidentification of the
 cause of toxicity.

        When effluent samples  are  readily  filtered
 (-2,000 ml for one 90  mm 1 urn filter) it may be possible
 to filter the effluent for the filtration test of Phase I but then
 use unfiltered effluent with the C18 SPE column test and
 the methanol eluate test  (Phase I).  Once it  has been
 demonstrated that filtration does not reduce toxicity, rou-
 tine filtering of these effluents (before passing the effluent
 through the SPE column)  can be eliminated. This will
 reduce the amount of toxicity testing required.


 2.2.3  Column Size
        Various sizes of C18 SPE  columns are available
 ranging from 100 mg to 10,000  mg packing material. We
 routinely have used Baker® 1,000 mg columns for 1,000
 ml of effluent (J.T. Baker Chemical Co,  Phillipsburg, NJ).
 Volumes for a 1,000 mg C18 SPE column are used in the
 following description, since this is the size most often
 used for acutely toxic effluents. Other  available column
 sizes and  the appropriate  volumes to be used  in their
 preparation are listed in Table 2-1. Positive pressure
 pumps (EPA, 1991 A) are convenient for the large volume
                                                      2-3

-------
 effluent samples because flow rate can  be controlled.
 Vacuum  manifolds can be used for drawing the small
 samples  and solvents through  the column.  Whichever
 system is used, it must be made of materials that dilute
 acid and solvents do not destroy, or from which chemicals
 are not leached that are toxic or that interfere with analyti-
 cal measurements. Teflon, glass, and stainless steel are
 all acceptable choices.

 2.2.4  C18 SPE Column Conditioning
        The 1,000 mg C18 SPE columns are conditioned
 by pumping 10 ml of 100% methanol through the column
 at a rate of 5 ml/min. The pumping rate can be increased
 to 40-50 nWmin when using the larger C  SPE columns
 (e.g., 5 g or 10 g). The volumes of conditioning solvent
 recommended for other size columns are shown in Table
 2-1. We most commonly use methanol  as  the condition-
 ing solvent but other water miscible solvents such as
 acetonitrile, ethanol, or isopropanol may be substituted.
 Before the packing goes dry, 10 ml of high purity water
 must be added. As the last of the high purity water is
 passing through the  column, 25 ml of filtered dilution
 water is added. The last 10 ml  of dilution water is col-
 lected for a dilution water column blank. After the dilution
 water has been collected,  pumping is continued until no
 dilution water emerges from the column.

 2.2.5  Elution Blanks
       To generate  elution blanks from  a  1,000 mg
 column, two successive 1.5 ml volumes of 25% methanol/
 water (%v/v) are pumped sequentially through the condi-
 tioned column  and collected in  one analytically clean,
 labeled glass vial to produce a 3 ml sample. This proce-
 dure is repeated with two successive 1.5 ml volumes of
 50%, 75%, 80%, 85%, 90%, 95% and  100% methanol/
water. The column  should be allowed to dry for a few
 seconds between each elution  with the different 3 ml
 volumes of methanoI/water solutions. This will result in
 eight 3 ml SPE fraction blanks (Figure 2-2). The volume of
 methanol solutions used for elution will vary depending on
 column size as shown in Table 2-1.


 2.2.5  Column Loading with Effluent
        The same column is then reconditioned with 10
 ml of 100% methanol and 10 ml of high purity water, as
 described in Section 2.2.4. Without allowing the column to
 dry, 1,000  ml of filtered effluent is pumped through the
 column at a rate of 5 ml/min (Figure 2-3).  The pumping
 rate can be increased to 40-50  ml/min when using the
 larger C18SPE columns (e.g., 5 g or 10 g). Three samples
 (-25 ml) of the post-C18 SPE column effluent are collected
 after 25 ml, 500 ml and 950 ml of the sample has passed
 through the column.  Each post-column aliquot is toxicity
 tested to determine the presence of acute toxicity in the
 post-column effluent. This  information can be used to
 determine whether the toxicant is removed from the efflu-
 ent by the column. As Phase II progresses, the recom-
 mendation is to increase the volume of post-column effluent
 collected to 50-60 ml so that dilutions can be made and
 LC50 values obtained.  Pumping is  continued until no
 effluent emerges from the column.

        The efficiency of the C18 SPE column is deter-
 mined by the extraction efficiency  (i.e., how well the
 column sorbent removes the effluent components), and
 the elution efficiency  (i.e., how well sorbed effluent com-
 pounds are removed from the  column  by the  solvent
 elution). For purposes of the TIE, "efficiency" applies only
to recovery  of those compounds causing  or affecting
 effluent toxicity. Since most acute effluent tests do not
 require large volumes of post-column effluent, the ques-
tion of extraction efficiency can be determined by measur-
 ing the toxicity of the post-C18 column effluent sample.
The toxicity of each aliquot collected after different vol-
Tablo2-1.  Solid Phase Extraction (SPE) Column Fractionation Information1
C SPE
Sorbent
Amount8 (mg)
100
500
1,000
5,000
10.000
Volume
Conditioning
Solvent (ml)
2
5
10
50
100
High Purity
Water
Volume (ml)
2
5
10
50
100
Maximum
Volume
Effluent (ml)
100
500
1,000
5,000
10,000
Minimum (500x)
Elution
Volume3 (ml)
2x0.1
2x0.5
2x 1.0
2x5.0
2x 10
Suggested (333x)
Elution4
Volume3 (ml)
2x0.15
2 x 0.75
2x1.5
2x7.5
2x15
 'The Information is based on manufacturer's guidance and experimental data from ERL-D.
 *The smaller columns (100, 500. and 1.000 mg sorbent) are available pre-packed from J.T. Baker Chemical Co., the larger columns (5 000 and
  10,000 mg sorbent) are available pre-packed from Analytichem International.                          -a         i -
 'Elution with two successive allquots of the volume listed.
 *Tho 333x concentration factor is most often used for acute work.                                     >
                                                   2-4

-------
                                           C18 SPE Column
                                                 Conduct Toxicity Test on Each Fraction
Figure 2-2. Procedures for eluting the SPE column with a gradient of methanol/water solutions.
                                           Filtered
                                           Effluent
                                                                                Concentration Factor
1X
                                                                      C-| g SPE Column
                                             Test Post C-| g
                                             Effluent
 1X
Figure 2-3. Concentrating effluent on the C]8 SPE column.
                                                                2-5

-------
 umes of effluent have passed through the column can be
 compared. If there is toxicity in these  aliquots, but it is
 independent of the volume of effluent previously passed
 through the column, then the post-column effluent toxicity
 is probably caused by toxicants that are not extracted by
 the column. If toxicity increases as the volume of post-
 column effluent passed  through the column increases,
 the capacity of the column to sorb the toxicants was
 probably exceeded.

        In some post-column effluent, a biological growth
 may  occur during  toxicity testing which may result  in
 artifactual toxicity. Such growth can make it appear as if
 the toxicant is not removed by the column. While this
 growth does not occur in all effluents, when it does occur
 with one post-column effluent sample,  the growth often
 occurs in each subsequent post-column effluent sample
 from the same preparation. The growth may appear to be
 filamentous and  give a milky appearance  in the test
 vessel.  This effect has been linked to methanol stimula-
 tion of bacterial growth. Methanol is present  in the post-
 column samples because a small amount of methanol is
 constantly released from the column during  the sample
 extraction. Effluents from biological treatment plants may
 develop this  characteristic more readily than industrial
 effluents.

        Additional filtering  of  the post-column effluent
 sample through a 0.2 urn filter before testing to remove
 bacteria and eliminate the growth has  been helpful. To
 avoid art'rfactual toxicity as much as possible  in the post-
 column effluent, initiate the tests with  the post-column
 samples on the same day the effluent is extracted even if
 fractions are  not tested  simultaneously.  For those few
 effluents where we have not eliminated this type of arti-
 factual toxicity, holding the post-column effluent is prob-
 lematic in that more time is available for bacteria to cause
 problems in the post-column sample matrix. When post-
 column  artifactual growth is not readily eliminated,  a
 different solvent (e.g., acetonitrile) to condition the col-
 umn (but not for eluting) may be useful in reducing the
 post-column artifactual bacterial growth. This artifactual
 growth has not occurred in the toxicity tests with methanol
 SPE fractions (Section 2.2.8).
2.2.7
C1g SPE Column Elutlon
        Once the effluent sample has been loaded onto
the column, elution  can begin. To  elute a 1,000  mg
column, two  successive 1.5 ml volumes of the 25%
methanol/water mixture are pumped through the column
and collected  in one labelled, analytically clean vial to
make a 3 ml sample. Subsequently, two successive  1.5
ml volumes of each of the 50%, 75%, 80%, 85%, 90%,
95% and 100% methanol/water are pumped through  the
column and collected in separate vials (Figure 2-2). The
next elution volume should be added when no more of the
preceding one is emerging from the column.

        This entire procedure (conditioning through elu-
tion) Is repeated using  a second 1,000 mg C18 SPE
 column for the second 1,000 ml of filtered effluent. The
 dilution water column blank samples should be kept sepa-
 rate. The corresponding fractions from the blank and the
 sample from each 1,000 ml fractionation can be com-
 bined. For example, the 3  ml 100% methanol sample
 fraction from the first column and the 3 ml 100% methanol
 sample fraction from the second column are combined to
 produce a total  of 6 ml.  There will be eight 6 ml blank
 fractions and eight 6 ml effluent fractions.

        The vials containing the methanol/water fractions
 are tested immediately or sealed with perfluorocarbon or
 foil-lined caps and stored under refrigeration. These frac-
 tions represent a "first cut" separation of effluent compo-
 nents. Elution volumes will  vary if columns  of different
 sizes are used or if the particular effluent under study or
 the research question being posed dictates .method modi-
 fication.

 2.2.8   Blank and Effluent Fraction  Toxicity
        Tests
       The next step is to determine the toxicity of the
 blank and effluent fractions. While  the  choice of test
 concentration depends on the toxicity of the effluent in
 most instances, we have used a high test concentration of
 2x or 4x  (the LC50 or 100% effluent) for acutely toxic
 effluents. The methanol content in the fractions limits the
 concentration that can be tested, and at this point  the
 amount of methanol is assumed to be 100% in all  the
 fractions for dilution calculations;  however,  this is  not
 assumed  for add-back tests (described below).  Usually
 120  u.l of each blank and sample fraction (333x) is in-
 jected into separate 10 ml aliquots of dilution water to test
 at 4x the 100% effluent2. This will give a 1.2% methanol
 concentration which is below the methanol LC50 for both
 C. dubia  and fathead minnows  in the 100% methanol
 fraction. The resulting methanol concentration must be
 adjusted  for the  species tested (see  Section 8 of EPA,
 1991 A). During the initial stages, five  animals in each 10
 ml aliquot are used without duplicates. Using the above
 volumes, the tested solution is more concentrated (i.e., 4x) than
 100% effluent, assuming 100% extraction and 100% elution
 in one fraction.  These test solutions can be diluted to
 provide an LC50 for each sample fraction. Blank fractions
 need not be diluted, since hopefully they are nontoxic.

       Individual chemicals in the fractions could  be
toxic even when  they are not toxic in  the whole effluent,
since the concentration  tested  may  be  as high as 4x
whole effluent. Therefore, to be toxic at  whole  effluent
concentrations, an individual fraction must have an LC50
of 25% or less. Since there is no way to know whether the
toxicant(s) eluted over more than one fraction or what the
percent extraction and elution efficiency are, fraction tox-
                                               2ln the Phase II document published in 1989, testing at 5x was
                                                recommended, the methanol level was 1.5% at this concentration. In
                                                order to lower the methanol level, this was changed to 4x in this
                                                document.
                                                    2-6

-------
icily up to 100% (4x whole effluent) should not be disre-
garded.

       If toxicity occurs in any of the fraction blank tests
and it is small relative to the toxicity in the corresponding
sample-fraction  (e.g., 20%  mortality versus  80%), the
sample fraction  results  should not be dismissed. If all
organisms die in the blanks and the effluent fractions,
dilutions should be tested to make  sure the sample frac-
tion is substantially more toxic than the blank. In general,
blanks should not have measurable toxicity.

       If the SPE fractions are toxic at effluent concen-
trations of 1x or 2x and toxicity is reduced in  two of the
three post-column effluent  samples, the toxicant could
still be a non-polar  organic compound. If the effluent
fractions are not toxic individually  and the post-column
samples  are non-toxic, it is possible that the toxicity has
been spread across several fractions or has not been
recovered from the column. Combining and concentrating
fractions may be useful  or other elution procedures may
be necessary. If toxicity is observed in the fractions at 1x,
2x, or 4x and  in the post-column effluent samples,  it is
possible  that not all  the toxicity is  caused by non-polar
compounds, that break-through of the toxicant has oc-
curred, or that the toxicity is artifactual.

       In addition to concentrating  column artifacts to
toxic  levels, effluent constituents  present at nonlethal
levels may be concentrated to  toxic  levels in this test if
they have a relatively high recovery value. Actual effluent
toxicants with poor recovery  may not  be present in these
test solutions  at toxic  levels.  Spurious  results  of  this
nature will be identified in the later stages of Phase II and/
or in Phase III.

       Elution efficiency may be approximated by sum-
ming the amount of toxicity (i.e., TUs)  in the toxic fractions
(provided dilutions are tested) and comparing this value
to whole effluent toxicity expressed as TUs. When sum-
ming acute toxicity, it is important that all values are for
comparable endpoints (i.e., LCSOs). Adding of TUs may
be somewhat imprecise for several reasons. A single
toxicant may occur in more than one  adjacent fraction, in
which case a small amount of the toxicant in one fraction
may not be detectable  because it is present below the
effect concentration.  For acute toxicity, this problem may
be solved by combining  a portion of each effluent fraction
(and separately testing the corresponding blank fractions)
and measuring  total toxicity at 1x. If  more  than  one
toxicant is present, the effluent fraction toxicity may not be
strictly additive in their toxicities, and when separated into
different fractions the sum of the fraction toxicities may be
low even if extraction and elution efficiencies were 100%.
Table 2-2 illustrates a hypothetical example. The toxicity
test results from the test with a portion of all fractions or a
few of the fractions may  show somewhat greater toxicities
than those of the whole effluent. This may be caused by
enhanced toxicity due to matrix effects. When this occurs,
it may be possible to compensate for toxicity enhance-
ment by methanol,  by adding methanol to  the whole
effluent and evaluating the toxicity. This methanol addi-
tion may in turn stimulate
Table 2-2. Comparison of Toxic Units (TUs) in Each Toxic Fraction to
      i  TUs of All Fractions Combined and Whole Effluent
Toxic Fraction (% Methanol)

         75
         80
         85
        SUM
  Combined Fractions
    Whole Effluent
TUs

0.5

1.2
0.6


,2.3

2.7
2.5
biological growth, and if this happens, the test is negated.
We have rarely used this approach since the fractions
have seldom caused more toxicity than the effluent itself.
At this point in Phase II, the effluent fractions should also
be tested in water with TOG and suspended solids which
mimics the effluerit'to lessen matrix effects on toxicity. As
the identification step moves into Phase III, it is better to
use dilution water that mimics effluent or receiving water
characteristics.

2.2.9   SPE Fractions: Concentration and
        Subsequent Toxicity Testing
        The SPE fractionation provides a general separa-
tion of non-polar  organics  and except in relatively
uncomplicated effluents, GC/MS analysis of the concen-
trates of toxic C18 SPE fractions will result in very compli-
cated chromatograms from which the toxicant(s) cannot
be distinguished from other effluent  components. A sec-
ondary fractionation using HPLC is  often needed to fur-
ther simplify toxic effluent  fractions prior to component
identification by GC/MS analysis.
        In order to maximize the chromatographic sepa-
ration capability of the HPLC, the volume of the sample
injected onto an analytical size HPLC column should be
as small as possible (i.e., <0.5 ml); therefore, the toxic
SPE fractions (usually >1 ml) must be concentrated prior
to injection onto the HPLC column. This concentration
step will provide the added  benefit  of an increase in
concentrations of constituents in the HPLC fractions as
well as rid  the SPE fractions of water. The latter issue is
important if GC/MS analysis will be  performed  on the
concentrated SPE fraction prior to injection on the HPLC
(Durhan et al., 1990).

      , The volume of the  fractions from the initial SPE
fractionation procedure and the number of fractions to be
combined will determine the size of the SPE column to
use for the concentration procedure. Table 2-3 contains
information on the column sizes we  have found to be
most useful. In the procedure outlined below (Figure 2-4),
we have used  a 100 mg column which is the most
commonly  used size for concentrating SPE fractions of
acutely toxic effluents. Most often the toxic effluent SPE
                                                     2-7

-------
 Table 2-3.  Information for Concentrating SPE and HPLC Fractions'
C,,SPE
Sorbont
Amount (mg)
100
200
500
1,000
Volume
Conditioning
Solvent (ml)
1
2
5
10
High Purity
Water
Volume (ml)
1
2
5
10
Maximum
Toxic Fraction
Volume (ml)
20
40
100
200
Maximum
Diluted Fraction
Volume (ml)
100
200
500
1,000
Minimum
Elution
Volume2 (ml)
3x0.1
3x0.2
3x0.5
3x1.0
Approximate
Eluate
Volume (ml)
0.22
0-44
1.10
2.20
 "Concentration information is based on manufacturers guidance and experimental data from ERL-D.
 *EIut!on with three successive aliquots of the volume listed.
                Diluted Toxic Fraction(s)
                       1
            100 mg Ctl SPE Column Sorption
                        I (discard post-C|S
                        T   effluent)

             Dry Ot, Column with Nitrogen
                    (optional)
             Elute Column with three 0.10 ml volumes
                     of 100% Methanol
                       I
              Collect Eluate (Concentrate)



                 Conduct Toxicity Test

Rguro 2-4. Procedure to concentrate toxic SPE fractions.
fractions are combined and diluted with high purity water
and the corresponding blank fractions are treated simi-
larly.  In cases where there are multiple non-polar toxi-
cants, and when toxicity occurs in several fractions, it may
be more useful to concentrate each fraction separately for
subsequent HPLC separation. The percent methanol in
the diluted  fraction  sample  should be <20% and  the
volume to which the fractions can be diluted is dependent
on the amount of column packing. For example, the total
volume of the  diluted fractions should not exceed  100 ml
for the 100 mg C18 SPE column (Table 2-3). No more than
three toxic fractions  of 6 ml each can be combined and
concentrated  on the 100mg column.  When the total
volume of combined fractions or the individual fraction
volume is above 20  ml, larger columns  should be used;
consult Table 2-3 for column size and elution volume
Information. The effluent and blank concentrates and  the
column blank are  tested for toxicity to  ensure that  the
toxicant Is still in  the concentrate and that  artifactual
toxicity was not introduced by the  procedure. If there is
not measurable toxicity in the concentrate, it is possible
that the percentage of methanol in the diluted f ra'ction was
too high. The concentration procedure should then be
repeated with a new set of toxicity tested fractions diluted
to a lower methanol concentration, e.g., 10%.

        Below is an example of how to prepare effluent
and blank fraction concentrates. First, a 100 mg C]8 SPE
column is conditioned with 1 ml of methanol and 1  ml of
high purity water similar to the procedures described in
the SPE Column Conditioning Section (2.2.4). Column
blanks  for toxicity testing  are obtained  by rinsing the
column with at least 20 ml of dilution water. After collect-
ing the column blank,  recondition the column with 1 ml of
methanol and rinse with 1 ml of high  purity water. The
diluted blank fractions (for dilution guidance see Table 2-
3) are then drawn through the 100 rng C18 SPE column
under a pressure of 380 mm Hg using a  vacuum manifold.
Unlike the first fractionation step (Section 2.2.6) the post-
column sample cannot be tested for toxicity because of its
high methanol concentration (i.e.,  10-20%). The column
is then dried for 10 min using a gentle flow of nitrogen (10-
20  ml/sec). Drying the column  usually  increases the re-
covery of toxicity, but sometimes toxicity is not recovered
from the column, possibly as a result of volatilization. If
this occurs the concentration procedure can be repeated
without the nitrogen drying step.

        After drying the sorbent, the luertip of the column
is fitted with a  luer-Iock needle  and  100uJ  of 100%
methanol is  placed into the column using a  microliter
syringe. Nitrogen is then applied to the column at a rate of
~4 ml/sec to force the methanol through the sorbent. The
luer-Iock needle is  needed to  ensure  the collection  of
small volumes;  when using  larger column sizes  (e.g.,
>500  mg) this is  not necessary. The first 100 uJ aliquot of
methanol applied to the column will yield approximately
25  uJ of eluate. Two more 100  uJ aliquots  of 100%
methanol are also  forced through  the column. The final
volume of eluate collected will be approximately 220 u.l. If
desired, measure the  exact volume collected (using a uJ
syringe) to calculate concentration factors (Table 2-3). As
in most chromatographic separations  and extractions,
three  separate smaller  elutions of methanol are  more
efficient than  one large one.
                                                     2-8

-------
       The 100 mg C18 SPE column is reconditioned
with 1 ml of methanol and rinsed with 1 ml of high purity
water. It is then used to concentrate the diluted toxic SPE
column fractions, using the same procedure used for the
blank fractions (Figure  2-4). In lieu of  reconditioning the
same column, two columns can be conditioned, one used
for the diluted blank fractions and the other used for
concentrating the diluted toxic SPE fractions. The result-
ing column blanks should be toxicity tested separately.

       The original effluent volume of 2,000 ml is now
concentrated into a 220 u.l sample or a nominal concen-
tration of 9,091x (ignoring the amount used for testing).
As work progresses and  more quantitative  results are
needed, the eluate volume must be measured to provide
the correct concentration factor. If 9 u.l of concentrate is
diluted to 10 ml in  dilution water, the resulting test con-
centration will be 8x whole effluent. Additional test con-
centrations (e.g., 4x, 2x, 1x) can be prepared to determine
an LC50 of the concentrate, and toxicity recovery can be
calculated by comparing this LC50 to the LC50 of the
effluent. The concentrate toxicity might  be higher than the
sum of the individual toxic fractions because some of the
toxicant may have been in adjacent fractions that were
concentrated in  the first  step  (Section 2.2.7) but not
detectable by the toxicity test of the single fraction. The
concentrate toxicity may also be  lower .than  expected
because of low extraction and elution efficiencies. Where
greater concentration factors are desirable, SPE fraction-
ation should be repeated with additional volumes of efflu-
ent, followed by combining the toxic fractions before
concentration. The size of the column used for concen-
trating may have to be increased, along with the appropri-
ate changes in .dilution  and elution volumes (Table 2-3).

       The important concern here is not 100% recovery
of toxicants but enough recovery for GC/MS analyses and
to obtain measurable toxicity in the HPLC fractions.  If
recovery is too low, changing or eliminating the column
drying time may help.  Sometimes recovery appears to
increase with drying time while other compounds are
volatilized from the column during the drying process. For
concentrates analyzed using  GC/MS,  column drying to
remove water is critical to GC column performance.

2.2.10  HPLC Separation
        The same column packing functionality should be
used in the HPLC column as the SPE column. At later
stages, when more is  known about the toxicants, other
sorbent types may be used.

         The HPLC conditions presented in this section
are general. As more information on the effluent is gath-
ered, HPLC conditions should be  modified to achieve
better separation and  higher concentration factors. We
use a flow rate of 1  ml/min on an instrument equipped with
a 5 urn C  reverse phase column (250  mm x 4.6 mm i.d.).
The HPLC elution conditions will change depending  on
which SPE fractions have been concentrated. The HPLC
conditions for the four most commonly toxic SPE fractions
are listed in Table 2-4.  Depending on the size of the
Table 2-4. Example HPLC Elution Gradients fpr Four Commonly Toxic
        SPE Fractions

  75% or 85% SPE Fractions       85% or 90% SPE Fractions

Time (min)   % Methanol/Water   Time (min)  % Methanol/Water
0
1
13
20
25
50
60
90
100
100
0
1
13
'20
25
60
70
90
100
100
HPLC injector and column, more than one HPLC fraction-
ation run may be required to fractionate the entire blank
concentrate. When multiple HPLC fractionations are con-
ducted, collect all the corresponding HPLC fractions in
the same set of vials. For example, if two HPLC fraction-
ations were performed for the blank concentrate, 25-2 ml
HPLC fractions would be obtained.

        Using the HPLC equipment described above, all
of the blank concentrate remaining after toxicity testing is
injected (<500 u.I) and 25-1 ml fractions are collected in
analytically clean glass vials  (Figure 2-5).  The  same
procedure is followed using the effluent sample concen-
trate. The vials should be sealed (e.g., with foil lined caps)
and stored at 4°C after use. As soon as toxicant identifica-
tion is obtained by GC/MS, then HPLC conditions (gradi-
ent, fraction size, and number of fractions) can be optimized
for further fractionations.

2.2.11 HPLC Fraction Toxicity Tests
        Before specific toxicants are  identified, toxicity
tests on each HPLC blank fraction and sample fraction
are conducted  using non-replicated exposures of five
animals each. The amount of methanol in the HPLC
fractions limits the concentration that can be tested. As-
sume that each fraction is 100% methanol to calculate the
necessary dilution. A methanol concentration of 1.2%
should not be exceeded for C. dubia and fathead minnow
acute toxicity tests.
               Fractionate SPE Concentrate
                     Using HPLC
                         I
                  Collect 25-1 ml HPLC
                      Fractions
                         1
               Conduct Toxicity Test on Each
                       Fraction
 Figure 2-5. Procedure to fractionate acutely toxic SPE concentrates
          using HPLC.
                                                     2-9

-------
        For acute studies, when all of the SPE fraction
concentrate remaining  after toxicity testing  is  injected
(one injection) on the HPLC (Figure 2-5), each resulting 1
ml HPLC fraction equals 2,000 ml of effluent (assuming
no loss and toxicant elution in only one fraction) or a
2,000-fold concentration.  If each  HPLC fraction is then
diluted for testing (80 uJ to 10 ml) the resultant concentra-
tion is 16x the original effluent concentration. In prelimi-
nary Phase II testing the HPLC fractions are tested without
dilutions. Only the toxic HPLC fractions are tested again
with dilutions to generate an LC50. Some loss of toxicant
tends to occur in each concentration step and the result-
ing toxic'rty  may be decreased relative  to the original
effluent.

       The blank fractions should not be toxic. If they
are, then additional tests with dilutions must be conducted
on both blanks  and toxic  fractions to  find out whether
there is enough additional toxicity in the sample fractions
to warrant analysis.

       The toxicity of the HPLC fractions  should  be
tested at twice (at least) the concentration at which the
original SPE column fractions were tested because  re-
covery of toxicity and analytical measurements indicate
that up to 50% of the initial concentration of toxic com-
pounds may be lost in this step (Durhan et al., 1990). The
amount of methanol should not exceed the amount used
in the SPE fraction tests described above (Section 2.2.8).

2.2.12 HPLC Fractions: Concentration and
       Subsequent Toxicity Testing
       The HPLC fractions that exhibit toxicity and their
corresponding blank fractions must be concentrated in a
solvent suitable for GC/MS or other analytical techniques.
The procedure is identical to that described  in  Section
2.2.9 and is depicted in Figure 2-6. Judgement must be
used to decide whether to concentrate each toxic fraction
separately or to combine various toxic and adjacent frac-
tions prior to concentration. If, for example, three succes-
sive fractions exhibit toxicity, there  is a good chance that
the same toxicant is in all three. If there are other,fractions
that show toxicity but they are separated from the first set
by several non-toxic fractions, there is high  probability
that the second set contains a toxicant  different from the
first three. There is also a good chance that at least one
non-toxic  fraction on  either  side  of  the toxic fractions
contains some of the tpxicant(s). The advantage of com-
bining fractions is to reduce the work load andjncrease
concentration In the final concentrate. The disadvantage
is that more constituents that are not the toxicant(s) will
also be concentrated. This decision is not always straight-
forward and must be based on trial  and  error, and experi-
ence. Blank fractions corresponding to the toxic fractions
are concentrated the same way.

       The HPLC fraction and blank concentrates should
be finally  checked  for toxicity  before  GC/MS analysis.
This concentrate is now nominally  9,091x more concen-
trated than the effluent. If 18 jil is diluted to  10 ml, the
resultant test concentration will be 16x the original sample
                 Diluted HPLC Fraction^)

              100 mg C18 SPE Column Sorption

                          | (discard post -C18
                              effluent)
             Dry Column with Nitrogen (optional)
                         1
               Elute Column with three 0.10 ml
                  Volumes of Methanol
                         i
                Collect Eluate (Concentrate)
                         Tox

                         1
    Conduct Toxicity Test

           1
Analyze Concentrate on GC/MS
Figure 2-6.  Procedure to concentrate toxic HPLC factions.
concentration. To quantitate toxicity and use the Phase II
data later, additional lower concentrations should be tested
(e.g., 8x, 4x, 2x); TUs of this concentrate can then be
compared to previous toxicity test results.  The HPLC
concentrate should be tested at one to two times the test
concentration of the HPLC fraction tests (i.e., 16x or 32x).
This is the last opportunity to assure that the toxicant is
still present in the concentrate before it is subjected to
GC/MS analysis. Whether the toxicant is detected by the
analytical detector (mass spectrometry in our laboratory)
is always  a question. Since GC/MS  detects only about
20% of organic chemicals (EPA, 1989B), even such a
broad  spectrum  method  is not  certain to identify the
toxicant. As work progresses with more samples of the
effluent and quantitative results are needed, the amount
of eluate  collected  should be carefully measured  and
recorded to accurately calculate the concentration  fac-
tors. In addition, the volume of concentrate removed for
toxicity  testing  and analytical analyses should also be
recorded.


2.3     Chronic Toxicity: Fractionation and
        Toxicity Testing Procedures
        The chronic Phase II non-polar organic toxicity
identification follows the  same  general  approach  and
employs manipulations similar to  those described for the
acutely toxic non-polar organic compounds (Section 2.2).
One major difference  is that the concentration of the
eluting  solvent (e.g.,  methanol)  must  be lower in the
chronic toxicity tests than in acute  tests. In the initial
stages of Phase II, toxicity tests may be conducted on C18
SPE effluent fractions and blank fractions to detect the
presence of toxicants, and not to quantify the magnitude
                                                    2-10

-------
of the toxicity in each. However, as suspect toxicants are
identified, quantitative toxicity measurements will be
needed to compare with the analytical measurements. If
Phase II data will be used to correlate effluent toxicity to
toxicant concentrations (Phase III), then more replicates
per concentration, randomization of test concentrations,
careful  observation  of organism exposure  times, and
organisms of approximately the same age should be used
(Section 1.2). Also the amount of eluate that is collected
from the SPE fractionation, SPE concentration, and the
amount of eluate used for testing and GC/MS analysis
should be measured at all steps. If it is expected that the
Phase II data will be needed later, it is prudent to measure
the degree of toxicity in the SPE effluent fractions (Sec-
tion 2.3.5) at the onset of testing. We rarely see blank
fraction toxicity, therefore, there is little need to evaluate
the blank fraction toxicity  with dilutions. Also, the volume
of eluate must be measured to determine the actual
toxicity concentration in each step of the procedure.

        The following discussion is based on our experi-
ences with C. dubia and  fathead minnows (see Section
1.2). The use of other species will require reconsideration
of the appropriate test volumes and methanol concentra-
tion for each step. Chronic testing is more labor intensive
and generally requires more effluent sample volume than
acute testing. For the most part, in the descriptions below,
for C. dubia there are five replicates containing 10 ml of
test solution and one animal per cup.  For the fathead
minnow tests, two replicates of 10 animals per 50 ml and
the control are usually used (Section  1.2). Typically we
use four concentrations and a control.

        As soon as the cause of toxicity has been deter-
mined to be a non-polar organic compound (e.g., metha-
nol eluate test; EPA, 1992) it is prudent to concentrate
large volumes of effluent for the subsequent analyses. By
concentrating large amounts of the effluent it is possible
to plan the optimal usage of the amount of column eluate
available for toxicity testing.

2.3.1   Sample Volume
        The volume of effluent needed depends on its
toxicity, the toxicity of the  chemicals causing  effluent
toxicity, and the sensitivity of the analytical method. Since
only the first of these will usually be known when Phase II
begins, the volume  of effluent to process should  be
considered at the beginning of the identification process
to minimize the amount of re-fractionating and re-testing
of effluent and fractions. Ideally, fractionation should pro-
vide  enough volume of  post-column  effluent (Section
2.3.6),  C18 SPE fractions (Section 2.3.8), SPE  fraction
concentrates (Section 2.3.9), HPLC  fractions (Section
2.3.11), and HPLC fraction concentrates (Section 2.3.12)
to conduct all chronic toxicity testing and chemical analy-
ses. Because of the many factors affecting the  amount of
effluent needed, a significant amount of thought should
be put into the volume of  effluent to obtain and process at
one 'time. It is  prudent for the investigator to  anticipate
how  many  identification  procedures will  be done, and
then  calculate the volume of effluent needed  using the
particular test parameters desired, before extracting any
effluent to ensure that sufficient volume of fractions, con-
centrates, and post-column effluent is available for the
planned procedures.  It  may  be best to  perform these
calculations with .several different effluent volumes and
test conditions to ascertain the optimal volume of effluent
to fractionate.  A worksheet to assist with these calcula-
tions and an example are provided in Appendix A.

       The volumes of eluate needed for chronic toxicity
testing at 2x, 1x, and 0.5x are provided in Table 2-5 for
the C. dubia and fathead minnow short-term tests based
on the methanol concentration that can safely be used for
the chronic tests. The amount of SPE fractionation eluate
needed for toxicity testing is  presented for the range of
tests that are commonly performed  with  C. dubia or
fathead minnows,  these volumes can be used in the
calculation worksheets found  in Appendix A (Table A-1).
The approximate volume of effluent that will be needed
for testing with C. dubia and fathead minnows is listed in
Table 2-6 for various fractionation schemes and toxicity
testing parameters. When only a portion of the TIE proce-
dures will be used, obviously  less effluent volume will be
needed. In Table A-2, the example calculations are based
upon the  use of minimum elution volume for the SPE
columns (Table 2-1), concentrating only one SPE fraction
(Section 2:3.9), and taking into account the toxicity testing
(Sections 2.3.8,  2.3.9, 2.3.11, and 2.3.12) and  GC/MS
analysis volumes (Section 2.5). These parameters are
discussed in detail below. If additional eluate  is needed,
the chronic tests must be repeated for each fractionation.
In Phase II and Phase III more confidence in the toxicity
estimates is needed than in Phase I, therefore tests may
require more replicates. The  volumes  needed for those
tests are also presented in Table 2-5. When only limited
amounts of effluent are available, one must be creative
and plan  its usage very carefully to  obtain meaningful
results.

2.3.2  Filtration
       For filtration of chronically toxic effluents, the use
of glass fiber filters (1 u.m nominal pore size) is recom-
mended. Both 45 mm and 90 mm diameter filters have
been used routinely, but the 90 mm diameter filter allows
about four times more effluent to be passed over one filter
than the 45 mm filter. All filters and glassware should first
be pre-rinsed with pH 3 high  purity water to remove any
residual metals followed by a  high purity water (e.g., Milli-
Q® Water System) rinse which is discarded. Low levels of
metals (e.g., ug/l) from the  filters  may cause toxicity
interferences and pre-rinsing the filters may provide cleaner
blanks and less contamination in effluent samples. To
collect the dilution water filter blank, first  pass a volume
(-200  ml) of dilution water over the filter and discard it.
Next, collect the volume of dilution water  needed to
conduct the filtration blank test. It is a good idea to prepare
excess volume, at least 500 ml for the C. dubia 7-d test and 800
ml for the fathead minnow 7-d test. A portion of the filtered
dilution water is collected for testing and a portion is re-
served for the solid phase extraction test blank (Section
6.6; EPA, 1992).
                                                     2-11

-------
 Table 2-5.  Eluata Volumes Needed for Chronic SPE Fraction Toxicity Tests with Ceriodaphnia dubia and Pimephales promelas
Test
Species
C. dubia
C. dubia
C.dvbia
C. dubia
C. dubia
C. dubia
C. dubia
C, dubia
P. promelas
P. promotes
P. promotes
P. promotes
Test
Duration
4-d
4-d
7-d
7-d
4-d
4-d
7-d
7-d
7-d
7-d
7-d
7-d
Original
Sample &
No. Renewals
2
4
3
7
2
4
3
7
7
7
7
7
High Test
Cone, of
SPE Fraction
2x
2x
2x
2x
2x
2x
2x
2x
2x
2x
4x
4x
No.
Rep
5
5
5
5
10
10
10
10
2
4
2
4
Volume (ml) of 500x
Eluate Needed
for Testing1
0.70
1.40
1.05
2.45
1.40
2.80
2.10
4.90
4.90
9.80
9.80
19.60
Test
Concentrations
2x, 1x, 0.5x
2x, 1x, O.Sx
2x, 1x, O.Sx
2x, 1x, O.Sx
2x, 1x, O.Sx
2x, 1x, O.Sx
2x, 1x, O.Sx
2x, 1x, O.Sx
2x, 1x, O.Sx
2x, 1x, O.Sx
4x, 2x, 1x
4x, 2x, 1x
 'Test volumes per replicate are 10 ml/cup for C. dubia and 50 ml/cup for P. promelas. The fraction test solutions are prepared as one solution and
  divided into aliquots for the replicates. For the SOOx eluate concentration, this volume is based on the assumption that the C. dubia test solutions
  are prepared as 200 uj of SOOx into 50 ml for 2x, 100 uJ into 50 ml for 1x, and 50 ul into 50 ml for 0.5x. More volume will be needed if serial
  dilutions are prepared (400 uJ vs 350 uJ). For the fathead minnow tests this assumes test solutions are prepared as 400 ul into 100 ml for 2x, 200
  ml into 100 ml for 1x, and 100 uJ into 100 ml for O.Sx. More volume will be needed if serial dilutions are prepared (800 ul vs 700 ul). For the 4x
  fathead minnow test,  800 uJ per 100 ml can be prepared in a similar manner.
Table 2-6.  Approximate Effluent Volumes Needed for the Chronic Non-Polar Organic Identification Procedures'


Test
Species
C. dubia
C. dubia
C. dubia
P. promotes
P. promelas


Test
Duration
4-d
7-d
7-d
7-d
7-d
Original
Sample &
Number of
Renewals
4
3
7
7
7
High Test
Cone, in
SPE Fraction
Test
2x
2x
2x
2x
2x


No.
Rep.
5
5
5
2
4

Are
Dilutions
Used?
Yes
Yes
Yes
Yes
No
Volume Effluent (ml)
Needed to Conduct
SPE & GC/MS2
Analyses
3,000
2,000
5,000
10,000
5,000
Volume Effluent (ml)
Needed to Conduct
SPE & HPLC & GC/MS3
Analyses
15,000
15,000
20,000
50,000
40,000
'Calculation of toxlcity testing volumes assumes that: 4x high concentration for SPE concentrate test (Section 2.3.9), 8x high concentration for
 HPLC fraction test (Section 2.3.11), 16x high concentration for HPLC concentrate test (Section 2.3.12), concentration of only one toxic fraction
 (SPE and HPLC), the maximum amount of sample is concentrated on the SPE columns and all SPE columns are eluted with the minimum elution
 volume.
*TIE procedures used: SPE fractionation and GC/MS of SPE concentrate.
JTIE procedures used: SPE fractionation, GC/MS of SPE concentrate, HPLC fractionation, and GC/MS of HPLC concentrates.
                                                              2-12

-------
       After the filtration blank has been obtained, the
effluent sample is filtered using the same filter, a portion
of the filtrate is collected for toxicity testing, and a portion
is set aside for concentrating on the C18 SPE column. For
some effluents, one filter will  often not suffice. A tech-
nique we use to prepare several filters at once is stacking
three to eight filters together in one filter holder, followed
by sequential  rinses with  pH 3 high purity water, high
purity water and dilution water (using the same rinse
volumes as above). Finally, the filters are separated  and
set aside, using one at a time for the effluent sample. If
the samples have high suspended solids concentration,
pre-filtering using a larger  pore size filter may  help,  and
the appropriate blanks should be used. If the  sample
cannot be effectively filtered due to the presence of many
fine  particles,  centrifugation  may be  used (of  course,
blanks must be prepared).

       The filter housing should be thoroughly cleaned
before use to prevent any particle build-up or toxicity
carry-over from previous samples. We have found large
filtration apparatus (1,000  ml), removable glass frits, or
plastic filtering apparatus (e.g., Millipore®)  to be useful.
The glassware cleaning procedure that is described in the
acute Phase I  TIE manual (EPA, 1991 A) is sufficient for
chronic TIE work.,The glass  frits may require rigorous
cleaning (i.e., soak in aqua regia for 20-40 min) to remove
residuals that may remain after filtering, since the glass
frit may itself act as a filter. Also available are removable
stainless  steel filter  supports  in a  glass  vacuum filter
apparatus  (available from Millipore®).  These filter sup-
ports do not require as rigorous cleaning as fritted glass-
ware, and therefore are a good substitute.

       When effluent samples  are readily  filtered
(~2,000 ml for one 90 mm 1 u,m filter) it may be possible
to filter the effluent for the filtration test of Phase I but then
use  unfiltered  effluent with the C18 SPE column test and
the  methanol  eluate test  (Phase I). Once it  has been
demonstrated  that filtration does not reduce toxicity, rou-
tine filtering;of these effluents (before passing the effluent
through the SPE column) can be eliminated,  which will
reduce the amount of toxicity testing required.

2.3.3  Column Size
        Available C18 SPE column sizes and the appropri-
ate water and solvent volumes used in their preparation
are  listed in Table 2-1. Positive pressure pumps are the
most convenient to use for  the  large volume effluent
samples because the flow rate can be  controlled. Pumps
and vacuum manifolds can both be used for eluting C18
SPE columns. Whichever system is used, it  should be
made of  materials that dilute acid and solvents do not
destroy, or from which chemicals are not leached that are
toxic or  interfere with  analytical measurements. Teflon,
glass, and stainless steel are all acceptable.

         When SPE is used for isolating  non-polar or-
ganic toxicants, use the maximum volume of effluent and
the  minimum elution volume for the column size  selected
to optimize the concentration of toxicants in the methanol
eluates. For example, if 6,000 ml is processed, it is best to
use one 5,000 mg column with 5,000 ml and one 1,000 mg
column  with 1000 ml of effluent and elute both columns
with the minimum elution volumes (Table 2-1) and com-
bine eluates. It is always best to process the maximum
volume  of effluent on each column to achieve the highest
concentration of toxicants in the eluate.

2.3.4   Cia SPE Column Conditioning

        The 10,000 mg C   SPE columns (Analytichem
International, Harbor City, CA) are conditioned by pump-
ing 100  ml of methanol through the column at a rate of 40-
50  ml/min. This  size column can process  10,000 ml of
effluent  and is  the largest commercially pre-packed SPE
column  available at this time. The example presented in
this section will be for 10,000 ml effluent using a 10,000
mg SPE column. The volumes of conditioning solvent will
change  when other size columns are used, as shown in
Table 2-1. We most commonly use methanol as the
conditioning solvent but other water miscible  solvents
such as acetonitrile, ethanol, or isopropanol may also be
used to  condition columns. Before the packing goes dry,
100 ml of high purity distilled water must be added. As the
last of that water is passing through, filtered dilution water
is  added. The volume of dilution water needed may vary
from 250 ml to 1,200 ml depending on the species tested.
The first 100 ml  is discarded and the remainder is col-
lected for the dilution water column blank. After the dilu-
tion water has been collected, pumping is continued until
no water emerges from the column.

        Low dissolved oxygen (DO) in the post-column
dilution  water blanks (even in  reconstituted waters) has
occurred during some chronic tests; therefore, we discard
the first 100-200 ml and collect the remainder of the post-
column dilution  water. Low DO has been a problem,
particularly in  the fathead  minnow growth test, and is
attributed to the small amount of methanol that bleeds
into the post-column sample. This may be alleviated by
discarding the first post-column aliquots.

2.3.5   Elution Blanks
        For chronic work, we have been using seven
methanol/water fractions (50%, 75%, 80%, 85%,  90%,
95%, and 100%) rather than the eight used in acute TIEs.
By eliminating 25% methanol/water fraction used in acute
work the toxicity testing workload is reduced,  in turn  a
reduction in separation of toxic and non-toxic components
can occur. _

        To collect the fraction blanks from the 10,000 mg
column, two successive 10 ml volumes of 50% methanol
in water are pumped through the conditioned column and
collected in one  analytically clean labeled vial, to make a
20 ml sample. This procedure is repeated six more times
with two successive 10 ml volumes of 75%, 80%, 85%,
90%, 95% and 100% methanol/water solutions. The col-
umn should be allowed to dry for a few seconds between
 each elution with the different 20 ml volumes of methanol/
water mixtures. This will result in seven 20 ml blank SPE
                                                    2-13

-------
fractions.  The volume of methanol solutions used for
elution will vary depending on column size as shown in
Table 2-1.

2.3.6   Column Loading with Effluent
        The same 10,000 mg column  is reconditioned
with 100 ml of 100% methanol and 100 ml of high purity
water, as described in Section 2.3.4. The sorbent must be
reconditioned when the maximum volume of dilution wa-
ter has been  passed over the column,  otherwise the
sorbents' capacity will be exceeded. After the high purity
water rinse  and  without allowing the column  to  dry,
10,000 ml of filtered effluent sample is  pumped through
the column at a rate of about 40 - 50 ml/min.

        Discard the first 100-200 ml of post-column efflu-
ent, to reduce the possibility of higher concentrations  of
methanol in post-column samples, which may contribute
to art'rfaclual toxicity. To evaluate the post-C18 SPE col-
umn effluent for toxicity, collect at least two aliquots (e.g.,
beginning  and end) separately. If only small quantities
(<500 ml)  of post-column effluent are needed for toxicity
testing (e.g., C. dubiatesl), several separate post-column
effluent samples may be more helpful in determining if the
toxicants are retained by the column. About 800 ml  of
post-column effluent is needed for the  fathead minnow
test if  only one concentration  (100%) of post-column
effluent is  tested for toxicity. If two concentrations (100%
and 50%) are used, then the required volume for  that
species increases to 1,200 ml for each post-column ali-
quot. As Phase II progresses, the recommendation is  to
collect enough post-column  effluent to conduct  toxicity
tests with dilutions.

2.3.7   C18 SPE Column Elution
        To elute the C18 SPE column, two successive 10
ml volumes of the 50% methanol/water mixture are pumped
through the column and collected in one labelled, analyti-
cally clean vial. Subsequently, two successive 10 ml total
volumes of each of the 75%, 80%, 85%, 90%, 95% and
100% methanol/water solutions are pumped through the
column and collected in separate vials.  The next elution
volume should not be added until no more of the preced-
ing one is emerging  from the column. This results  in
seven 20 ml SPE fractions. If one 5 g column and two 1 g
columns are used to concentrate 7,000 ml of effluent, the
corresponding fractions can be combined. For example,
the 10 ml  eluate of the 80% fraction from the 5 g column
can be combined with the two 2 ml 80% fractions from the
two 1 g columns.  This applies to both sample and blank
fractions for a total of 14 ml.

        This entire procedure (conditioning through  elu-
tion) is repeated  using  a second 10,000 mg C18 SPE
column for a second  10,000 ml of filtered effluent.  The
dilution water column blank samples should be kept sepa-
rate. The  corresponding fractions from both the blanks
and the sample from each 10,000 ml fractionation can be
combined as described above. There will be seven 40 ml
blank fractions and seven 40 ml effluent fractions, repre-
senting 20,000 ml effluent.

       The vials containing the methanol/water fractions
are sealed with perfluorocarbon or foil-lined caps, and
stored at 4°C if not tested immediately. These fractions
represent a "first cut" separation of effluent components.
Volumes will vary if columns of different sizes are used or
if the  particular  effluent  under study or the research
question posed dictates method modification.

2.3.8  Blank and Effluent Fraction Toxicity
       Tests
       While the choice  of test concentration depends
on the toxicity of the effluent (Section 1.2), in most in-
stances we have used a concentration of 4x or 2x as the
high test concentration for testing SPE fractions. The high
test concentration of the SPE fraction is in part controlled
by the tolerance of the organisms to methanol. For chronic
testing the concentration of methanol should be less than
0.6% for C. dubia, and less than or equal to1 % for fathead
minnows (see Phase  I; EPA, 1992).

       If the minimum elution volumes are used, typi-
cally SPE eluates  are 500x effluent concentration.  For
fathead minnow testing, eluates can be toxicity tested at
4x effluent concentration by diluting 80 u.l to 10 ml, which
results in a 0.8% methanol concentration. For C.  dubia,
eluates can be toxicity tested  at 2x the 100% effluent
concentration by diluting 40 ul to 10 ml which results in a
methanol concentration of 0.4%. If there is the need to
toxicity test the 500x eluate with C. dubia at 4x then the
SPE eluates can be concentrated by gently airing the
eluate  down (using nitrogen) to half  its original volume.
However,  by using this procedure you risk losing the
toxicant because of evaporation or insolubility. Also real-
ize  that when a water and methanol mixture is aired
down,  the percent methanol composition changes, be-
cause methanol will evaporate faster than water.

       If toxicity occurs in any of the fraction blank tests
and it is small relative to the toxicity in the corresponding
sample fraction, the sample fraction results should not be
dismissed.  If all organisms die in the blanks and effluent
fractions, dilutions of each should be tested to make sure
the sample fraction is substantially more toxic than the
blank.  In general,  blanks should not have  measurable
toxicity.

       When  the  post-column  effluent sample is toxic
and the fractions are toxic at effluent concentrations of 1x
or 2x, the  toxicant could still be a  non-polar organic
compound. If the fractions are not toxic individually and
the post-column sample is non-toxic, it is possible that the
toxicity is spread out among the fractions. Combining and
concentrating these fractions may be  useful or other
elution procedures may be necessary (Section 2.6). If the
fractions are toxic and the post-column effluent is toxic, it
is possible that the  toxicant(s) is in the fractions, and that
either an additional toxicant(s)  is present in the post-
                                                   2-14

-------
column effluent, that break-through of the toxicant(s) oc-
curred, or  that the toxicity  is artifactual.  If toxicity  is
recovered at 1x, 2x, or 4x and in one of the post-column
effluent samples, it  is  possible that not all the toxicity is
caused by non-polar organic compounds or the possibility
exists of break-through in the post-column sample.

       For the chronic  TIE, the question of extraction
efficiency cannot be as readily addressed as it is for the
acute TIE (Section 2.2.8). Measuring the chronic toxicity
of the post-column effluent will be  limited by the species
tested, the test volumes required  for the test and the
frequency of sample replacement.  Without a measure of
the toxicity in the post-column effluent, conclusions re-
garding extraction  efficiency are difficult to make.  The
limitations created by this concern are addressed in Phase
III (EPA, 1993A). Artifactual toxicity in the post-column
effluent has been a problem in chronically toxic effluents
as it was in some acutely toxic effluents. For a detailed
discussion  of this artifactual toxicity that appears as a
biological growth and suggestions to avoid it please refer
to Sections 2.2.6 and 2.3.4., and EPA,  1992.

       At this point in  Phase II,  the  effluent fractions
should also be tested in water with TOC and suspended
solids that mimic the effluent to lessen matrix effects on
toxicity. As the identification step moves into Phase III, it
is better to use dilution water that mimics effluent  or
receiving water characteristics.

2.3.9  SPE Fractions: Concentration and
       Subsequent Toxicity Testing
       The SPE f ractionation provides a general separa-
tion  of non-polar organics and   except in  relatively
uncomplicated effluents, GC/MS analysis of the concen-
trates of toxic C18 SPE fractions will result in very compli-
cated chromatograms  from which the toxicant(s) cannot
be distinguished from other effluent components. A sec-
ondary fractionation using HPLC is often needed  to fur-
ther  simplify toxic effluent fractions prior to component
identification by GC/MS analysis.

       In order to  maximize the chromatographic sepa-
ration capability of the HPLC, the volume of the sample
injected onto an analytical size HPLC column should be
as small as possible  (i.e., <0.5 ml); therefore the toxic
SPE fractions (usually >1 ml) must be concentrated prior
to injection onto the HPLC column. This concentration
step will  provide the  added benefit of an  increase  in
concentrations of constituents in the HPLC fractions as
well as rid the SPE fractions of water. The latter issue is
important  if GC/MS analysis will  be performed  on the
concentrated SPE fraction prior to injection on the HPLC.

       The volume of the SPE fraction and the number
of toxic fractions to be combined will determine which size
SPE column will be used for the concentration procedure.
Table 2-3 contains information on  column sizes and the
appropriate volume of conditioning and eluting solvents
we  have found to  be most useful. In the  procedures
outlined below we have  used a 200 mg SPE column  to
concentrate one 40 ml toxic fraction from two 10,000 mg
SPE columns. Often the toxic effluent SPE fractions are
combined and diluted with  high purity water. If enough
toxicity occurs in each fraction it may be more useful to
concentrate each fraction separately for subsequent HPLC
separation. The corresponding blank fractions are simi-
larly treated. The percent methanol in the diluted fraction
sample  should be <20% and the volume to which the
fractions can be diluted  is dependent on the amount of
column  packing. For example,  the total volume  of the
diluted fraction(s)  should not exceed 200 ml for the 200
mg C18 column (Table 2-3).

        A 200 mg C18 column is conditioned with 2 ml of
methanol and rinsed with 2 ml of water similar  to the
procedures described in the SPE Column Conditioning
Section  (2.3.4). The diluted blank fractions are then drawn
through  the 200 mg C18 SPE column under a pressure of
380 mm Hg using a vacuum manifold. When processing
larger volumes, or using larger columns, positive pres-
sure can be used. The solution passing through the
column  cannot be tested for toxicity because of its high
methanol concentration  (e.g., 10-20%  methanol). The
column  is then dried for 10 min using  a gentle flow of
nitrogen (10-20 ml/sec). Drying the column  usually in-
creases the recovery of toxicity, but sometimes toxicity is
not recovered from the column possibly because of vola-
tilization. If this occurs, the concentration procedure can
be repeated without the nitrogen drying step.

        After drying the sorbent, the luer tip of the column
is fitted with a luer-lock needle (to ease collection of small
volumes) and 200 u.l of 100% methanol is placed into the
column using a microliter syringe. Nitrogen is then applied
to the column at a rate of ~4 ml/sec to force the methanol
through  the sorbent,  which is then collected in a  small
glass vial. The first 200 u.l aliquot of methanol applied to
the column will yield approximately 125 uJ of eluate. Two
more 200 uJ aliquots (applied separately) of 100% metha-
nol are also forced through the column. The final volume
of eluate collected will be approximately 440 uL. Measure
the exact volume collected using a u.I syringe or pipet. As
in  most  chromatographic separations and  extractions,
three separate smaller elutions of methanol are  more
efficient  than one large one.

        The 200 mg C18 SPE column  is reconditioned
following the directions given above in Section 2.3.4. It is
then used to concentrate the diluted toxic SPE fractions,
using the same sequence used for the blank fractions
(Figure 2-4). The concentrated blank fractions will serve
as the dilution water column blank because it cannot be
obtained for chronic toxicity testing  as  it can for acute
testing.

        When the total volume of fractions is above 40
ml, larger columns should be used; consult Table 2-3 for
column  size and elution volume information. The size of
the column used for concentrating should be chosen to
maximize concentration in the eluate. Therefore, choose
the smallest column appropriate for the diluted fraction
volume.
                                                   2-15

-------
        If there is a large toxicity loss after the concentra-
tion step, it is possible that the percentage of methanol in
the diluted fraction was too high. The concentration pro-
cedure should then be repeated with a new set of toxicity
tested SPE fractions diluted to a lower methanol concen-
tration (e.g., 10%). Both the effluent and blank concen-
trates are toxicity tested at each step  to track toxicity.
Generally we suggest that this toxicity test be at least at
two times higher than the concentration used in the first
SPE fraction test. The tests are conducted exactly as the
SPE fraction tests.

        if an original effluent volume of  20,000 ml (using
two 10,000 mg SPE columns) is now represented by a
440  uJ concentrate, then  the sample is 42,670x more
concentrated than the effluent (accounting for volume removed
for toxic'rty testing, see Table A-2 example). If 1 |*l  of
concentrate is diluted to 10 ml in dilution water, the resulting
test concentration will be about 4x whole effluent. How-
ever, the  4x  test solution should  be prepared as one
sample before solutions are spirt among replicates. For
example, 5 uj is diluted to 50 ml for five replicates with the
C. dubiaiest described above (Table A-2). Additional test
concentrations (e.g., 2x, 1x, 0.5x) can then be prepared to
determine an IC25 or IC50 of the concentrate,  and toxicity
recovery can be calculated by comparing this value to the
toxfcity of the effluent. The concentrate  toxicity might be
higher than the sum of the individual toxic fractions be-
cause some of the toxicant may have been  in adjacent
fractions that were concentrated in the first step (Section
2.3.7) but not detectable by the toxicity  test of the single
fraction. The concentrate toxicity may also be lower than
expected because of low extraction and elution efficien-
cies.

        The Important concern here is not 100% recovery
of toxicants but enough recovery for GC/MS analyses to
be successful and to obtain measurable toxicity in the
HPLC fractions. If recovery is too low, changing or elimi-
nating the column  drying  time  may help. Sometimes
recovery appears to increase with drying time while other
compounds are volatilized from the column during the
drying process. For concentrates analyzed using GC/MS,
column drying to remove water is critical to GC column
performance.

2.3.10  HPLC Separation
        The same column packing functionality should be
used In the HPLC column as is used in  the SPE column,
such as C1§. At later stages, when more is known about
the toxicants, other sorbents might be more appropriate.

        The HPLC conditions presented  in this section
are general. An important consideration  of HPLC fraction-
ation Is the number of HPLC fractions  to collect. Since
chronic toxicity testing is very time consuming, deciding
the appropriate number of fractions to collect is an impor-
tant  step.  However,  when choosing  which collection
scheme to use, keep in mind the trade-off between sepa-
ration and toxicity testing load. When the fraction volume
is increased (toxicity testing load decreases) the separa-
tion of the toxicants from the non-toxic components de-
creases. We have used a 20 min separation gradient with
the collection of 20-1 ml fractions. There are many other
collection options that could be  used, such as  10-2 ml
fractions or 4-5 ml fractions  using the same separation
gradient. As information on the effluent is gained, HPLC
conditions should be modified from the general conditions
described b°elow, to achieve better separation and higher
concentration factors.

        We use a flow rate of 1 ml/min on  an  instrument
equipped with a 5 |om C1B reverse phase column (250 mm x 4.6
mm i.d.). The HPLC elution conditions will change depend-
ing on which  SPE fractions have been concentrated. An
example of HPLC conditions for commonly toxic SPE
fractions is listed in Table 2-7. First, the blank concentrate
is injected (<500 \i\) and 20-1 ml fractions are collected in
analytically clean glass vials. Depending on the size  of
the HPLC injector and  column,  more than one HPLC
fractionation run may be required to fractionate the entire
blank concentrate. When  multiple HPLC fractionations
are conducted, collect and combine all the corresponding
HPLC fractions in the same  set of vials. For example, if
two HPLC fractionations were performed for  the  blank
concentrate, 20-2 ml HPLC blank fractions would be ob-
tained. The same procedure is followed using the effluent
sample concentrate. The vials should be  sealed (e.g.,
with  foil lined caps) and stored at 4°C  if  not tested
immediately. As soon as toxicant identification is obtained
by GC/MS (Section 2.5), then HPLC conditions (gradient,
fraction size, and number of fractions) can be optimized.
      Table 2-7.  Example HPLC Elution Gradient for
               SPE Fractions from Chronically Toxic
               Effluent Samples


              80 oV 85% SPE Fractions
      Time (min)
% Methanol/Water
         0

         10

         12

         20
      80

      90

     100

     100
2.3.11 HPLC Fraction Toxicity Tests

        In the HPLC fraction toxicity tests for chronically
toxic effluents, the methanol in the HPLC fractions is one
of the limiting factors of the concentration of the fractions
that can be tested. Each fraction is assumed to be 100%
methanol  to  calculate  the  necessary dilution. A  0.6%
methanol  concentration or  less can be tested with C.
dubia, while a 1% or less methanol concentration can be
tested with fathead minnows.

        In a chronic TIE with C. dubia,  when all of the
SPE  concentrate remaining  after toxicity testing from
20,000 ml effluent is injected on the HPLC (one injection),
                                                    2-16

-------
 each resulting 1 ml HPLC fraction equals 15,575 ml of
 effluent (assuming the toxicant elutes in only one fraction,
 see Table A-2). If 11 uJ of each HPLC fraction is then
 diluted to 10 ml, the test concentration is 16x the original
 effluent concentration. However, the 16x solution should
 be prepared as one sample before aliquots are split to
 provide replicates. For  instance, in the  example used
 above, 55 u.l should  be diluted to 50  ml, which is then
 equally distributed into five test cups. Additional concen-
 trations are prepared in  a similar fashion to estimate the
 IC25 or  IC50  and to compare toxicity recovery to the
 toxicity of the sample. Of course, some loss of toxicant
 will occur in each step and the toxicity may be less.

       The blank fractions should not be toxic.  If they
 are, then additional tests with dilutions must be conducted
 on both  blanks and  toxic fractions  to find out whether
 there is enough additional toxicity in the sample fractions
 to warrant analysis.

       The toxicity  of  the HPLC fractions should be
 tested at twice (at least) the concentration at which the
 SPE fraction concentrates were tested because recovery
 of toxicity and analytical measurements indicates that up
 to 50% of the initial concentration of toxic compounds
 may  be  lost in  this step (Durhan  et al., 1990). The
 concentration of methanol should not exceed the amount
 used in the SPE fraction tests described above (Section
 2.3.8).

 2.3.12  HPLC Fractions: Concentration and
       Subsequent Toxicity Testing
       The toxic HPLC fractions and their corresponding
 blanks must be concentrated in a solvent suitable for GC/
 MS or other analytical techniques.  Use the procedure
 described in Section 2.3.9, Concentration of Fractions
 (Figure 2-6). Judgement must be used to decide whether
to concentrate each toxic fraction separately or to com-
 bine various toxic fractions prior to concentration.  If, for
 example,  two successive fractions are toxic, there is a
good probability that the same toxicant is present in both.
 If one toxic fraction is separated from the other by several
 nontoxic  fractions, there  is a high probability that they
contain different toxicants. There is also a good probabil-
 ity that at least one nontoxic fraction on either side of the
toxic fractions contains some of the toxicant. The advan-
tage of combining fractions is to reduce the workload and
to increase the amount of toxicant in the concentrate. The
disadvantage is that  more constituents that are not  the
toxicant will be included. The decision has to be based on
trial and error and experience. Blanks corresponding to
the toxic fractions are concentrated the same way.

       The HPLC fraction and blank concentrates should
also be checked for toxicity before analysis on the GC/
MS. Generally, we suggest that these toxicity tests be
done at concentrations at least 2x higher than the con-
centration used in the previous HPLC fraction tests. Hope-
fully, the amount of concentrate available will be enough
to conduct the toxicity test and perform a GC/MS analy-
sis. Dilutions of the concentrate may be useful to compare
toxicity of this concentrate to each previous toxicity test
result. The HPLC concentrate (of 20,000 ml effluent) is
now 48,495x more concentrated than the effluent (see
Table  A-2). If 3 uJ is diluted to 10 ml the resultant test
concentration will be about 16x the original sample con-
centration. This 16x solution should be prepared as one
solution before aliquots are removed for the replicates.
For instance,  15u.l  is diluted to 50 ml for use in the
example given above, then split into five 10 ml test cups.
It  is prudent to verify toxicity in the HPLC concentrate
before it is subjected to GC/MS analysis. Whether the
toxicant is detected by the analytical detector is always a
question.  Since GC/MS detects only about 20% of or-
ganic chemicals (EPA, 1989B), even such a broad spec-
trum method is no guarantee that  the toxicant will be
identified.

2.4   GC/MS Analyses

       Procedures and methods provided in this section
are based upon our experience in performing GC/MS
analyses on fractions from numerous effluents and are
applicable to both acute and chronic toxicity identification.
In general, these procedures should be used.

       A GC/MS system equipped to perform standard
chemical residue analyses is suggested; i.e.,  a 30 m
capillary column, electron impact ionization, scan range
of 50-500 amu, scan rate  of 1  or  2 scans/sec, a GC
temperature program of 50 to 300°C at 5°C/min, and a
data system with library searching capability.

       Prior to GC/MS analysis, the prepared blank and
toxic fraction concentrates should be tested for toxicity
(Figure 2-6). After verification of the toxicity in the metha-
nol concentrate, inject 1 or 2 \i\ of the concentrate (to
which an internal standard has been added) and collect
the mass spectral data. Note, methanol  is not a typical
solvent for GC analysis and the injection of methanol on a
capillary column will shorten the column's life. Therefore,
routine GC/MS QA/QC procedures should be followed
closely to monitor the performance of the column.

       The mass spectral data should be collected, the
chromatogram integrated, and all detected peaks library
searched. Reverse search is preferred.  Concentration
estimates for all chromatographic peaks can be obtained
by  using the response factor of the internal standard.
Usually the internal standard is added to a small aliquot
(10-20 |j.l) of the concentrate prior to GC/MS analysis. The
selection of internal standard to use is an  individual
choice, and many different standards are available. An
external standard method could also be used for deriving
concentration estimates.

       The MIST  (National  Institute of Standards and
Technology, Gaithersburg, MD) mass spectral library has
been used in ERL-D for performing library searches.
Other mass spectral  libraries are available, but some of
the larger libraries  contain multiple spectra for some of
the compounds in the database. Library searching results
that contain multiple  identifications  of the  same  com-
                                                   2-17

-------
pound are not as useful as those obtained using the NIST
library.

        Once the library search results are available, the
search report for each peak must be examined to decide
whether the  identification by  the  search is valid and
reasonable. The help  of a  trained GC/MS chemist is
required to do this evaluation.  Questions we consider in
our laboratory when performing this process include: A)
are all major ions present in the correct proportions?, B) is
this identification consistent with other information about
the fraction?, C) do forward  and reverse searching pro-
vide similar fits? and  D) are  the  library searching fits
greater than 70%? Factor A must be met! Consistency,
factor B, considers circumstances such as "has the iden-
tified chemical been found in vastly different fractions," or
"has the same identification been given  to numerous
peaks in the same chromatogram?" Both factors C and D
are somewhat relative  and depend a great deal on the
sample and "rts matrix. In addition, the toxicants are often
very minor components in the GC/MS total ion chromato-
gram  and thus, the quality of the mass spectral data even
after background subtraction can lead to poor results for
factors C and D.

        After examination of the library search results, a
list of identified chemicals is assembled and evaluated
using the methods  in the following section. For the confir-
mation analyses we suggest  EPA method 625 (EPA,
1982).

2.5     Identifying Suspect Toxicants
        If one toxicant  is identified, then the goal of the
rest of Phase II is to determine if there are any other
toxicants contributing to effluent toxicity. Two parallel
lines of investigation should  be pursued to achieve that
goal. The first is to determine whether or not the concen-
tration of the suspect toxicant is sufficient to cause toxicity
(EPA, 1993A). The second is to estimate the proportion of
the effluent toxicity that is  caused by the  suspected
toxicants, so that a decision  can be made as to whether
other toxicants are present in the effluent.

        The first line  of investigation should begin by
comparing the estimated concentrations  of identified
chemicals in the SPE or HPLC concentrate to their known
toxicity values. Recovery of  100% of each effluent toxi-
cant In the C18 SPE fractions  may not be crucial, because
at this stage, only the  estimated concentration of com-
pounds in the fraction and the toxicity of the fraction are
compared.  Assumptions about the  concentration  of
toxicant(s) in the whole  effluent are not made at this point,
nor is any statement made regarding recovery of whole
effluent toxic'rty in C18SPE column fractions. In later stages
of Phase II, inferences regarding the relationship between
the concentration of the suspected toxicant(s) in whole
effluent and the observed toxicity in the SPE fractions are
made. At this step, the compound quantification will have
been  performed using an internal or external standard
response and since the compound's recovery is unknown,
considerable error may be involved in the concentration
estimate. Secondly, the toxicity data, if available, may be
for a different species than that used in the TIE. Species
differences are usually as large as 100-fold  and often
1,000-fold. Given these two  sources of uncertainty and
the chance that they may reinforce one another, certainly
if the estimated concentration of a chemical accounts for
the toxicity within a factor of 100, the chemical  should
remain  a suspect. To the extent that data  for either
quantitation or toxicity values of the compound are known
to  be better, concentration differences of smaller magni-
tude may be used to  eliminate suspects.

        Once a list of suspects is available, the measure-
ments for both concentration and toxicity should be re-
fined. This will usually require obtaining pure compound
to  make better analytical measurements and to establish
acute or chronic toxicity estimates for the species  of
concern. This step requires as much separation as practi-
cal before analysis so that the list of suspects is small.

        At this stage, only the concentration of the sus-
pected toxicant(s) in  the concentrate is known; until re-
covery  through all the fractionation  and concentration
steps is complete, suspect compound concentrations in
whole effluent are not known.  Since the concentrate is
virtually devoid of suspended  solids and  much  of the
effluent TOC, both of which may dramatically affect toxic-
ity of non-polar organics, the toxicity of non-polar chemi-
cals may be quite different in the fraction tests than in the
effluent test. Therefore, the toxicity of suspects in the
fraction test should be compared to the suspect's toxicity
in  a relatively pure water,  such as  reconstituted water.

        During this same  stage, the steps leading to the
final concentrate should be checked for toxicity recovery.
The objective is to place a good estimate on how much of
the whole effluent toxicity is contained in the final concen-
trate. This is best done  by testing the toxicity of the
concentrate at concentrations near those of whole efflu-
ent, correcting for volume losses  due to toxicity  testing
SPE column fractions (which was previously ignored). If
the toxicity of the final concentrate  is similar to that of
whole effluent, allowing for losses, and if the concentra-
tion of  the suspect(s) is  sufficient  to account for the
concentrate's toxicity, it is time to  begin Phase III (EPA,
1993A). If multiple toxicants occur, the toxic units of each
are compared to the whole effluent toxic units.

        If the concentrations from  quantitation and toxic-
ity measurements are close to one  another, Phase III
procedure should be started, recognizing that  other toxi-
cants may yet be identified. If  no suspects are found,
more concentration, more separation, and possibly differ-
ent or  more sophisticated analytical methods must be
used. In some of the effluents  we have tested,  finding
other candidates has taken months and  concentration
factors of >100,000 have  been required. Since few labo-
ratories will have all the needed analytical equipment,
instrumentation from other sources should be considered.
                                                    2-18

-------
        Because artifactual toxicity that equals toxicity
 due to lost or unidentified toxicants can be created, as
 one progresses to  Phase III the suspect toxicant should
 be identified. One purpose of Phase III is to identify such
 errors. Should this error occur, one must start again at the
 beginning of Phase II, or even return to Phase I. If several
 different effluent samples were evaluated during Phase II,
 redoing Phase I on additional samples may be time well
 spent since the effluent may have changed in the interim.

        In practice  therejs no sharp boundary between
 Phases  II and III.  In  general, as  soon as a probable
 suspect is identified, confirmation procedures of Phase III
 should begin. If a toxicant has  been assumed to have
 been identified when it has not, the identification of other
 suspected toxicants can be hampered.

        A final suggestion is to investigate the additivity of
 toxicity for several  constituents, if all toxicity is  not ac-
 counted for. Enhancement  of toxicity by methanol should
 also be checked.

 2.5.1   Identifying Organophosphate Pesticides
        Certain compounds must be metabolically acti-
 vated  by the  test organism before they become  toxic.
 These activation  reactions consist of oxidative metabo-
 lism by a family of enzymes collectively known as cyto-
 chrome P-450. Compounds such as piperonyl butoxide
 (PBO) can block the toxicity of metabolically activated
 toxicants  making it a useful  tool in the TIE. PBO is  a
 synthetic methylenedioxyphenyl compound that effectively
 binds to and blocks the catalytic activity of cytochrome P-450.
 Thus, when a nontoxic amount of PBO is coadministered with
 the effluent or the effluent fractions that exhibited toxicity,
 the toxicity of  the compound  requiring metabolic activa-
 tion is greatly  reduced or completely blocked  (Ankley et
 al., 1991).

       Phosphorothioates are organophosphates known
 to require cytochrome P-450 activation before expressing
 toxicity and include common insecticides such as diazinon,
 malathion, parathion, methyl parathion andfenthion. There
 also are a number of organophosphates that are toxic in
 the absence of metabolic activation; these include insec-
 ticides such as dichlorvos, mevinphos and chlorfenvinphos.

       We  have found organophosphate  insecticides
 present in effluents  and ambient waters at acute and
 chronic toxicity levels (Amato et al., 1992; Norberg-King
 et al., 1991). The toxicity of most organophosphates will
 be removed from the sample by the C  SPE column, and
 they are typically recovered in the methanol eluates (see
 EPA,  1991 A; EPA,  1992).  The addition of  PBO to the
 effluent before addition of the test organisms was used as
 a subsequent test in Phase I (EPA, 1991A; EPA, 1992). In
 addition to the C18 SPE column removing the  toxicity, a
 reduction  in toxicity with the addition of PBO would sug-
gest the presence of metabolically activated compounds
such as  organophosphates. PBO  has similar utility in
 Phase II of the TIE in that either SPE fractions (Sections
2.2.8 and  2.3.8) or HPLC fractions (Sections 2.2.11 and
 2.3.11) can be tested for toxicity both in the presence and
 absence of PBO. A reduction in toxicity of the test fraction
 would suggest the presence of a metabolically activated
 chemical, and together with chemical analyses, can pro-
 vide powerful evidence along with GC/MS data, for spe-
 cific organophosphates as the toxicant(s). While PBO
 should be useful  for both acute  and chronic  TIE work,
 most of our experience has been  in the area of acute
 toxicity. Thus, guidance presented below is based mainly
 on acute tests.

        Toxicity values for PBO are presented  in Phase I
 (EPA, 1991 A; EPA, 1992). In acute toxicity tests, concen-
 trations  of PBO ranging from 250-500  u.g/1 have effec-
 tively  blocked  the  acute  toxicity  of  relatively  large
 concentrations of metabolically  activated organophos-
 phates to cladocerans (Ankley et al., 1991).  In chronic
 toxicity tests with C. dubia, PBO concentrations of 50 u.g/1
 have been effective in blocking toxicity in the SPE fractions.
 Detailed information on stock solution preparation  is pre-
 sented in the Phase I documents  and is not repeated
 here.

        When toxicity tests are conducted on  SPE frac-
 tions or HPLC fractions, aliquots of the PBO solution are
 added to the test solutions and mixed well before the test
 organisms are added. As for any TIE manipulation, the
 successful use of PBO is dependent upon the use of
 appropriate controls and  blanks. Effluent fractions and
 blank fractions with and without the addition of PBO must
 be tested simultaneously. A reduction in toxicity  of the
 effluent fraction occurring with the PBO added, and no
 toxicity exhibited in either of the blanks, indicates that the
 toxicant requires metabolic activation to exhibit  toxicity. If
 toxicity associated with the PBO addition is observed in
 the blank fraction, either PBO was present at toxic con-
 centrations or the  methanoi concentration (from fraction
 and/or PBO stock addition) in the test was too high.  If
 toxicity is observed in the effluent fraction with  PBO
 added, but not in the effluent fraction without the PBO or
 in either  of the blank fractions, this result is essentially
 meaningless, in the latter  situation it is possible that the
 PBO has interacted in  a synergistic fashion with another
 compound present in the test effluent that normally would
 not be toxic.

 2.5.2  Identifying Surfactants
       The goal in this section of Phase II is to identify
the toxicants when surfactants are implicated by Phase I
and Phase  II results. The Phase I procedures of filtration,
aeration,  and C18 SPE all  affect surfactant toxicity, and
effluent samples that exhibit several or all of these behav-
iors may contain toxic concentrations of surfactants (EPA
1991 A).

       Surfactants are surface active agents that have a
molecular structure that includes a polar,  hydrophilic seg-
ment (either ionic or nonionic) and a relatively large non-
polar, hydrophobic, hydrocarbon  segment. Surfactants
are used for a variety of household and industrial pur-
poses and therefore are ubiquitous in effluents, particu-
                                                    2-19

-------
(arly in untreated wastewater,  and potentially could be
present at toxic concentrations in effluents (Ankley and
Burkhard, 1992). Some examples of surfactants are soaps,
detergents, charged stabilization polymers, and coagula-
tion polymers used in chemical manufacturing processes.
The  molecular structure of surfactants causes them to
congregate at interfaces between water and other phases
such as  air, oily liquids  and  particulate matter. This
congregative characteristic is responsible for the cleans-
ing and dispersive properties of surfactants.

       There are many different kinds of surfactants and
they are  classified by the nature of their polar segment.
When in aqueous solution, the polar segment of a surfac-
tant  molecule can be either nonionic (not  charged) or
ionic (charged). The ionic polar segment can be either
negatively charged (anionic), positively charged (cationic),
or both negatively and positively charged (amphoteric).
Based on this, surfactants are classified into the following
major classes: nonionic,  anionic,  cationic, and  ampho-
teric.

       Surfactants physical/chemical properties set them
apart from  both strictly polar or non-polar organic com-
pounds and these properties uniquely influence the re-
sults of Phases I and li procedures for surfactants.

       Experiments were conducted with a small sample
of surfactants from nonionic, anionic, and cationic catego-
ries with the Phase I procedures of filtration, aeration, and
C16 SPE (Ankley et al., 1990A).  In these experiments,
filtration  removed the toxicity of most of the surfactants
tested to some degree, and the  degree of removal is most
probably dependent on sample matrix, especially solids
concentration. Aeration removed  the  toxicity  of all the
surfactants tested to  some degree while the C18 SPE
column removed the toxicity completely for all surfactants
regardless of class. Surfactants  behave unpredictably
with regard to elution  from C18 SPE  columns.  For ex-
ample, toxicity from surfactants of the nonionic and an-
ionic classes, eluted in all fractions 80% to 100% methanol/
water (Ankiey et al., 1990A). Elution in several fractions
rather than eluting in one or two fractions may  be caused
by the polar/non-polar nature inherent in surfactants. The
toxicities from the cationic surfactants were  either not
recovered  in any of the fractions or were recovered to
only a small degree in the 100% methanol fraction.

        Important indicators of surfactant toxicity are the
toxfcHy test results from aeration experiments. If volatility
can be eliminated and toxicity is reduced by aeration, this
is strong evidence that a surfactant might  be contributing
to effluent toxicity (EPA, 1991 A). During aeration, surfac-
tants are most probably removed from solution by the
process  of sublation.  Sublation occurs because surfac-
tant molecules tend to congregate at the interface be-
tween the aqueous sample and the aerating nitrogen or
air bubbles and are brought to the surface of the liquid
sample by the bubbles. At the  liquid surface the bubbles
break releasing the surfactant,  which then adheres to the
aeration vessel walls. A compound that can be removed
by sublation  is by definition  a surfactant. It  might  be
possible to recover surfactants from glassware after the
sublation process. The glassware can be rinsed with a
solvent such as methanol, which can then be toxicity
tested and analyzed in the same manner as  methanol
SPE fractions (Sections 2.2.8 and 2.3.8).

       Overall, most surfactants exhibit some of the
behavior that is common to non-polar organic compounds
such as removal from the effluent by the C18  resin and
recovery in the methanol/water SPE fractions. While sur-
factants in general can be considered to be  non-polar
organics, GC/MS analysis will probably not provide suc-
cessful surfactant identification. Most surfactants are not
readily chromatographed because of the polar segment
of the surfactant molecule. One exception is a class of
surfactants in common use that can be analyzed directly
by GC/MS, the alkylphenol ethoxylates. Gieger et  al.
(1981), provides mass spectral data for the nonylphenol
mono-, di- and tri-ethoxylates, which can be used to help
identify  these compounds.  Techniques  such  as
derivatization can make some other specific surfactants
compatible with GC and GC/MS,  but it is necessary to
know the specific identity of the surfactant.

       It  is  difficult to  positively identify  an unknown
surfactant. Although there are many analytical methods
available for accurately quantifying specific surfactants,
these methods are useful only if the identity of the surfac-
tant is known, or at least suspected. It is not reasonable or
practical to analyze a sample using numerous intricate
methods,  in  the hope that one of these  methods will
detect the surfactant in the sample. Unfortunately, there is
no analytical technique available that can readily provide
the identity and quantity of an unknown surfactant. Envi-
ronmental  samples (such as municipal  and industrial
effluents) contain numerous substances that can interfere
with available analytical methods. Also, pure surfactants
are actually mixtures of homologous and oligomers with
varying chain lengths and, in the case of many nonionic
surfactants, varying degrees of ethoxylation. The compo-
sition and therefore the toxicity of such a mixture  might
vary. In the course of a TIE, it might become  necessary
not only to identify the surfactant causing toxicity, but also
to learn which particular horriologue  or  oligomer  is  the
most toxic.

        One approach to reducing the complexity of iden-
tifying an unknown surfactant is to determine whether the
unknown  surfactant falls into the anionic or nonionic
class. APHA (1989) describes a method for determining
anionic surfactants as methylene blue active substances
(MBAS). MB AS method can successfully measure  the
concentration of anionic surfactants of the sulfonate type,
the sulfate ester type, and sulfated nonionicstype. Unless
the identity of the anionic surfactant is known, the analyti-
cal measurement is calculated and expressed  in terms of
the anionic surfactant linear alkylbenzene sulfonate (LAS).
APHA (1989) also  describes  a method for determining
nonionic surfactants  as cobalt thiocyanate active sub-
stances  (CTAS). This method is  applicable  to a wide
                                                    2-20

-------
range of polyether nonionic surfactants, which includes
the widely used alkyl and alkylphenol ethoxylated alcohols.

       With these methods the relative amount of an-
ionic or nonionic surfactant can be estimated, but the
exact nature or  molecular composition of  the  unknown
surfactant will not be determined. These analyses can be
conducted on the SPE fractions, HPLC fractions, fraction
concentrates,  and the whole effluent.  Determining the
class can be significant progress toward identifying the
unknown surfactant. With the class known, specific analy-
ses for the more  common surfactants in that class can be
performed as a subsequent effort. Unless the identity of
the nonionic surfactant is known, the analytical measure-
ment is expressed in terms  of an arbitrarily chosen refer-
ence nonionic  surfactant.

       The type of discharge being processed by the
wastewater treatment plant might provide information that
would enable one to target specific surfactants for analy-
sis. For example, industries feeding into the treatment
plant might be discharging  certain surfactants  or a par-
ticular kind of surfactant that is being used in the manu-
facturing or housekeeping processes. An analytical method
suitable for that particular surfactant could  then be used
to determine whether toxic concentrations can be found in
the toxic effluent, fractions,  or concentrates.

2.6    Alternate Fractionation Procedures
        If toxicity is not recovered in the methanol proce-
dures described  above (Sections 2.2 and 2.3), and toxic-
ity is not observed in the post-column effluent, alternative
elution procedures can be  used. These procedures are
not as widely  used as the  methanol/water elutions dis-
cussed  above but are effective for highly hydrophobic
compounds.

2.6.1   Modified Elution Method
       The current Phase II method for fractionating
non-polar organic toxicants  in aqueous samples does not
effectively fractionate compounds that are highly hydro-
phobic.  Modifications made to the method  have been
successful in  overcoming this  limitation (Schubauer-
Berigan and Ankley, 1991; Durhan et al., 1993). Hydro-
phobic  compounds probably  are  more  prevalent in
sediment pore waters than in treated effluents. Tracking
toxicity caused by these kinds of compounds will be more
difficult  because of the potential for  artifactual toxicity
from the solvents  required to elute  them.  An elution
scheme  incorporating water, methanol, and methylene
chloride  has been designed that effectively fractionates
compounds over a log Kow range from 2.5 to 6.9.  The
higher log Kow compounds, however, elute in the same set
of fractions. Further fractionation by HPLC  might be nec-
essary to  achieve  better  resolution of these kinds of
compounds. Substituting other sorbents for the currently
used C18 SPE resin have also produced encouraging
results. Both the C8 SPE and XAD-7 (Rhom and Haas,
Philadelphia, PA) sorbents  might have utility with particu-
lar kinds of toxicants.
       The modified elution scheme eliminates the 100%
methanol fraction used in the original method,  and re-
places it with one 50% methylene chloride/methanol, and
three 100% methylene chloride fractions (v/v). The com-
position of the  resulting eleven  3 ml  (when using a
1,000 mg C18SPE column) fractions is shown in Table 2-
8. The methylene chloride containing fractions are com-
bined, then solvent exchange is conducted as described
below. The modified elution scheme would be used when
the original methanol/water  elutions did not effectively
elute toxicity in the SPE fractions. In  addition, if  the
suspect toxicants were known to be highly hydrophobic,
as  in sediment pore water,  then the  modified  elution
scheme would be indicated. Blank toxicity should provide
insight concerning artifactual methylene chloride toxicity;
however,  slight reductions in young  production might
occur in both the blanks and sample fractions. Develop-
ment of this  alternate  procedure for chronic toxicity is
underway for the  C.  dubia and  should be used  with
caution at this time. If this procedure is used, it is impor-
tant to accompany the solvent exchanged methanol blank
with a methanol only blank.

       When toxicity testing SPE fractions, it is always a
concern that the matrix of the effluent has been changed
and that chemicals might become bioavailable, whereas
they were not in the  original sample.  If this were to
happen, the fractions might be more toxic than expected
and chemicals might be added to the suspect toxicant list
erroneously. This kind  of mistake should be caught by
obtaining a good toxicity value for the suspect toxicant in
an appropriate matrix.  For instance, if the suspect toxi-
cant is highly insoluble in water, then when tested in an
effluent matrix  it should have low toxicity because  it is
unavailable to the organism. The alternate solvent elution
might enhance this problem because the solvent is more
likely to solubilize the more hydrophobic compounds than
 Table 2-8. Composition of 11 Recommended Fractions in Modified
         Elution Scheme
                  Composition of Eluting Solutions (% v/v)
Fraction
Water
Methanol
Methylene Chloride
1
2
3
4
5
6
7
8
9
10
11
75
50
25
20
15
10
5
0
0
0
0
25
50
75
80
85
90
95
50
0
0
0
0
0
0
0
0
0
0
50
100
100
100
                                                    2-21

-------
methanol. Therefore, additional confirmation steps might
be needed to eliminate the false suspects.

2.6.2   Solvent Exchange
        Since methylene chloride is quite toxic to aquatic
organisms, even at very low concentrations (NOEC for C.
dubta Is 0.03%), it must be removed from SPE fractions
before the fractions can be tested for toxicity. The  ex-
change of the methylene chloride fraction into methanol is
a relatively easy process because of methylene chloride's
volatility. The combined fractions to be exchanged (e.g.,
15 ml) are placed in a centrifuge tube with a teflon stir bar
and an additional 15 ml of methanol. The tube is placed in
a 30°C water bath and stirred while a gentle  stream of
nitrogen is passed over the solution surface. When  the
volume of the solution reaches 3 ml, the sides of the tube
are carefully rinsed with an additional  3 ml of methanol,
and the solution is reduced again to a  final 3 ml volume.
Adjust the volume of methanol used in this procedure to
reflect the total volume of  combined fractions. The final
volume of methanol may then be tested as suggested
previously In Sections 2.2.8. and 2.3.8. It is important to
obtain and toxicity test a methanol-only blank in addition
to the solvent exchanged methanol blank.

2.6.3   Alternative SPE Sorbents and
        Techniques
        In the SPE method described above, C18 bonded
silica is used as the  solid phase for fractionating and
isolating non-polar organic toxicants.  C18 bonded silica
was  selected because, with proper conditioning, it does
not usually contribute artifactual toxicity to sample or
sample fractions, it often achieves the required degree of
separation and isolation of non-polar organic compounds,
and  it Is commercially available in inexpensive,  easy to
use, disposable columns. There is, however, no restric-
tion on the solid phase that is used in the TIE procedure,
as long as it results in the isolation and separation of non-
polar organic toxicants and at the same time does not
contribute artifactual toxicity. We have evaluated several
sorbents other than C  bonded silica to use  for this
purpose (Durhan et ai., 1993).
       We evaluated two prepurified XAD sorbents, XAD-
4 and XAD-7 (Rohm and Haas, Philadelphia PA) and a C8
bonded silica sorbent. Of these sorbents, only XAD-4, a
non-polar styrene-divinyl benzene copolymer performed
as well as C18 bonded silica in the fractionation of non-
polar organic compounds. One disadvantage of using an
XAD sorbent such as XAD-4 is that it is not commercially
available in prepacked disposable columns. In addition, it
is important to obtain prepurified XAD-4 sorbent that is
free of toxic artifacts, otherwise extensive, time consum-
ing cleanup  procedures  are required before the sorbent
can be used in a toxicity based fractionation. We found
that  on XAD-7,  an acrylic ester copolymer,  non-polar
organic compounds were inadequately fractionated be-
cause  of  resolution  and co-elution  problems. The  C8
bonded silica yielded results that were similar but signifi-
cantly inferior to those obtained with C18 bonded silica.

       Traditionally, SPE is  carried out with the solid
phase  particles packed  in a  cylindrical column or car-
tridge. An alternative form of SPE has been developed,
the Empore™ Extraction Disk, in which C18 bonded silica
particles are enmeshed in an inert PTFE matrix which is
then formed into a disk. The manufacturer (3M, St. Paul,
MM) claims good recovery of non-polar organics with flow
rates as high as 100 ml/min, which would make this an
attractive alternative form of SPE. We have evaluated this
technique to a limited degree with acutely toxic effluents
and sediment pore waters and feel it has great potential in
a toxicity based fractionation scheme.  Especially attrac-
tive is the high  flow rate  which would allow for large
volumes of sample to be processed quickly. However, a
procedure for eluting non-polar organics from the disk into
several fractions has not yet been developed and could
prove to be a challenge.
                                                   2-22

-------
                                            Section 3
                                            Ammonia
3.1    General Overview
       Unlike Phase  II procedures for non-polar or-
ganic compounds or metals, the toxicant identification
methods described in this section are specific for ammo-
nia. The  procedures used in this  phase of the  study
assume that Phase I tests and ammonia measurements
(see below) have implicated the pH sensitive toxicant,
ammonia as causing the acute or  chronic toxicity (see
Phase I;  EPA, 1991 A;  EPA, 1992). Other compounds
with toxicities that increase directly with pH may lead to
confounding results or may give results similar to ammo-
nia. For instance, experiments at  our laboratory have
shown that C. dubia are more acutely sensitive to cad-
mium,  nickel, and zinc in  acute tests at high pH levels
(Section  4). The  testing  in  Phase II  should help  to
discern the toxicity caused by ammonia from that caused
by other compounds that might also become more toxic
as pH increases. The methods described below can be
used to identify ammonia as the toxicant and these data
could also be used in Phase 111 confirmation.

       Ammonia is relatively unique in its behavior as
pH changes. When ammonia (NH3) dissolves in water,
some of the molecules react to form the ammonium ion
NH4+, and the equilibrium between these two species is
affected by both pH and temperature (EPA, 1985A). The
term "total ammonia" refers to the sum of the un-ionized
(NH3) and the ionized (NH4+) forms and is referred to as
N+. The toxicity of ammonia to some aquatic species
appears to be primarily caused by the un-ionized form.
The equilibrium shifts to increase the un-ionized ammo-
nia concentration with increasing pH  and  increasing
temperature. In a constant temperature situation, Table
3-1 shows that as pH increases by one  unit, there is
nearly a  10-fold increase in the percent  of un-ionized
ammonia  NH3 present in aqueous solutions at pH 6.0-
8.5. The data in  Table 3-1  are  calculated using the
dissociation constants for ammonia (EPA, 1979). There
are two  effects to consider for ammonia  as the pH
increases; first, the concentration of NH3 increases (Table
3-1) and second, the toxicity of NH3 decreases (Tables
3-2 and 3-3). One possible explanation for the second
effect is that  NH4+ is contributing to the toxicity (EPA,
1985A). Measuring and maintaining the pH of the test
solution and  understanding  the effect of  pH on the
toxicity of ammonia are very important.
       As  discussed in EPA's ammonia  water quality
criteria document (EPA, 1985A), the slope of the LC50-
pH curve for acute toxicity is similar for different aquatic
species (i.e.,  an average slope can be used for many
species). A model  was developed  to describe the  pH
dependence of ammonia toxicity,  primarily with data for
fishes and cladocerans (i.e., daphnids, fathead minnows,
rainbow trout, and coho salmon, see EPA, 1985A). This
model has been used with acute toxicity data generated
at a pH of 8 and a temperature of 25°C for both C. dubia
and fathead minnows, to predict the LC50 of NH3 at other
pH values (Tables 3-2 and  3-3). It  is apparent that the
toxicity of NH3 is about seven times less at pH 7.0 than at
pH 6.0, but the amount of NH3 is ten times greater at pH
7.0 than at pH 6.0. Similarly, at pH 8.0, NH3 is three times
less toxic than at pH 7.0 but ten times more is available at
pH  8.0. Ammonia can  be  implicated as  the cause  of
toxicity if the effluent toxicity and the  suspect toxicant
exhibit both of these pH effects. Acute  toxicity test data
generated at ERL-D indicate that this model is not appro-
priate for all  species. For  example, the  trend of  pH-
dependence  has not been observed  in acute tests
conducted with  the amphipod, Hyalella azteca, over a
range of pH values in reconstituted waters  (EPA, 1991B)
until the hardness is greater than 160 mg/l. In hard or very
hard waters, H. azteca is more sensitive to NH3 at higher
pHs  (P. Monson, personal communication, University of
Wisconsin,  Superior, Wl). We recommend that the effect
of pH on the toxicity of ammonia be characterized for the
TIE organism, if it has not been done,  so that accurate
predictions  can be made for the organism.

       It has not yet been  determined whether the pH
dependence of ammonia toxicity described for acute tox-
icity is appropriate for chronic toxicity. The chronic toxicity
of ammonia to species typically used in effluent tests, at
temperatures similar to those used in TIEs and a variety
of pHs is presented  in Table 3-4.  If chronic ammonia
toxicity has not been characterized with respect to pH for
the TIE species, it is  prudent for the investigator  to
generate the ammonia toxicity data for at least three
distinct pH levels.

       Generally, three procedures  are used to implicate
ammonia in addition  to measuring  the ammonia in the
effluent. These are 1) the graduated pH test (in place of
                                                   3-1

-------
T«blo3
pH
6.0
6.1
6.2
6.3
6.4
6.5
6.6
6.7
6.8
6.9
7.0
7.1
7.2
7.3
7.4
7.5
7.6
7.7
7.8
7.9
8.0
8.1
8,2
8.3
8.4
8.5
8.6
8.7
8.8
8.9
9.0
•1. Percent Un
15
0.0274
0.0345
0.0434
0.0546
0.0687
0.0865
0.109
0.137
0.172
0.217
0.273
0.343
0.432
0.543
0.683
0.858
1.08
1.35
1.70
2.13
2.66
3.33
4.16
5.18
6.43
7.97
9.83
12.07
14.7
17.9
21.5
•Ionized Ammonia in Aqueous Solutions for Selected Temperatures and pH
Temperature (°C)
20
0.0397
0.0500
0.0629
0.0792
0.0865
0.125
0.158
0.199
0.250
0.314
0.396
0.497
0.625
0.786
0.988
1.24
1.56
1.95
2.44
3.06
3.82
4.76
5.92
6.43
9.07
11.16
13.6
16.6
20.0
24.0
28.4
21
0.0427
0.0537
0.0676
0.0851
0.107
0.135
0.170
0.214
0.269
0.338
0.425
0.535
0.672
0.845
1.06
1.33
1.67
2.10
2.62
3.28
4.10
5.10
6.34
7.85
9.69
11.90
14.5
17.6
21.2
25.3
29.9
22
0.0459
0.0578
0.0727
0.0915
0.115
0.145
0.182
0.230
0.289
0.363
0.457
0.575
0.733
0.908
1.14
1.43
1.80
2.25
2.82
3.52
4.39
5.46
6.78
8.39
10.3
12.7
15.5
18.7
22.5
26.7
31.5
23
0.0493
0.0621
0.0781
0.0983
0.124
0.156
0.196
0.247
0.310
0.390
0.491
0.617
0.776
0.975
1.22
1.54
1.93
2.41
3.02
3.77
4.70
5.85
7.25
8.96
11.0
13.5
16.4
19.8
23.7
28.2
33.0
24
0.0530
0.0667
0.0839
0.106
0.133
0.167
0.210
0.265
0.333
0.419
0.527
0.663
0.833
1.05
1.31
1.65
2.07
2.59
3.24
4.04
5.03
6.25
7.75
9.56
11.7
14.4
17.4
21.0
25.1
29.6
34.6
Values1
25
0.0568
0.0716
0.0901
0.113
0.143
0.180
0.226
0.284
0.358
0.450
0.566
0.711
0.893
1.12
1.41
1.77
2.21
2.77
3.46
4.32
5.38
6.68
8.27
10.2
12.5
15.2
18.5
22.2
26.4
31.1
36.3

26
0.0610
0.0768
0.0966
0.122
0.153
0.193
0.242
0.305
0.384
0.482
0.607
0.762
0.958
1.20
1.51
1.89
2.37
2.97
3.71
4.62
5.75
7.14
8.82
10.9
13.3
16.2
19.5
23.4
27.8
32.6
37.9

27
0.0654
0.0823
0.104
0.130
0.164
0.207
0.260
0.327
0.411
0.517
0.650
0.817
1.027
1.29
1.62
2.03
2.54
3.18
3.97
4.94
6.14
7.61
9.40
11.6
14.1
17.1
20.7
24.7
29.2
34.2
39.6
'Data from EPA, 1979.
the equftoxic solution test as described in the first Phase II
document; EPA, 1989A); 2) use of the zeolite resin to
remove the ammonia; and 3)  air-stripping the ammonia
from the sample at a high pH  (i.e., pH 11). For both the
zeolite resin method and the air-stripping method, subse-
quent toxicity tests and ammonia measurements are per-
formed on whole effluent and the post-treatment samples.

        Depending on the presence of other toxicants in
the effluent, additional  sample manipulations  may be
needed before proceeding with the three basic tests. For
example, if toxic oxidants such as chlorine are also present
in the effluent, sodium thiosulfate must be added to the
sample before conducting the Phase II ammonia tests. To
date we have not seen  ammonia and chlorine as co-
occurring toxicants  in chronic tests,  probably because
chlorine degrades rapidly in a test system at 25°C, while
ammonia does not. If the additional toxicant(s) can be
removed by the C18 SPE column, it may be possible to
conduct  Phase II tests  for ammonia on post-C18  SPE
column effluent sample. However, the problem of artifac-
tual toxicity associated  with the post-C18 SPE column
effluent may prevent the use  of the graduated pH test
(EPA, 1992) and/or the air-stripping test (see Section 8 of
EPA, 1991 A) on post-column samples.
       The results of the graduated pH test, the post-
zeolite column test, and the air-stripping test, all will be
important in identifying ammonia as a toxicant in acutely
or chronically toxic samples.  Use of pH  changes where
graded responses are observed are particularly useful for
data evaluation in Phase III correlation steps. Some of the
Phase II tests for ammonia are the same steps that are
used  for Phase III confirmation procedures; therefore,
tests such as spiking the effluent with ammonia and then
performing the graduated pH test or spiking the post-
zeolite effluent samples and then testing the samples
simultaneously with the Phase II tests will support the
confirmation steps in Phase III.
3.2    Toxicity Testing Concerns
       A key issue in interpreting acute or chronic test
results for a pH dependent toxicant such as ammonia is
monitoring pH  changes during the test period. Toxicity
differences  in Phase I manipulations may be misinter-
preted simply because differences in NH3 toxicity can
occur with  only a  slight pH change. To illustrate, the
change in pH from 8.0 to 7.9 lowers the concentration of
NH3 20%, as does a change in pH from 6.1 to 6.0, but a
20% difference is much more important  to the toxicity
                                                   3-2

-------
               Table 3-2.  Calculated Un-lonized Ammonia LCSOs (mg/l) Based on 24-h and 48-h Results of a Ceriodaphnia dubia Toxicity
                        Test Conducted at pH 8.0 and 25°C1
pH
6.0
6.1
6.2
6.3
6.4
6.5
6.6
6.7
6.8
6.9
7.0
7.1
7.2
7.3
7.4
7.5
7.6
7.7
7.8
7.9
8.02
8.1
8.2
8.3
8.4
8.5
8.6
8.7
8.8
8.9
9.0
Percent
Dissoc.
at 25°C
0.0568
0.0716
0.0901
0.1134
0.143
0.180
0.226
0.284
0.358
0.450
0.566
0.711
0.893
1.12
1.41
1.77
2.21
2.77
3.46
4.32
5.38
6.68
8.27
10.2
12.5
15.2
18.5
22.2
26.4
31.1
36.3
Un-ionized
Ammonia
Expected
24-h LC50
0.09
0.12
0.14
0.18
0.22
0.27
0.33
0.40
0.48
0.58
0.69
0.81
0.93
1.06
1.21
1.34
1.48
1.61
1.73
1.83
1.93
2.01
2.08
2.14
2.19
2.23
2.27
2.30
2.32
2.34
2.35
Total
Ammonia
24-h LC50
158
168
155
159
154
150
146
141
134
129
122
114
104
95
86
76
67
58
50
42
36
30
25
21
18
15
12
10
8.8
7.5
6.5
Un-ionized
Ammonia
Expected
48-h LC50
0.07
0.09
0.11
0.14
0.17
0.21
0.25
0.31
0.38
0.45
0.53
0.62
0.72
0.82
0.93
1.04
1.14
1.24
1.33
1.42
1.49
1.55
1.61
1.65
1.69
1.73
1.75
1.77
1.79
1.81
1.82
Total
Ammonia
48-h LC50
123
126
122
123
119
117
111
109
106
100
94
87
81
73
66
59
52
45
38
33
28
23
20
16
14
11
9.5
8.0
6.8
5.8
5.0
               1 LCSOs for each pH interval were calculated using EPA's water quality criteria document formula (EPA, 1985A)
                shown below.
                                                    (LC50[pH = 8.0])(1.25)
                                    Formula LC50 = •
                                                         1 + 10
                                                              7.4-pH
               2The 24 h and 48 h LC50s to C. dubia are 1.93 mg/l and 1.49 mg/l, respectively, at pH 8.0. The formula was used to
                generated expected LC50s for pH values above 8, though the model is not recommended above pH 8, because
                generally we have found C. dubia data to track with these predictions.
expressed by the ammonia at pH 8.0 than at pH 6.0. For
this reason frequent pH monitoring (at least daily) must be
performed on tests conducted to determine the trend of
ammonia toxicity. Ideally, continuous monitoring of pH is
desired. The pH should be measured on each test con-
centration and each replicate. Experience has shown that
the choice of pH meters and probes is critical to produce
reliable results. The pH meter used must read accurately
to two decimal places and should lock-on the stabilized
reading after the  rate of change has  diminished to  a
specified  rate. Routine cleaning of the probe and a stan-
dardized  calibration procedure  should be  established.
The pH values can also be recorded after an  elapsed time
of 60-90 sec. The pH readings should be made using a
constant and reproducible stirring rate. The stirring should
not result in excessive loss (or gain) of CO  which will of
course change the pH. The choice of the pH electrode is
important. We have found that the glass-bodied combina-
tion electrodes provide the most consistent pH readings.
However, these should not be left in the test solutions for
longer than is needed to obtain constant readings of pH
because ions from the electrode reference solution  can
leak into the test solution, potentially causing artifactual
toxicity.

        For the Phase II  ammonia toxicity tests more
replicates (at least double that used in Phase I) must be
used and tighter QA/QC procedures must be adhered to
than those described in the acute  or chronic Phase  I
manuals (see Section 1.2). For example,  a control and at
least four effluent dilutions using concentrations that more
closely bracket the effect and no effect concentrations
(that were determined in Phase I) are used. While param-
eters such as time to mortality or onset  of symptoms in
the acute and chronic tests are not an integral part of the
tests described below, these observations may be very
                                                      3-3

-------
 Table 3-3,   Calculated Un-lonized Ammonia LCSOs (mg/l) Based on 24-h, 48-h, 72-h, and 96-h Results of a Fathead Minnow (Pimephales
            pnmelas) Toxicity Test Conducted at pH 8.0 and 25°C'
pH
6.0
6,1
6,2
6.3
6.4
6,5
6,6
6,7
6,8
6.9
7.0
7.1
7.2
7.3
7.4
7.5
7.6
7.7
7.8
7.9
8.0
Percent
Dissoc.
at253C
0,0568
0.0716
0.0901
0.1134
0.143
0.180
0.226
0.284
0.358
0.450
0.566
0.711
0.893
1.12
1.41
1.77
2.21
2.77
3.46
4.32
5.38
Un-ionized
Ammonia
Expected
24-h LC50
0.075
0.093
0.12
0.14
0.18
0.22
0.27
0.32
0.39
0.47
0.56
0.65
0.76
0.87
0.78
1.09
1.20
1.30
1.39
1.48
1.56
Total
Ammonia
24-h LC50
131
130
128
127
124
121
118
114
109
104
98
91
85
77
55
62
54
47
40
34
29
Un-ionized
Ammonia
Expected
48-h LC50
0.064
0.080
0.10
0.12
0.15
0.19
0.23
0.28
0.34
0.40
0.48
0.56
0.65
0.75
0.67
0.94
1.03
1.12
1.20
1.27
1.34
Total
Ammonia
48-h LC50
113
112
111
109
107
104
102
98
94
90
85
79
73
67
48
53
47
40
35
29
25
Un-ionized
Ammonia
Expected
72-h LC50
0.049
0.061
0.076
0.094
0.12
0.14
0.18
0.21
0.26
0.31
0.36
0.43
0.50
0.57
0.51
0.72
0.79
0.85
0.91
0.97
1.02
Total
Ammonia
72-h LC50
86
85
84
83
81
80
77
75
72
68 '
64
60
56
51
36
40
36
31
26
22
19
Un-ionized
Ammonia
Expected
96-h LC50
0.036
0.045
0.056
0.069
0.086
0.11
0.13
0.16
0.19
0.23
0.27
0.31
0.36
0.42
0.38
0.53
0.58
0.63
0.67
0.71
0.75
Total
Ammonia at
96-h LC50
63
63
62
61
60
58
57
55
53
50
47
44
41
37
27
30
26
23
19
17'
14
'LCSOs for each pH interval were calculated using EPA's water quality criteria document formula (EPA, 1985A) shown below. The 24-h, 48-h,
72-h, and 96-h LCSOs to fathead minnows are 1.56 mg/l, 1.34 mg/l, 1.02 mg/l, and 0.75 mg/I, respectively, at pH 8.0.
                                        Formula LC5Q =
(Z.C50[pH = 8.0])(1.25)

      1 + 107'4-""
Table 3-4. Un-Ionlzed Ammonia Toxicity Values for Species Frequently Used in Effluent Testing

Species                           Method1              pH            Temp (°C)
                                  LC502 (rng/1)
ChV3

C.dubisf
C. acanthla?-'
Simocephakis vstutus?-'
C.dubla'
C.dubia'
Daphnfamagnsf
P. pmmelas?
P. prome/as*
P. promalas?

C.dubtt?
C. <*/iwV
C. scanthia?-'
D. nwgna?
C.duW
P. pfomelasf
P. promefos*
P. pcomefas*
P. prome/os4

S, M
FT.M
FT.M
S.M
S,M
S,M
FT,M
FT, M
FT, M

4d-R, M
4d-R, M
7d-FT, M
NR
4d-R, M
FT, M
7d-R, M
7d-R, M
7d-R, M
Acute Data
6.2
7.1
7.1
7.2
8.2
8.2
7.8
8.0-8.3
8.1
Chronic Data
6.03
7.05
7.0-7.5
7.6
8.03
8.0
7.5-7.6
7.5-7.7
8.4

25
24
24
25
25
25
25.6
25.2
26.1

25
25
24-25
20.2
25
24.0
25.0
25.0
25

0.12
0.77
0.61
0.78
1.73
2.08
1.87
1.65
2.55


„
__
__
__
—
..
~"
—

_.
..
__
__
	
—
—
„
—

0.065
0.28
0.34
0.63
0.62
0.13
0.48
0.45
0.66
'FT - (tow-through; S « static; R m renewal of solutions at 24 or 48 h; M = measured concentration; NR = not reported.
*48-h LC50 for invertebrates and 96-h LC50 for fish.
*ChV • chronic value which is the geometric mean of the no observed effect concentration (NOEC) and the lowest observed effect concentration
 {LOEC)oranlC25.
••Data generated at ERL-D.                                                                                                    >
*C. acanthia is equivalent to C. dubla.
«Data from EPA, 1985A.
'Data from 4-d C, dubfa tests conducted at ERL-D; the effect level is an IC25 (mg/l)
'Data from Betgger, 1990.
                                                              3-4

-------
useful in describing the identification steps used in con-
firming ammonia as the cause of toxicity.


3.3     Measuring Ammonia Concentration
        We have found that the ammonia-selective elec-
trode method has been satisfactory for measuring the
ammonia concentrations in most samples, (EPA,  1983;
APHA, 1992). Other methods for measuring ammonia are
available (such as distillation, nesslerization, and titration)
and can be used successfully for determining ammonia
concentrations in effluents (EPA, 1983; APHA, 1992).
The level of detection for total ammonia generally need
not be below 0.5-1.0 mg/l, since concentrations of <1.0
mg/l  of total ammonia have not been found to be toxic to
fathead minnows and  C.  dubia. If ammonia  measure-
ments are below 1 mg/l and the sample is toxic, it is likely
that the toxicant is not ammonia and other identification
procedures should be pursued.

        The most reliable ammonia measurements are
obtained on fresh samples. However, samples can  be
preserved by adding concentrated sulfuric acid and stor-
ing the samples at 4°C. The pH of the preserved samples
should be in the range of 1.5 to 2.0 (EPA, 1983; APHA,
1992). In recent experiments, we have used samples that
were stored without acidification at 10°C or refrigerated at
4°C for short periods with good success.

        During several effluent tests, the amount of am-
monia in the test solutions (see test details below) has
decreased over the duration of the test. When levels are
in the  range of 0-30 mg/l, it is prudent to measure the
initial concentration of ammonia in the test solution and
again after animals were exposed.


3.4     Graduated pH Test
        The purpose of the Phase II graduated pH test is
to provide more definitive toxicity test data  to implicate
ammonia as the toxicant in Phase II. In turn, this data may
be used in Phase III to confirm the role of ammonia in the
toxicity of the effluent. More stringent pH control and  pH
monitoring  will  be needed to interpret test results and
more precise  toxicity  estimates (i.e., more replicates,
more dilutions, larger number of organisms;  see Section
1.2; EPA, 1991 A; EPA, 1992) are needed in Phase  II than
in Phase I. When it  is important to predict the impact of
the toxicant in the receiving water, the pH of the dilution
water should be maintained at receiving water pH. The
test procedures discussed below provide good pH control
for the  graduated pH test. Greater detail is  provided for
some of the procedures in Phase I (EPA, 1991 A; EPA,
1992).

      The test chamber size, number of dilutions, species
to be  tested,  type of  test (acute or chronic), and the
degree of toxicity of the effluent will dictate the volume of
effluent needed for the graduated pH test. As a general
guide for acute toxicity tests, 300 ml  of effluent should
suffice  for any of three pH adjustment tests described
below. The volume for chronic tests will vary based on the
type of  chronic test  performed, the species used, the
number of concentrations tested, and number of solution
renewals in addition to the items discussed above (Sec-
tion 1.2  and EPA, 1992).

        The procedure for conducting the graduated pH
test  is to evaluate  and determine the toxicity of the
effluent  at three different pHs (e.g., 6.0,7.0, and 8.0). The
pH should be measured in all of the chambers. If the pH
drifts 0.2 pH units or more, the results may not be usable
and better pH control must be achieved. However, if pH
fluctuates more than  0.2 pH units and toxicity is present
only, at one pH, the toxicity results may still be useful. The
pH levels selected must be within the physiological toler-
ance of the test  species used  (which generally is a pH
range of 6 to 9).  We  recommend use of two methods of
pH control and comparison of these results to determine
that the pH adjustment  itself did not introduce an artifact
of toxicity. This type of testing may be critical to explaining
effects in Phase  III (EPA, 1993A).

        Regardless of the pH control method chosen, the
selection of the appropriate blank is difficult. The change
in pH of the dilution water or surface water is not compa-
rable to that of the effluent because the composition of the
solutions are different. For some effluents, the addition of
either acid or base can be used to adjust and hold the pH
within 0.1 pH unit. If this is possible, this technique can be
used to compare the  results  with either the CO2-pH
controlled test or the buffer-pH controlled test. Test re-
sults should be  similar and these comparisons  can be
used as a basis for identifying ammonia as a toxicant.


3.4.1   pH Control: Acid/Base Adjustments
        The first method  of pH adjustment is the acid/
base adjustment described in Phase I (EPA, 1991 A; EPA,
1992). For this  manipulation,  the adjustment of pH is
relatively easy and quick,  and the loss of volatile com-
pounds is minimized. However, the drawbacks are that:
toxicity enhancement from the additives may occur (espe-
cially in a chronic TIE), the addition of strong acid or base
disrupts the carbonate system  equilibrium, the effects of
the pH change in the blanks may not serve as a toxicity
control for the effluent, the pH stabilization time is lengthy,
and pH tends to drift in longer term tests. In the pH range
6 to 9, the amount of high quality acid or base added is
usually  negligible, and the likelihood of toxicity caused by
increased salinity levels is low.

        The pH of each concentration and replicate must
be frequently monitored because a constant pH during
the toxicity test must  be maintained. Larger test volumes
may be useful  to prevent rapid pH  fluctuations. The
amount of acid and/or base added should be recorded for
each pH adjustment  to track the additive  amount in the
effluent samples and the blanks. If toxicity  increases
dramatically, the concentrations of salts should be calcu-
lated to be sure  the salinity has not increased above the
tolerance level for the TIE species.
                                                    3-5

-------
 3.4.2   pH Control: CO, Adjustments
        The second method  uses CO2 to adjust and
 control test solution pH. The pH is adjusted by varying
 and controlling the CO2 concentration of the gas phase
 over the water or effluent sample in closed headspace
 test chambers. It is necessary to maintain a constant pH
 throughout the test period. The pH of most natural waters
 and some effluents is controlled by the bicarbonate buff-
 ering system and surface waters normally contain <10
 mg/I of  COr Therefore, the amount of CO2 to add de-
 pends on the desired pH  and the chemistry of  each test
 solution. The CO2 adjustment has the advantages that the
 pH is controlled without placing additives directly into the
 effluent  test solutions, the pH change  is easy  to make,
 and the  pH is generally stable for at least 24 h if the gas-
 tight container is not opened. Frequent pH measurements
 are still possible because the headspace can be  ref lushed
 with a predetermined concentration of CO2/air. The disad-
 vantages are that toxicrty can  occur from the  CO2, the
 concentration of CCyair varies for each dilution  and efflu-
 ent (which requires sample specific experimentation) and
 the manipulations for chronic tests can be time-consum-
 ing relative to the acid/base adjustment method. We have
 not observed any increased toxicrty from the addition of
 CO8 unless the concentration in the chamber is over 10%.

        Adjustments of the pH to 6.0 or 7.0 can be made
 by using CO2 with or without first adding HCI to the test
 concentrations. The CO2 is purchased in pure form through
 local commercial gas suppliers, and if particular concen-
trations of COj/air are frequently used, a cylinder of gas of
the desired concentration may prove to be resource-
 efficient. The amount of CO2 needed to adjust the pH of
the solution Is dependent upon sample volume, the test
 container volume, the desired pH, the temperature, and
the effluent constituents (e.g., dissolved solids). Some
 preliminary work is needed to determine the concentra-
tion of CO2 to add to  achieve the desired pH. When
 dilutions of an effluent have the same hardness and initial
 pH as the effluent, about the same amount of CO  will
 usually be  needed for each dilution. Sometimes, higher
concentrations of CO2  are  needed for the higher test
concentrations. Use of a dilution water of similar  hardness
 as the effluent may make the CO2 volume adjustments
 easier. A different dilution water may only be used in
these tests if  the toxicity has not been shown to be
dependent on water hardness at any pH.

        In our  laboratory, we have found that glass  can-
 ning jars with rubber seals and metal balers work well as
 a gas-tight testing chamber. The testing chamber should
 be large enough to hold the desired number of test cups,
with sufficient headspace to ensure proper DO levels. For
 example, a 2-quart glass canning jar lying on its side will
 easily hold  6-1 oz cups. We simultaneously test C. dubia
 and fathead minnows in the same chamber using the test
solution  volumes described  in Section  1.2. Since many
plastics  are permeable to  CO2, glass containers are rec-
ommended. When CO,,/air is flushed into the headspace
of the test chamber, the pH of  the test  solutions  will
usually reach equilibrium in about 1 h and a reliable pH
can be achieved. Generally, as the alkalinity increases,
the concentration of CO2 that is needed to maintain the
pH also increases. After 1 h, check the pH of the solutions
and flush the chambers again. Check the pH again after
2-3 h and from these data determine the concentration of
CO2 to add for initial pH adjustment for the  actual toxicity
test and the amount needed for ref lushing after the cham-
ber is opened for feeding or pH measurements. In most
instances, the amount of CO2 produced by the test organ-
isms will not cause further pH shifts. When testing with
fish, which usually increase in size during the test, a pH
fluctuation  may occur that  would require  flushing with
different (e.g., slightly lower) concentrations of CO2.

       When the concentration of CO2 to inject for the
target pH values has been determined, prepare test solu-
tions, add test organisms  (and food if necessary) and
inject the appropriate concentration of CO2 in air using a
1-liter gas  tight syringe, and quickly close the test cham-
ber. The chambers should  be flushed with the CO^air
mixture several times to ensure the displacement of air
currently in the chambers. Place the chamber out of direct
laboratory  light, as temperatures tend to rise out of the
desirable test range in the closed chambers.

       For effluents that have initial pH values from 7.8
to 8.5,0-10% CO2 concentration in the chamber has been
used to lower the pH to 6.0. Experiments in  hard reconsti-
tuted  water have shown that up to  8%  CO2  can be
tolerated by C. dubia and fathead minnows  in acute tests,
but 8% has been toxic to C. dubia and fathead minnows in
the 7-d tests. About 2-3.5% usually will lower the pH of
most effluents to 6.5-7.0. If more than 10%  CO2 for acute
tests or 5% CO2 for chronic tests  is  needed to lower the
pH of the test solutions, before adding test animals adjust
the pH with high quality acid (EPA, 1991A; EPA, 1992)
and then flush the headspace with CO^air. The neces-
sary concentration of CO2 to use must first be determined
experimentally with effluent test solutions adjusted to the
appropriate pH with acid solutions. Sometimes >5% CO2
cannot be  used for the dilution water pH adjustment test
without the CO2 causing toxicity.

       The use  of a single encloised test chamber for
controlling the pH at all test concentrations  may allow the
transfer of volatile compounds among treatments. We
have experienced volatilization of ammonia in tests and
therefore, individual test chambers for each effluent con-
centration  are preferable. Methods that use continuous
flow of a CO2/air mixture, such as tissue cell incubators,
may be preferable and give better pH control provided
that volatilization or cross contamination is not a problem.
At this time we have not attempted to use a continuous
flow of COj/air mixture and therefore cannot recommend
a system to use.
                                                   3-6

-------
        Maintaining pH above the air equilibrium pH (gen-
erally above pH 8.3) is difficult without buffers (Section
3.4.3). The pH control in this high range is much more
difficult because the concentration of CO2 must be very
low and microbial respiration can increase the CO2 levels
in the test chamber. Use of CO2-free air in the headspace
may work or flushing a mixture of CO2-free air and normal
air through the headspace or test solution may be suc-
cessful. Because  such  small CO  concentrations are
needed and because CO2 evolution by microorganisms or
test organisms can significantly alter the CO2 concentra-
tion, frequently flushing (two to four times a day) of the
headspace in, static tests will probably be required to
adequately control  pH. For the chronic tests, we have not
attempted to  use the  CO2-free air bubbled through the
test solution, because more CO2 evolution tends to occur
during the chronic tests and the need for reflushing makes
the test labor intensive.

        For the CO2-pH controlled tests, the pH should be
measured at least every 24 h for both acute and chronic
tests and ideally, continuously during pH controlled tests.
At each reading, flush the headspace with the CO,/air
mixture. A small amount of experimentation will confirm
whether the concentration of CO2 previously determined
is adequate, or whether the amount required for flushing
will be less than that used for the  initial pH adjustment.

        For chronic tests, daily renewal  solutions should
be prepared, pH adjusted with HCI  if necessary, dis-
pensed into test cups, and placed into a second glass jar
chamber and flushed  with appropriate concentration of
CO2. These should be left to  equilibrate at least  1-2 h.
Measure the pH  quickly and transfer the animals to new
test cups and place them into the glass jar. Flush the
headspace again with the appropriate  CCyair mixture.
Table 3-5.    Percent Un-lonized Ammonia in Aqueous Solutions at
           25°C and Various TDS Levels'
TSD
(mg/l)
0
250
500
750
1000
1500*
2000
3000

6.0
0.0568
0.0521
0.0505
0.0494
0.0485
0.0471
0.0460
0.0443
PH
7.0
0.566
0.519
0.503
0.492
0.483
0.469
0.458
0.441

8.0
5.38
4.96
4.81
4.71
4.63
4.50
4.40
4.24

9.0
36.2
34.3
33.6
33.1
32.7
32.0
31.5
30.7
'Data from Skarheim (1973).
 For the 7-d tests with fathead minnows, the chambers
 must be opened once more each day to accommodate
 the feeding schedule. The experimenter can take advan-
 tage of this by making a pH reading prior to placing food
 into the test cups. CO/air must again be flushed into the
 chamber. It is important to note that in the fathead min-
 now test, the pH most likely will be lower after 24 h than in
 the C. dubia test because of the  food  added and the
 respiration of the fish which is considerably greater than
 that of C. dubia.

        Measurements of pH must be  made rapidly  to
 minimize the CO2 exchange between the sample and the
 atmosphere. Avoid vigorously stirring unsealed samples
 because at lower pH  values, the  CO   lost during the
 measurement can cause a substantial pH rise. If possible,
 measure the DO at the same time because ammonia may
 have  different toxicities when DO  is decreased  (EPA,
 1985A). Keep in mind that if the test animals have been
 dead for awhile, the pH and/or DO of the test water most
 likely will have changed.

        The controls in the CO2 chamber and the baseline
 test act  as  checks on the general  health of  the test
 organisms, the dilution water and most test conditions. If
 the effluent pH in the baseline test is close to the pH of the
 adjusted test solutions (at their respective LCSOs, IC25s
 or ICSOs), the toxicity expressed in the two tests should
 be similar. Significantly greater toxicity in the pH-adjusted
 test may suggest interference from other factors such as
 the ionic strength related toxicity if the pH was  adjusted
 with either HCI or NaOH, or possibly CO2 toxicity. Dilution
 water blanks at the various pH levels may or may not be
 appropriate since the effluent  matrix may differ from that
 of the dilution water. The  dilution  water blank will be
 useful in checking the acids and bases that are added for
 artifactual toxicity. Monitoring the acid and base additions
 may be useful in determining if artifactual toxicity resulted
 from the increase in salt content. Monitoring conductivity
 of the effluent solutions after the addition of the acids and
 bases may also be helpful in determining artifactual toxic-
 ity.  The  ionic strength of hardwaters or saline waters
 results in a decreased level of un-ionized ammonia (Table
 3-5). For values of TDS from 0-500 mg/l, the dissociation
 constants are expected to be more  accurate than values
 above 500 mg/l that were based on somewhat tenuous
 assumptions (Skarheim, 1973; see Table 3-5).


 3.4.3  pH Control: Buffer pH Adjustments
       The third method of pH control uses the addition
 of standard  buffers  to the effluent and dilution water to
 adjust the pH. This method has the  advantage in that pH
 is stable with the buffer addition, the pH change during a
test is slow, frequent  pH measurements  are  possible
 because test vessels  are not  in air-tight  chambers, and
the test method set-up is rapid. The disadvantages are
that toxicity enhancement or interference from buffers
 may occur, not all buffers can  be used without additional
                                                    3-7

-------
acfd/base adjustments, and the pH stabilization time may
be lengthy.

       Hydrogen ion buffers are used to maintain the pH
level In the graduated pH test (EPA, 1991 A; EPA, 1992).
Three hydrogen ion buffers were used by Neilson et al.
(1990) to control  pH in toxicity tests in concentrations
ranging from 2.5 to 4.0 mM. These three buffers were
chosen based on the work done by Ferguson et al.
(1980). These buffers are: 2-(N-morpholino) ethane-sul-
fonlc acid (Mes) (pK = 6.15), 3-(N-morpholinp) propane-
sulfonlc acid (Mops) (pK. = 7.15), and piperazine-N,N'-bis
(2-hydroxypropane) sulfonic acid (Popso) (pKa = 7.8). We
have also used two additional buffers: N-(2-hydroxyethyl)
pIperazine-N'-2-hydroxypropanesulfonic acid  (Heppso)
(pKa  » 7.8)  and N-tris-(hydroxymethyl)  methyl-3-
amlnopropanesulfonic acid (Taps) (pKa = 8.4). The Taps
buffer Is  more frequently used than the Heppso buffer.
We have experienced problems  of  having to  add an
excessive amount of base to obtain the desired  pH with
the Popso buffer. The Taps buffer effectively maintains
the pH above 7.8. Keep in mind that pH is best main-
tained at or near the pKa of the buffer.

       The acute toxicity of these buffers is low to both
C. dubfe and fathead minnows (EPA, 1991 A) and 4 mM
concentration or less  of all five buffers has not caused
chronic toxicity to C. dubia or the fathead minnow.  The
buffers are  added at sublethal (e.g., NOEC) levels  to
maintain  the pH of test solutions.  While these buffers
serve to  prevent the pH from drifting during the test, pH
adjustment to the desired level is required in the prepara-
tion of the solution. A portion of the buffer compound is
weighed  out and added to the  aliquots of whole effluent
and dilution water, and both are then pH adjusted  with
acid or base solutions to  the desired pH values. Serial
dilutions  are made, replicates prepared, and test organ-
isms are added. Care should be taken to ensure equilib-
rium of buffered solutions, which may take at least 1-2 h.
Dilutions should also be left to equilibrate and minor pH
adjustments should be made. In certain situations, it may
be desirable to prepare the solutions the day before tests
begin. At present, we  have found  we can use batch
solutions prepared ahead of time for solution renewals.
Our experience also  indicates that the amount of any
buffer needed to hold any pH is effluent specific. Experi-
mentation with effluents will be required to determine the
lowest concentration  of buffer needed to maintain the
desired pH. The test solutions need not be covered tightly
to maintain pH; however, pH should be measured at each
test reading at all dilutions.

        Use of the buffers is still being developed and the
effects caused by interferences  from the buffers them-
selves have not been fully studied. It is possible that the
buffers may reduce the toxicity of some toxicants, but this
has not generally been seen.
3.5    Zeolite Resin Method
       Zeolite is composed  of  naturally occurring or
synthetically created crystalline, hydrated alkali-aluminum
silicates. The general formula is Mn+O*AI2O3-ySiO2*zH2O;
M = group IA or IIA element, n = +2. for group IA, +1 for
group IIA, y>2, and z = the number of water molecules
contained in the interconnected voids or channels within
the zeolite (Windholz, et al., 1983). When zeolite is placed
in aqueous solutions, the positively charged group IA or
IIA  elements  (Mn+)  of the zeolite are mobile and can
undergo exchange with other  cations  in the water. As
such, zeolite has frequently been employed as ion ex-
change resins to remove the ammonium ion (NH4+) from
aqueous  solutions in TIE work (Ankley et  al., 1990S;
Burkhard  and Jensen,  1993).  Because of its ability to
exchange other cations such as heavy metals, and its use
as molecular sieves, filter adsorbents and catalysts, zeo-
lite  was not suggested for use in Phase I, except as a
subsequent test (EPA, 1991 A). Zeolite can be effective in
Phase II,  if Phase  I results implicate  ammonia as the
toxicant and establish that other types of toxicants (such
as non-polar organics  and metals) play no  role  in the
effluent toxicity.

       For the  acute  TIE procedure,  zeolite particles
should be screened to be in the range of 32 to 95 mm, to
ensure efficient ion exchange while preventing channel-
ing or excessive  resistance to flow. Extremely large or
small particles can be removed by screening the zeolite
with sieves or mesh screens. The zeolite column can be
prepared by taking 30 g of aquarium zeolite (Argent Chemi-
cal Laboratories, Redmond, WA) and adding it to 60 ml of
high-purity water. The zeolite slurry  is poured  into  a
chromatography column (11 mm  i.d. x 15 cm) and three
bed volumes of dilution water are passed  through the
column. The last 10 ml of dilution water is collected for
use as a zeolite blank and should not be toxic. Next, 200
ml of 100% effluent is  passed through the column at a
rate of 2 ml/min. The post-column effluent that is collected
will be toxicity tested  and its ammonia concentration
measured. Temperature and  pH should be recorded at
test initiation to provide the means to calculate both total
and un-ionized ammonia in the sample.

        For chronic toxicity tests larger amounts of zeolite
should be used. This can be scaled up proportionally from
the amounts used in the acute zeolite work. The amounts
of solution needed for testing and ammonia measure-
ments will dictate  the amount of sample to prepare.
Typically  a slurry of 60 g of zeolite and 120 ml of high
purity water is sufficient for levels of ammonia in the range
of 5-50 mg/l and for processing 2,000 ml of effluent. The
post-zeolite effluent is collected in aliquots, then each is
toxicity tested. In this manner, break-through of ammonia
can be measured and toxicity of the various samples with
different ammonia levels can be estimated.
                                                     3-8

-------
        Toxicity tests and ammonia measurements are
conducted on the effluent and post-zeolite column efflu-
ent. Removal of toxicity by the zeolite column and re-
moval of the ammonia concentration will add to  the
evidence implicating ammonia as the toxicant. An aliquot
of the effluent sample (not having passed through the
zeolite column)  is used for ammonia analysis  and the
baseline toxicity test. These data will be compared with
the same  data  for the post-zeolite column effluent to
determine if the post-column reduction in effluent toxicity
is consistent with ammonia removal by the zeolite. The
control for test organism survival, dilution water quality
and other test conditions will be provided through toxicity
tests on dilution water. Dilution water (at the same hard-
ness as the effluent) should be passed through the zeolite
column, and will act as a blank for toxic artifacts leached
from the zeolite. Increased toxicity in the post-zeolite
effluent, relative to the whole effluent, indicates the pres-
ence  of toxic artifacts. Since many cations will be  ex-
changed, adding solids in the acute tests, such as  the
YCT food (yeast-Cerophyl®-trout food) fed to C. dubia,
might improve control survival. Additional clean-up tech-
niques for the zeolite (such as Soxhlet extraction) or
alternate uncontaminated sources of zeolite might be
needed:  Column packing, effluent pH, ammonia levels,
and flow rate through the column can all affect the effi-
ciency of the cation exchange process. Lowering effluent
pH prior to zeolite treatment and/or lowering flow rate
through the column might also result in greater removal of
ammonia. Occluded gas between zeolite particles might
also impair the column's capacity to remove ammonia. If
this appears to be a problem, the zeolite slurry should be
degassed by using a vacuum prior to pouring it into  the
column.

       Zeolite columns can be  regenerated, but fresh
zeolite should be used to pack columns the first time. If
the graduated pH test and the zeolite test results  are
consistent with ammonia toxicity, Phase III confirmation
procedures should be started.

       Once ammonia is identified  and confirmation is
initiated,  the post-zeolite samples can be  spiked with
ammonia at the  same  concentrations as are present in
the effluent. These tests are an integral part of the Phase
III confirmation process (EPA, 1993A).


3.6    Air-Stripping of Ammonia
       This method of ammonia removal takes, advan-
tage of the fact that the  relatively volatile  un-ionized
ammonia (NH3)  predominates in a  solution  with a  pH
above 9.3. For this reason, one might expect that ammo-
 nia would be removed during the Phase I pH 11  adjust-
 ment/aeration test (acute testing) or the pH 10 adjustment
 and aeration test (chronic testing). Based on our experi-
 ence ammonia is not removed by this method, most likely
 because the Phase I aeration manipulation is done in a
 graduated  cylinder, which has  a low surface-to-volume
 ratio. By stirring the sample for a longer period of time
 (>1 h) at a high pH (pH 9.0 or higher) in a containerthat allows
 a large surface area to volume ratio, most of the ammonia
 can be removed from aqueous samples.

        A measured amount of effluent for subsequent
 analysis and testing is pH adjusted to 10 or 11 and placed
 into a large shallow glass container (e.g., 1000 ml crystal-
 lizing dish). The solutions are then agitated (stirred) con-
 tinuously. The length of time the sample  must be stirred is
 dependent on the concentration of total ammonia in the
 sample. We have found that for most samples of 10-100
 mg/l of total ammonia, 1-6 h is adequate to remove most
 of the ammonia.  After air-stripping  is  completed, the
 volume  of effluent should be measured and any appre-
 ciable loss replaced with high purity water or toxicity might
 be caused by the concentration of other components in
 the effluent. The ammonia concentration should be mea-
 sured immediately after air-stripping and  after volume
 adjustment is complete to  ensure ammonia levels are
 reduced before toxicity tests are initiated. Toxicity tests on
 the air-stripped solution can then be conducted for both
 acute and chronic TIE work.  Dilution water blanks at the
 various  pHs  may or may not be appropriate since the
 effluent matrix will probably differ from that of the dilution
 water. Monitoring the acid and base additions may be
 useful to determine if artifactual toxicity resulted from the
 increase in salt content and subsequent evaporation that
 occurred during the air-stripping  process. Monitoring con-
 ductivity of the effluent  solutions after the addition of the
 acids and  bases  may  also be helpful in  determining
 artifactual toxicity. The  dilution water blank should be
 treated in the same  manner as the effluent although it
 may not serve as a true toxicity control for the effluent.

       If the ammonia is decreased and the toxicity is
 reduced or absent after air-stripping, ammonia is strongly
 implicated as a contributing factor to the toxicity of the
 effluent. The results of this test should be compared with
the aeration test  results of Phase I, the  baseline effluent
test and the other graduated pH tests. Other compounds
 could precipitate as a result of the pH adjustment and
during the air-stripping procedure. Precipitates may form
during the air-stripping process and not dissolve after the
volume is readjusted, leaving these compounds unavail-
 able.
                                                    3-9

-------

-------
                                              Section 4
                                                Metals
 4.1     General Overview
         This section contains procedures that can be
 used to identify suspect metal toxicants. The initial evi-
 dence  used to implicate metallic toxicants is obtained
 from the Phase I characterization tests, with the results
 of the EDTA (ethylenediamine tetraacetic acid) addition
 test providing  the best indication of the presence of a
 metal toxicant. When certain cationic metal toxicants are
 present, a reduction in sample toxicity with the addition
 of EDTA should be observed. Other Phase I  manipula-
 tions that remove or reduce sample toxicity and suggest
 the  presence  of a cationic metal include the sodium
 thiosulfate addition test, the use of a C18 SPE column,
 and filtering the sample when combined with minor pH
 adjustments. One additional indication of metal toxicity
 may be when the organisms' response in the toxicity test
 is atypical of the expected dose response relationship
 (i.e., partial mortalities  in several test  concentrations
 Schubauer-Berigan et al., 1993B).

        Subsequent Phase I tests such  as  using ion
 exchange resins might also lead one to the conclusion
 that a metal is the toxicant. Toxicity removal or reduction
 after a sample  is treated with an anion exchange resin
 might implicate toxicants that exist as anionic oxides in
 water, such  as arsenic,  chromium, and/or selenium.
 These anionic oxides will not be specifically removed or
 rendered biologically unavailable by the routine Phase I
 tests. Therefore, when the Phase I tests  do not seem to
 show any  toxicity reduction, toxicants such  as these
 might be suspected and subsequent tests as discussed
 above could be useful (see Phase I, EPA,  1991A; EPA,
 1992). These situations should be approached on an
 individual basis since other classes of toxicants might
 demonstrate the same behavior in Phase I (e.q. total
 dissolved solids (TDS)).

        Further discussion and interpretation of the Phase
 I results which would lead to  the conclusion that a
 cationic metal  toxicant was present in  a sample are
 provided in the Phase I TIE documents (EPA,  1991 A-
 EPA, 1992).

       Other information, such as process details from
the discharger and information from past TREs and/or
TIEs, might also help to implicate cationic metals as the
 toxicants/However,  this type of information should be
 interpreted and used with caution as it might bias the TIE
 efforts.

         If the EDTA addition test in Phase I  showed that
 toxicity was removed or reduced one should proceed to
 the metal analysis  section  (Section 4.2). This section
 provides guidance and  recommendations for analyzing
 samples for metals  so that a list of suspect metal toxi-
 cants can be obtained. This section also discusses clean
 metal techniques, detection limits, a prioritization process
 for analyzing for specific metals, dissolved vs biologically
 available metals,  and provides the rationale for assem-
 bling the list of suspect metal toxicants. Prioritizing metals
 to analyze from Phase I results is strongly recommended
 in order to save money and time in the TIE process.

         If other Phase I tests implicate a meta! but EDTA
 does  not, it may be  helpful  to acquire additional test
 information through the use of EDTA addition tests so-
 dium thiosulfate addition tests, graduated pH tests, and
 ion-exchange resins. This additional toxicity testing  (Sec-
 tion 4.3) may be useful in certain situations before analyz-
 ing for metals, even when EDTA additions reduced toxicity.
 These situations include: when the addition tests of EDTA
 and sodium thiosulfate in  Phase I were performed using a
 single sample concentration (i.e., no dilutions), when the
 time it takes to obtain results of metal analyses is lengthy,
 or when Phase I results indicate another type of toxicant
 (non-metal) is present. The data obtained from the  addi-
 tional testing can  then be included in the prioritization
 process  for metals analysis. Professional judgement is
 required to decide when you have sufficient and appropri-
 ate toxicity testing  data to proceed to metals analysis.

       After processing  one sample, a list of suspects
 may be generated. As future samples are evaluated, the
 correlation  between  toxicity  of  a sample and the
 concentration(s) of metal(s) over time may also be used
 to narrow the list of suspect toxicant(s). In Phase III, the
 suspect metal toxicant is implicated based upon  the cor-
 relation of effluent  toxicity and metal concentrations ref-
 erence suspect metal toxicity data, the use of additives
that chelate metal  toxicants, and changes  in  toxicity ob-
served during manipulations of water quality characteris-
tics.
                                                    4-1

-------
       The procedures in this chapter are generally ap-
plicable for both  acute and chronic toxicity.  The main
differences between the acute and chronic procedures
are the concentrations of additives used in the EDTA and
sodium thfosulfate addition tests, lower analytical detec-
tion limits,  and generating non-toxic blanks for the ion
exchange resins for chronic toxicity testing. The use of
species other than  C.  dubia  or  fathead  minnows will
require consideration of appropriate test  volumes and
additive concentrations.


4.2    Analysis of Metals

4.2.1  Prioritizing Metals for Analysis
       Many cationic metals can be analyzed in a spe-
cific sample, but to simplify the amount of analytical effort
needed for metals analysis, we  suggest a prioritizing
process be performed before analyzing any samples. The
prioritization process is more  valuable when  the metal
analyses are performed by AA instrumentation since each
metal requires  an individual analysis. Conversely, with
ICP (inductively coupled plasma) instrumentation, numer-
ous metals can be analyzed at once, and the prioritization
process is  less valuable in this instance. With both ICP
and AA methods, a list of metals and required levels of
detection will be  needed before the samples are ana-
lyzed.

       This prioritization is  based primarily upon acute
toxicity data with C. dubia. its  applicability to  chronic
toxicity and other species is expected to be similar but
has not yet been determined. The toxicity test results from
the EDTA  additions, sodium  thiosulfate  additions,  and
graduated pH tests performed in Phase I form the basis
for prioritization.  When available, Phase II results from
using the procedures in Section 4.3, should be included in
this evaluation. Because we  do not have a complete
understanding of the effects of these procedures for each
metal, the following should be taken as a starting point for
metals analysis.

        Information regarding  historical discharge moni-
toring data, past or current TRE and/or TIE information, or
process  information may be useful  in prioritizing metals
for analysis. For example, if a discharger uses zinc in their
manufacturing process and EDTA removed the toxicity, it
would be  logical to analyze  for zinc first. If zinc was
present at nontoxic concentrations  or at concentrations
too low to cause  the observed toxicity, analysis for addi-
tional metals would be performed. If zinc was present at
concentrations high enough to cause the observed toxic-
ity, Phase III procedures (EPA,  1993A) should then be
started to confirm zinc as the identified suspect toxicant.

        When  EDTA  additions  reduce or remove the
toxicily of  the  sample, initially copper, lead,  cadmium,
nickel, and zinc should be measured. When sodium thio-
sulfate additions reduce or remove the toxicity of the
sample,  copper,  cadmium,  and silver should  be  mea-
sured.
       Phase I  results would not  normally lead to the
conclusion that  an anionic toxicant  was present (i.e.,
cationic metals that exist in aqueous samples as anionic
oxides). If additional  Phase I tests  had been performed
which characterized  anionic toxicants or other specific
discharger information was available, measurements  of
arsenic, chromium, and selenium should be made.

       As stated above, these metals should be a start-
ing point for metals analysis. Further interpretation of the
Phase I results could be done by including the results of
the graduated pH test and by jointly  examining the results
of the EDTA addition, thiosulfate addition, and graduated
pH tests.

       When multiple toxicants of different classes are
present, Phase I data are often difficult to interpret. One
should try to identify and confirm as soon as possible the
role of one toxicant when multiple toxicants  are present.
By defining the role of one toxicant, efforts can be better
focused on the remaining unidentified toxicants.


4.2.2  Metal Analysis Methods
       There are three types of chemical instrumenta-
tion available for the  analysis of cationic elements; these
are AA, inductively-coupled plasma-atomic emission spec-
troscopy (ICP-AES), and inductively-coupled plasma-mass
spectrometry (ICP-MS).

        EPA methods using ICP-AES, ICP-MS, and AA
(EPA,  1983; EPA, 1991D) are available for quantifying
cationic metals  in aqueous samples.  Tables 4-1 and 4*2
summarize method detection  limits  for the analysis  of
cationic metals in aqueous samples using AA with direct
aspiration, AA with the furnace procedure, ICP-AES, and
ICP-MS.

        The detection limits required in Phase II for the
identification of  suspect cationic metal toxicants will  be
determined by the toxicity of metals  for the TIE species. In
some cases, especially for chronic toxicity, the effect level
might be lower than the detection limits listed in Tables 4-1,,
and 4-2.  Detection limits should be  improved  to obtain
optimal levels of detection (i.e., at  least two times lower
than the effect level).

        Toxicity data for some species and test types  for
many metals have not been determined, especially for 7-d
chronic toxicity tests. Therefore, to  determine the needed
levels of detection, effect levels for specific metals may
have to be determined.

        The required level of detection will  often dictate
the method heeded for performing the metal  measure-
ment.  It will be beneficial for laboratories to compile a
database  containing method detection limits and toxic
effect  levels for cationic  metals using data,from their
organisms, analytical methods, and toxicity testing condi-
tions. These data are not necessary in advance but fthis
                                                     4-2

-------
                 Table 4-1.  Atomic Absorption Detection Limits and Concentration Ranges1

                                        Direct Aspiration
                                                                   Furnace Method2
Metal
Aluminum
Antimony
Arsenic3
Beryllium
Cadimum
Calcium
Chromium
Cobalt
Copper
Lead
Magnesium
Manganese
Mercury4
Molybdenum (p)
Nickel(p)
Potassium
Selenium2
Silver
Sodium
Tin
Vanadium (p)
Zinc
Detection
Limit
(mg/l)
0.1
0.2
0.002
0.005
0.005
0.01
0.05
0.05
0.02
0.1
0.001
0.01
0.0002
0.1
0.04
0.01
0.002
0.01
0.002
0.8
0.2
0.005
Optimum
Concentration
Range( mg/l)
5-50
1-40
0.002 - 0.02
0.05 -2
0.05 -2
0.2-7
0.5-10
0.5 -5
0.2 -5
1-20
0.002 - 0.5
0.1 -3
0.0002 - 0.01
1 -40
0.3 - 5
0.1-2
0.002 - 0.02
0.1-4
0.03 - 1
10-300
2-100
0.05 - 1
Detection
Limit
(W/l)
3
3
1
0.2
0.1
1
1
1
1
0.2
1
•|

2
0.2

5
4
0.05
Optimum
Concentration
Range (ng/l)
20 - 200
20 - 300
5-100
1 -30
0.5 - 10
5-100
5 -inn
1 VU
5-100
5-100
. 1-30
3-60
5Cf\
- OU
5-100
1 - 95
1 Ł.\J
20 -300
10-200
0.2-4
                2-rir °oul"°"=" «=K»-UUII iimns ana concentration ranges were taken from EPA 1983
                 The listed furnace values are those expected when using a 20 ul injection and normal gas flow except in

                 gX«h~^^                  intermpt is used The
                3Gaseous hydride method.
                "Cold vapor technique.
 Table 4-2.
 Element •
Estimated Instrumental Detection Limits for ICP-MS and
ICP-AES
       Estimated Detection
       Limit, ICP-MS' ftig/l)
Estimated Detection
limit, ICP-AES2 (pg/l)
Aluminum
Arsenic
Antimony
Beryllium
Cadmium
Calcium
Chromium
Cobalt
Copper
Lead
Magnesium
Manganese
Molybdenum
Nickel
Potassium
Selenium
Silver
Sodium
Vanadium
Zinc
0.05
0.9
0.08
0.1
0.1
_
0.07
0.03
0.03
0.08

0.1
0.1
0.2
_
5
0.05
_
0.02
6.2
45
53
32
0.3
4
10
7
7
6
42
30
2
8
15
.3
75
7
29
8
2
 The estimated instrumental detection limits are taken from EPA,
 1991D. They are given as a guide for instrumental limits, the actual
 detection limits are sample dependent and may vary as the sample
 matrix varies.
2The estimated instrumental detection limits as shown are taken from
 EPA, 1983. They are given as a guide for an instrumental limit. The
 actual method detection limits are sample dependent and may vary
 as the sample matrix varies.
3Highly dependent on operating conditions and plasma.
 type of information will be very useful for future TIE
 efforts.

        When toxicity effect levels appear to be below the
 detection limits of current analytical methods, the use of
 "clean" analytical techniques may be required through all
 steps in the analysis of the sample because background
 contamination is the major cause of inadequate levels of
 detection. Some general principles  of clean metal tech-
 niques  include the  use of contamination free reagents,
 acid  cleaned plastic  labware, acid cleaned  membrane
 filters (not  glass  fiber), class  100 benches for sample
 preparation, proper sample collection, preservation,  and
 storage procedures; and proper QA/QC procedures using
 blanks, spiked matrixes, and replicate analyses. A sum-
 mary of clean metal techniques and procedures for lower-
 ing the  levels of detection can be found in  Nriagu et al
 1993; Patterson and Settle, 1976; and Zief and Mitchell'
 1976.

        Some cationic metals, such as arsenic, selenium,
 and chromium, have different stable oxidation states in
 aqueous samples and more importantly the different oxi-
dation states may  have different toxicities.  In Section
4.2.3, procedures to determine the concentration of the
different oxidation states are provided.

        In some  TIEs,  a measurement of the metals
associated  with the suspended solids  may be needed
                                                        4-3

-------
(Section 4.2.4). Procedures for preparing suspended sol-
ids removed by filtration for metals analysis are available;
see  EPA  method 200 (EPA, 1983) and EPA  method
200.2 (EPA, 1991D).


4.2.3  Metal Speclatlon
       The procedures suggested above (Section 4.2.2)
are used to determine the total concentration of a metal in
an effluent. Many metals exist in water in different forms
due  to the various stable oxidation  states of the metal.
Arsenic (As3*, As5*), chromium (Cr3*, Cr6*), and selenium
(Se4*, Se**) are  important metals that exist in different
forms in water. Determining the speciation for these met-
als may be important in the TIE since the toxicities  are
different for the various forms of each metal. For example,
Cr5*  is the form that is of toxicological concern while Cr3*
is generally not toxic (EPA, 1985D).

       For chromium, methods for measuring  the
hexavalentform (Ct6*) such as method 218.5 (EPA, 1983)
are available.  The amount of the trivalent form  of chro-
mium (less toxic form) is determined by taking the differ-
ence between the concentrations for total and hexavalent
chromium.

        For arsenic, the method of Ficklin (1983) is sug-
gested for speciation measurements. This method uses
an anion-exchange resin to separate the arsenite (As3*)
and  arsenate  (As5*, more toxic form) species. Graphite
furnace atomic-absorption spectroscopy is then used to
measure the concentrations of each form.

        For selenium, the method of Oyamada and Ishizaki
(1986) is recommended for speciation. This method  (like
that for arsenic)  uses column  chromatography with an
anion-exchange resin to separate the selenite (Se4*)  and
selenate  Se6* (more toxic form) and  graphite furnace
atomic-absorption spectroscopy to measure each form.

        Ion chromatography can also be used to deter-
mine the different forms of the above metals (EPA, 1991 D),
but we have not used this technique to date.

4.2.4  Identification of Suspect Metal Toxicants
        Initial implication of suspect metals based on a
comparison of total  metal  analyses data and  effluent
toxiclty test results should be  made. Then analysis for
dissolved and suspended metals can be made  if neces-
sary. These metal  values should be compared to avail-
 able toxicity values, but tests on reference metals might
 have to be conducted with matching effluent  conditions,
 such as pH and hardness to obtain comparable toxicity
 values. Side-by-side tests with individual reference metal
 standards and effluent samples might prevent being mis-
 lead by different test designs  and  are worth the effort.
 Literature summaries of metal toxicity data are also avail-
 able (EPA, 1980; EPA, 1985B; EPA, 1985D; EPA, 1985E;
 EPA, 1985F;  EPA, EPA, 1986; EPA, 1987; EPA, 1988B;
and AQUIRE, 1992). In addition to matching the hardness
and pH of the dilution water to the effluent sample by the
addition of the appropriate ratios of magnesium carbon-
ate and calcium carbonate, it might be possible in some
cases to mimic the wastewater total suspended solids
(SS) and total organic carbon (TOG) in the water used to
test  the  metal. For  example, TOC  and SS from the
addition of the YCT food can be at levels such that the
total SS level in the dilution water might be similar to that
found in the effluent. TOC may  also be modified by the
addition of humic acid. If the dilution  water does not
closely match the effluent, nonstandard dose-response
relationships are observed in the toxicity test, i.e., several
test concentrations exhibit partial mortality. In addition, a
trend is noticed that as metal concentrations decrease at
the effluent LCSOs or IC25s, toxicity of the  effluent in-
creases.

        If a sample is to be filtered, a  membrane filter(s),
such as a 0.45 u.m polycarbonate filter should be pre-
pared by rinsing with high purity water, followed by an
appropriate volume of dilution water needed for  blank
toxicity tests  and  analysis. The  toxicity test guidance is
described in Section 1.2 and in the Phase I  documents
(EPA, 1991 A; EPA, 1992). An appropriate quantity (<50
ml) of the last portion  of the high purity water passing
through the filter should be  collected  as an analytical
blank to check for metals contamination from the filter and
the filtration apparatus. An aliquot of  the effluent is then
filtered through the 0.45 urn membrane filter(s). If more
than one filter is required for the effluent, a portion of each
can be combined for testing.

        The filtered and unfiltered effluent samples and
the filtration blank should be tested for toxicity to measure
the effect of filtration on sample toxicity. The toxicity test
techniques are described in the non-polar organic section
(Sections 2.2.3 and 2.3.3) unless data are needed for
Phase III confirmation  and then, greater replication and
randomization will  be  needed  (see  Section 1.2). The
toxicity tests should be performed for the  test species
using  a dilution  water (e.g., reconstituted water) of  a
similar hardness and pH to that of the  effluent. If toxicity is
reduced or removed upon filtration (and effluent toxicity
has not previously been affected by C18 SPE or filtration
through a glass fiber filter), it is possible that metals were
 retained by the 0.45 urn filter. Analysis for metals retained
by the filter may help in interpreting sample data.

        Metals analyses  should  be performed  on  the
 analytical blank collected from the filter and on the filtered
 and unfiltered effluent samples. The  choice  of metals to
 measure will be determined by the prioritization process
 described above. As stated previously, the level of detec-
 tion for the metal of interest should be lower than the
 effect concentration for the metal.

         Biologically Available Metals: Traditionally, dis-
 solved metals for aqueous samples have been defined as
 those that pass through a 0.45 urn membrane filter, i.e.,
                                                     4-4

-------
polycarbonate filter. The dissolved metals are in no way
synonymous with the biologically available metals. Other
than the use of an aquatic organism there is no technique
to determine the biologically available fraction of the total
metal. Furthermore, only rudimentary techniques are avail-
able to  specifically identify the individual species of  a
metal (e.g., free charged metal ions [Mn+], inorganic ion
pairs or complexes  such as aquoions, [M(HaO)n+m],
hydroxoions [M(OH) "-P+], oxoions [MO n-2<<+], organic com-
plexes and chelates [M x EDTA], metal species bound to
high molecular weight organic material [M x lipid] or metal
species in the  form of highly dispersed colloids or sorbed
on colloids [M  x clay]). Stumm and Morgan (1981) have
listed some general methods for assisting in identification
of individual  species. In some  cases, binding of metals to
inorganic and  organic ligands in effluents will reduce the
bioavailability of the metals and cause the metal concen-
tration at the effluent LC50, IC50, or IC25 to be  larger
than the metal  concentration determined in  the  metal
dilution water toxicity test. For a set of  effluent samples
with a wide  range of toxicities, better agreement should
occur between the effect concentration  of the  metal in  a
dilution  water  toxicity test  and the more toxic effluent
samples (where the toxicity testing matrix of the effluent
more closely matches that of the dilution water). Methods
for determining the bioavailable fraction of the total metal
are limited.

       Some  indication of the binding of metals to organ-
ics  in the effluent may be arrived at  through hexane
extraction of an aliquot of the  sample  (Stary,  1964).
Theoretically, metals bound to organic materials that are
soluble in hexane should be extracted from the effluent.
The hexane can then be evaporated  and the residue
reconstituted and analyzed for metals.  Additionally, the
loss of metals  can be estimated by repeating the metal
analysis on  the extracted effluent and comparing this
result to the hexane extract results. The toxicity attributed
to metals associated with organics might be estimated by
performing a toxicity test on the solvent extracted effluent.
Traces of hexane must be removed  from the extracted
eff|uent by aeration prior to toxicity testing. The effects of
aeration on  sample toxicity must  also be considered in
this analysis. In any case, metals strongly suspected of
causing or contributing to sample toxicity should be tested
in dilution water as described above with the TIE test
species.

       The effects of variable water quality characteris-
tics on metal toxicity must be  evaluated over the effluent
sampling period. One  way to assess this is to collect
several samples over a short time span. As an example,
for an acutely toxic effluent, collect six grab samples in 24 h, and
calculate the correlation coefficient for sample metal concen-
tration (or summed toxic units of metals) versus sample
toxicity for each sample. The set of correlation coeffi-
cients for multiple sampling events might give results less
affected by hardness, SS, and TOC, assuming that water
quality characteristics affecting metal toxicity will vary less
during short  time periods. For chronic toxicity, it might be
useful to  measure concentrations of  metals  in several
daily  samples and conduct separate chronic tests on
each sample. Obviously, metal concentrations must vary
enough to provide a sufficient range for correlation. When
one reaches this stage, Phase III work should start using
Phase III methods. Symptoms, species sensitivity, spik-
ing, water quality adjustments and correlation  are  all
applicable Phase III approaches to confirm the cause of
toxicity.
4.3     Additional Toxicity Testing Methods
        Guidance on EDTA addition tests, sodium thio-
sulfate addition tests, graduated pH tests, and the use of
ion-exchange resins for use in Phase II are presented in
this section. These procedures might be used before
performing analyses for cationic metals, but most often
they will be used to refine a list of suspect metal toxicants
and to provide  data to support  the identified suspect in
Phase 111.

        In the acute Phase I, EDTA and sodium thiosul-
fate addition tests can be conducted by adding incremen-
tal amounts of  EDTA or sodium thiosulfate to  a single
effluent concentration.  To provide  further  evidence in
Phase II, these  two tests should be conducted with efflu-
ent dilutions to  assess the toxicity reduction (see EPA,
1992). The data generated from these procedures pro-
vide a powerful  tool for identifying the cause of toxicity in
samples containing  mixtures of cationic metals. For ex-
ample, toxicity caused by either copper or zinc could be
determined by using the following test information: toxicity
of both metals would  be  removed  by EDTA  addition
(Section 4.3.1), sodium thiosulfate can remove toxicity
caused by copper but not zinc (Section 4.3.2), and copper
is more toxic at  higher pH levels  while zinc is not (Section
4.3.3). Depending on  how the toxicity of  the sample
changes with these tests, one could eliminate one of
these metals from the list of suspect metal toxicants.

        Results of this type of testing will be  used to
develop evidence implicating the identified suspect metal.
These tests would be performed on a number of samples
over time to demonstrate the consistency of the cause of
toxicity. In addition, when a mixture of toxicants is present,
additions of EDTA or thiosulfate  could be used to remove
the cationic metal toxicity after performing other Phase II
manipulations, e.g., C18 SPE.


4.3.1   EDTA Addition Test
        Any reduction in effluent toxicity effected by the
addition of EDTA suggests that certain cationic metals
might be present in the effluent at toxic levels. Back-
ground  information  and discussion of the  behavior of
EDTA and cationic metals can be,found in Phase I (EPA,
1991 A; EPA, 1992).

        ideally,  the amount of E/DTA added would be just
enough to chelate the toxicant(s) without causing EDTA
                                                    4-5

-------
toxteHy or substantially changing the water quality.  For
either C. dubia or fathead minnows, we have found it
useful to add two different EDTA concentrations to two
separate effluent tests (with dilutions).  Controls without
EDTA  must be  included. The  EDTA stock solution is
added after the effluent dilutions are prepared so that the
EDTA concentration is the same at each effluent dilution
(see Phase I, EPA, 1991A; EPA, 1992).

       In Phase II, conducting simultaneous EDTA addi-
tion tests on effluent and the suspect metal in matching
test water can provide evidence supporting the  suspect
metal as the toxicant if the results of these two tests are
similar. If the metal is chelated by EDTA in the dilution
water test but not in the effluent test then either there is a
strong matrix effect from the effluent or it is the incorrect
suspect metal. It is important to use the same pH in both
tests in case there is any pH effect on the metal's toxicity.

       In addition to removing toxicity caused by metals,
EDTA reduces the acute toxicity of some cationic surfac-
tants. This reduction of toxicity might also occur in chroni-
cally toxic  effluents,  and the toxicity reduced by EDTA
should not be assumed to be due only to cationic metals.
4.3.2   Sodium Thlosulfate Addition Test
        The acute Phase I oxidant reduction test (EPA,
1991A) or the chronic sodium thiosulfate addition test
(EPA, 1992) is used to determine to what extent constitu-
ents reduced by the addition of sodium thiosulfate
(NajS.O,)  are responsible for the  effluent toxicity. Al-
though the use of the sodium thiosulfate test was de-
signed  to  determine  if  oxidative compounds  (such  as
chlorine) were responsible for effluent toxicity, experience
has also shown that thiosulfate can also form a stable
non-toxic complex with some metals. Since the complexing
ability of thiosulfate is more metal specific than EDTA, this
reagent can be used to determine if a specific metal is
responsible for the effluent toxicity. Recent work by Mount
Tablo 4-3.  Metal LCSOs with Respect to Test pH1

                     	LC50 (ug/1)
Metal
Species
pH6.2
pH7.2
pH8.2
Zn
Ni
Pb
Cu
Cd
O. dubia
P. promelas
C. dub/a
P. promelas
C. dubia
P. promelas
C. dubia
P. promelas
C. dubia
P. promelas
>530
830
>200
>4000
280
810
10
15
563
54
360
333
137
3360
>2700
>5400
28
44
350
74
95
502
13
3080
>2700
>540
201
>200
121
<5
 'LC50 values were determined at 48-h for C. dubia and 96-h for
 P. promelas. Data taken from Schubauer-Berigan etal., 1993A.
(1991) has shown that in acute toxicity tests with C. dubia
in moderately hard water that Cu2*, Cd2+, Hg2+, Ag+, and
Se6* can  be complexed using sodium thiosulfate (see ,
EPA, 1991A for more details). This complexing ability
might not be applicable to chronic toxicity. For example, in
a C.  dubia 7-d test with  copper, the toxicity  was not
reduced with sodium thiosulfate addition but was reduced
with EDTA addition.

       If  the  addition of  sodium thiosulfate does not
reduce the effluent toxicity thought to be related to metals,
the use of SO (EPA, 1991A) additions followed by the
addition of sodium thiosulfate is recommended. In some
situations, the thiosulfate concentration may be reduced
by  non-toxic  oxidants and thus,  not be available for
complexing the toxic metal. The addition of SO should
preferentially reduce these non-toxic oxidants which will
allow the  now available thiosulfate to complex the toxic
metals. Depending  upon the complexation ability of so-
dium thiosulfate for a specific metal,  it might or might not
complex the toxic metal. If the suspected metal toxicant
can be complexed (e.g., cadmium, copper, selenium (as
selenate), mercury; see EPA, 1991 A; EPA, 1992), then a
reduction in sample toxicity should occur with the addition
of sodium thiosulfate. If the suspected metal cannot be
complexed (e.g., zinc, lead, manganese, and nickel), then
no  reduction in  sample toxicity should occur with the .
addition of the sodium thiosulfate.

       As with the EDTA addition test, sodium thiosul-
fate additions should be conducted  concurrently on the
effluent and on dilution water spiked with the  suspect
metal toxicant. Care must be used to conduct these tests
at similar pH levels. When  toxicity test results are consis-
tent with the expected behavior, strong evidence relating
the suspected metal toxicant to the cause of the effluent
toxicity has been obtained. These results in conjunction
with the ion exchange test, analytical measurements for
toxic metals, and the EDTA addition test provide evidence
sufficient  for one to  proceed to  toxicant  confirmation,
Phase III, of the TIE.

        Both sodium thiosulfate and EDTA can reduce
the toxicity of  some metals and this information can  be
helpful in identifying the toxicant.  However to date, this
effect of  thiosulfate/metal complexation has not been
demonstrated for chronic toxicity. Knowing which metals
are bound by both sodium thiosulfate and EDTA and
which metals are complexed with only one or the, other
additive can be very helpful in narrowing down the pos-
sible toxicant.
                                              4.3.3  Metal Toxicity Changes with pH
                                                     In Phase I, the graduated pH test is performed to
                                              evaluate the presence of compounds whose toxicity var-
                                              ies with pH. For ammonia, toxicity is greatest at pH 8.5
                                              and  least at pH  6.5 for some species.  Therefore, as
                                              suggested in the first Phase II document, that for samples
                                              in which toxicity is enhanced at elevated pH, the identifi-
                                              cation effort should focus on ammonia. However, some
                                                     4-6

-------
effluent and sediment pore water TIEs have indicated that
some toxicity caused by metals can be affected by pH
within the range of pH 6 to 9 (Schubauer-Berigan et al.,
1993A). Some metals, notably zinc, nickel and cadmium,
exhibit greater toxicity at elevated pH, which could con-
fuse their characterization with that of ammonia (Table 4-
3), while copper and lead show elevated toxicity at pH
6.2. These pH-dependent toxicities can be used as a tool
for the identification (and confirmation) of toxicity caused
by these metals. For example, toxicity to C. dubia in a
sediment pore water sample was completely removed by
additions of EDTA. The sample also exhibited  greater
toxicity at pH 6.5 than at 8.5, and metal concentrations
indicated that only  copper was present at toxicologically
significant concentrations. The pH dependent toxicity of
the sample  along  with  the EDTA addition  results  and
metal analysis supported the identification of copper as
the toxicant.
4.3.4  Ion-Exchange Test
       Ion-exchange resins have been used in TIEs for
generating supporting evidence for identifying the cause
of toxicity in effluents (Doi and Grothe, 1989; Phase II
zeolite test). For cation exchange resins, removal of toxic
cations such as NH4+, Cd2+, and  Pb2+ from the  effluent
occurs with  the corresponding release of cations (i.e.,
counter ions) such as H+ and Na+ into solution. Similarly,
for anion exchange resins, removal of toxic anions such
as Cr2O/- and  AsO/- from the effluent occurs with the
corresponding release of anions such as OH- and CI" into
solution.  For both cation  and anion exchange resins,
charge neutrality exists between the resin  and aqueous
phase and therefore, if the resins remove 5 u.moles of
Cd2+ from solution, 10 u,moles of  H+ would be released
into  solution. The exchange process  is concentration
dependent and  is reversible. Cations removed from the
solution may then be recovered from the exchange resin
by passing an acidic solution over the resins (e.g., 1 N
HCI for analysis of metals).

       We  have had  limited  experience  with  ion ex-
change resins but the following general guidance can be
provided.  First,  ion  exchange resins are  not chemical
specific but  rather remove a wide range  of cations or
anions, metallic and non-metallic. We have observed that
anion exchange resins can remove cations  (e.g., Zn2+)
from solution quite efficiently.  The reasoning that only
cationic materials are removed by cation ion exchange
resins is not always reliable. Experimental verification of
which materials were removed by the resin will be neces-
sary on a case-by-case basis. Second, wide changes in
the pH of the post-column effluent can occur depending
upon the type of cation or anion released by the resin.
These changes in pH will cause problems in interpreting
toxicity tests if the pH is not adjusted prior to the toxicity
test. Third, many of the ion exchange resins are based
upon a styrene  or acrylic divinylbenzene backbone and
this material can remove other types of toxicants such as
non-polar organics. Consequently, because of its non-
specificity the removal of toxicity by  an ion exchange
column should not be used as the only piece of evidence
to implicate a metal as the toxicant.

       Resins under evaluation and/or those which have
been used  include IRA-35, IRA-68,  IRA-94, IRA-900,
IRC-718, and GT-73 (Rohm and Haas, Philadelphia PA)
and  aquarium  zeolite  (Argent  Chemical  Laboratories,
Redmond WA). The key to obtaining useable data from
an ion exchange test is to obtain non-toxic blanks. Since
numerous ion exchange resins exist, guidance for prepar-
ing all resins for TIE work cannot be provided. A variety of
procedures have been used in our laboratory to condition
the columns and to obtain non-toxic blanks.

       Effluent volumes ranging from 1,000 to 10,000 ml
have been used, and the volume is dependent on  the
hardness of the dilution water, bed volume of the column,
strength and type of the ion change  resin, which ions
were being exchanged, the toxicity of the effluent, and the
species being tested. For example, for acutely toxic efflu-
ents, glass chromatography columns  (11  mm i.d.)  are
packed with about 10 cm of resin and the solutions  are
pumped up through the column at a flow rate of 4 to 5 ml/
min.  First, a small volume of high purity water (e.g., 200
ml) is passed through the column, and discarded. Next,
the dilution  water  (volumes  are variable, i.e., 1,000-
5,000 ml) is passed through the column until the pH of the
post-column dilution water is above 7.0.

       Following this procedure, the necessary volume
of dilution water to use for toxicity testing is passed
through the  column and collected. The type of dilution
water to use is effluent specific and in general, should be
the same as the dilution water used in the toxicity test for
the effluent. The pH of the  post-column dilution water
should be monitored and the pH adjusted to return  the
water solution to  its original  pH. Toxicity tests are then
performed on the post-column dilution water sample (col-
umn blank). After obtaining non-toxic blanks for a particu-
lar batch of resin, the conditioning process can be used
on other aliquots of the resin with a similar procedure;
however, column toxicity blanks must always be tested.

       To identify acute toxicity, we generally begin by
using 200 ml of effluent (filtered or unfiltered) and collect
the post-column  effluent. The  pH of the  post-column
effluent is checked and if necessary the pH is adjusted to
that  of the  baseline test, and tested for  toxicity.  For
chronic toxicity, the volume  of  effluent needed for  the
toxieity test will dictate the amount of resin and the size of
the column.  When evaluating a new resin, use propor-
tions of water, effluent, and resin,  similar to those de-
scribed above for acutely toxic effluents. New aliquots of
resins  should  be prepared  and  used  for each ion  ex-
change test.  By doing so,  artifactual  toxicity problems
                                                    4-7

-------
from other effluents and sample manipulations can be
avoided.

        We have had limited success in the elution of the
Ion exchange resin to recover the exchanged toxicant(s);
therefore, we cannot provide specific guidance. In theory,
catfons and anions can be eluted  from ion exchange
resins using a strong acidic (HCI) or basic (NaOH) solu-
tion. Performing successful toxicity testing on these solu-
tions is extremely difficult because of  artifactual toxicity
problems.

        When toxicity is  removed by the ion exchange
test, useful information about the  toxicant(s)  may be
obtained. However, as discussed above, the removal of a
toxicant by the column may not be as straightforward as
first perceived. The use of other manipulations and ana-
lytical measurements on the pre- and post-column efflu-
ents will be required to establish the significance of the
results of the  manipulation.

        When toxicity is not removed by the ion exchange
test  and non-toxic blanks are obtained, the  conclusion
that  the toxicant is not a cation or anion  can be made.
However, the slight possibility exists that the resin may
not be able to exchange the toxicant because of steric
and size considerations.
                                                     4-8

-------
                                             Section 5
                                             Chlorine
5.1    General Overview
       One of the first analytical measurements recom-
mended in the Phase I documents (EPA, 1991A; EPA,
1992) upon arrival at the laboratory is for total residual
chlorine (TRC)  in each  effluent sample.  Chlorine is a
commonly used biocide and oxidant and is frequently
found at acutely toxic concentrations in municipal efflu-
ents (EPA, 1985C). Sublethal chronic toxicity from chlo-
rine in effluent samples is not as likely to occur due to the
degradation of chlorine (see below) with holding of the
sample. Chlorine is  unstable in  aqueous  solutions and
decomposition is more rapid in solutions when chlorine is
present at low concentrations. From the TRC measure-
ment and the Phase I tests (sodium thiosulfate addition
and  aeration tests),  further steps to identify the effects
that  might be due to  chlorine can be taken. Oxidants
other than chlorine occur in effluents and the removal of
toxicity by the addition of sodium thiosulfate does not
prove that chlorine  was the cause of effluent  sample
toxicity.

       Molecular chlorine  or hypochlorite  dissociates
into free aqueous chlorine, hypochlorous acid, and hypo-
chlorite ion when added to  effluents. Chlorine can also
combine with ammonia to form chloramines, i.e., mono-,
di-, and tri-chloramines  and with  organic compounds,
especially organic nitrogen (APHA,  1992). The measured
total residual chlorine (TRC) of an effluent is the concen-
tration  of free and combined forms (mentioned above)
added together. The portion of the TRC associated with
an individual form is matrix dependent. Chlorinated in-
dustrial and wastewater effluents normally contain only
the combined form of chlorine (APHA, 1992).

       These various forms of combined chlorine may
have different effect concentrations for toxicity, and the
toxicities of these individual forms  are not all known for
acute or chronic toxicity to C. dubia or fathead minnows.
However,  while the  TRC level in  the effluent samples
may be the same, the concentration of the various forms
may be different because of the matrix inherent to the
effluent. This matrix of TRC may also  be variable  from
sample to sample for the same discharger.

       Another complication  is that  Current analytical
methods for measuring  TRC are  not chlorine specific:
Other oxidizing compounds, e.g., bromine, iodine, hydro-
gen peroxide, ozone, and manganese, will be quantified
as chlorine by the analytical methods for measuring TRC
and  may  provide the analyst with a false  positive for
chlorine.
5.2    Tracking Toxicity and TRC Levels
       Several methods are available for measuring to-
tal TRC (EPA methods 330.1, 330.2, 330.3, 330.4,  and
330.5 (EPA, 1983)). Measurements of TRC in the effluent
upon arrival of the sample at the laboratory should always
be made. If TRC is not detected, chlorine should not be
considered a suspect toxicant since the analytical meth-
ods do not yield false negatives.

       For acutely  toxic effluents, grab samples both
before and after the chlorination process should be col-
lected simultaneously (i.e., within minutes of each other).
Upon arrival of these samples at the laboratory, a baseline
toxicity test should  be initiated and  at pre-determined
intervals after day 1  (e.g., day 2, day 3, day 5, day 8) to
evaluate whether the toxicity  is degrading. TRC determi-
nations should  be performed in  conjunction with each
toxicity test.

       Generally the TRC in most effluent samples stored
at 4°C degrades in 2 to 5 d after collection. Therefore, if
residual chlorine is  a toxicant the toxicity  of  the post-
chlorination sample should decrease as TRC levels de-
crease, and pre- and post-chlorination  samples should
have the same toxicity after the decay of TRC.

       The toxicity of chlorine in an effluent sample will
be dependent on the matrix of the effluent and the spe-
cies tested. If chlorine toxicity data does not exist for the
species being used, it will be necessary to measure the
LC50 or IC25 of chlorine using the TIE organisms  and
dilution water. Using those LC50 and/or IC25 values, the
comparison of TUs of the effluent to the TUs of residual
chlorine is  useful to evaluate  the effects of the TRC.
When the TU comparison data and pre- and post-chlori-
nation  toxicity data indicate TRC as a suspect toxicant
Phase III procedures should be initiated.

       With  the measurable levels of  TRC at sample
collection, the loss  of toxicity with the corresponding
decreasing levels of TRC, and the pre- and post-chlorina-
                                                    5-1

-------
tion samples exhibiting similar toxicity with the decrease
!n TRC, Phase 111 confirmation should begin (EPA, 1989B;
EPA, 1993A). However, these steps will not insure that
the toxicant is chlorine since other oxidants will be de-
tected by the TRC measurement techniques.
                                                   5-2

-------
                                             Section 6
                      Identifying Toxicants Removed by Filtration
6.1    General Overview
       If the results of Phase I.tests indicate that the
filtration manipulation removed or reduced toxicity, the
investigator should carefully  compare these results to
those of the other manipulations before trying to identify
the toxicants that  might be on the filter. We have ob-
served that metals, non-polar organic compounds and
volatile compounds can all be removed under certain
filtering conditions, but these observations  have been
dependent  on the individual effluent or the sediment pore
water samples. Other Phase I  manipulations (e.g., EDTA,
C18 SPE  extraction)  can lead to subsequent Phase II
identification steps. However, for toxicity reductions ef-
fected by filtration, more intermediate steps of  Phase I
type manipulations must be done before analytical proce-
dures are  used  to identify the toxicant(s). In addition,
some other manipulations  may. provide specific informa-
tion regarding the identity of toxicants that may have been
removed by filtration;  these  include additions of  PBO
(Section 2.5.1), the graduated pH test (Phase I tests for
determining toxicity caused by  ammonia, metals and
ionizable organic compounds), and the sodium thiosulfate
test (Phase I test for detecting toxicity caused by volatile
oxidants  such as chlorine  or  metals). If one or more of
these manipulations removes toxicity, then identification
work should proceed as described in the previous sec-
tions to identify the cause of toxicity.

       It is important to consider that all toxicity removed
by filtration may  not be actually removed by the process
of filtering.  For example, when the pH of the sample is
altered,  the mechanism(s)  for removal by filtration can
change. While ammonia is predominantly ionized at  a
sample pH of 8.3, the ammonia would not  tend to be
removed through volatilization if a vacuum was applied
for filtration purposes. Yet by adjusting the sample pH to
11, the ionized ammonia concentration decreases to 1.7%
at 25°C. When  a  sample  is adjusted  to a pH of 11,
volatilization of a toxicologically significant amount of the
un-ionized  ammonia could occur and the toxicity results
would indicate that filtration removed toxicity. Also, changes
in speciation at elevated  pH render many metals in-
soluble, which could result in their removal by the filter at
pH 11 (Schubauer-Berigan  etal., 1993B).

       If the toxicant is thought to be a non-polar organic
toxicant, and filtration partially removes toxicity, it may be
useful  and save toxicity testing time to eliminate  the
filtration step altogether before applying the sample to the
C  SPE column (discussion in Section 2.2.2 and Section
2.3.2).

 6.2    Filter Extraction
       When filtration has been the only manipulation to
affect the toxicity, then extraction of the filters and track-
ing the toxicity of the extracts should be attempted. In
addition, the use of other types of filters should be evalu-
ated (i.e., nylon, teflon, and polycarbonate) to see  if
toxicity removal is a function of the filter type. In using the
extraction procedures, the idea is to separate the toxic
compounds associated with the filter by  extracting them
into a solvent. Next, efforts are made to  concentrate the
toxic compounds in the filter extract  and test them at a
concentration that can be related to the  original sample
and evaluate the efficiency of the extraction. Identifying
the filter-removable contaminants without additional infor-
mation can be difficult because of the  lack of specificity of
the filtration process. But once a suspect candidate  has
been discovered, then measurements can be  made to
determine whether a lexicologically significant concentra-
tion of the suspect toxicant(s) had indeed been removed
by filtration. If this is the case, then it may not be neces-
sary to consider further extractions  of the filters. If, how-
ever, the concentrations of the suspect toxicant(s) are not
decreased after filtration then it may be useful to attempt
additional identifications by solvent extraction of the filters
as described below.

       One technique we have used  with filterable toxic-
ity is to extract the filters with either polar or non-polar
solvents. To  remove toxicants from  the filter we have
used either organic solvents (methanol, methylene chlo-
ride) or pH 3 high purity water as the extraction solvent.
The solvent is then toxicity tested to  track toxicity (methyl-
ene chloride must first be exchanged  into  methanol),
additional Phase I tests are performed to characterize the
filter extract, and then chemically analyzed using Phase II
procedures. It is important to remove all of the methylene
chloride before toxicity testing  a filter extract and these
procedures are described in detail in Section 2.6.2. To
date,  methanol has been used to  extract toxicity from
filters used with effluent samples and methylene chloride/
methanol solutions have been used to extract filters from
                                                    6-1

-------
sediment pore water. The experiences described below
are based on acute toxicity experiments, and efforts to
recover filterable toxicity for chronically toxic effluent have
not yet been needed.

       To Isolate a toxicant removed through filtration,
several filters can be combined and extracted simulta-
neously if  necessary.  The  volume of sample passed
through the filters is important for calculating concentra-
tion factors, and should be recorded. The filtrate should
also be reserved for toxicity comparisons and analytical
testing. Sufficient sample should Be passed through the
filter to allow for both toxicity testing and chemical analy-
sis on both the filtered sample and the filter-extract solu-
tion (generally >200 ml).  Carefully move the filters to a
glass (acid leached) or  plastic  beaker, then  soak the
filters (1-5) in 20 ml of solvent for 1 h. Cool water sonica-
tfon is optional to attempt to recover particle-associated
compounds. Carefully remove the filters and save (store
at 4°C) in case additional extractions are necessary. If pH
3 high purity water is used as the extraction solvent, the
extract should  be  readjusted to the initial pH of  the
sample, then toxicity tested. If  methanol  is used, it is
evaporated to  ~2ml under a  stream of nitrogen. Be
careful to rinse the sides of the containers with methanol
to ensure complete solubilization of organic compounds.
This methanol solution can then be toxicity tested using
SPE fraction testing procedures (Section 2.2.8). Alterna-
tively, if a methylene chloride/methanol solvent is used,
the solvent should first be exchanged into pure methanol
(Section 2.6.2), then treated as the methanol extract
described above. The concentration of the solvent extract
will depend on the volume originally passed through the
filters, which depends on the desired high test concentra-
tion, and the volume of extract  and  filtered sample re-
quired for analytical purposes. Blank filters (through which
has been passed a volume  of dilution water) should be
extracted and tested identically  to the sample filters to
ensure that the solvents do not introduce artifactual toxic-
ity.
        For any of the extraction techniques, the solu-
tions should be tested at the same time as the baseline
test (unfiltered) and filtered sample test to compare the
toxicity  recovered by the  filter extraction with that re-
moved from the sample.

        Another option for toxicants removed by filtration
is to try other techniques to remove the toxicants which
avoid filtration. For example, sediment pore water samples
have been centrifuged at relatively high speeds (10,000-
20,000 g) for 30 min prior to passing the sample over the
C18SPE column and filtration could thus be eliminated.

        Filter extractions (EPA, 1991 A) have been used
in  several sediment  TIE studies, with procedures  sug-
gested for both non-polar organics and metals (Schubauer-
Berigan et al., 1990; Schubauer-Berigan and Ankley,
1991). In some effluent and pore water samples, toxicity
thought to be  caused by non-polar organic compounds
(e.g., PAHs and polymers) has  also been removed by
filtration. These compounds may be associated with par-
ticulate material, and be physically filtered from the sample,
or removed by association with oil and grease that sorbs
to the filter.

        In some cases, binding of  metals  or organic
compounds to inorganic and organic ligands  in effluents
or sediment pore waters will reduce their bioavailability
and  when toxicity testing  filter extracts, it is always a
concern that the matrix of the sample has been removed
and that chemicals  might  become available when  they
were not in the original sample. If this were to happen, the
extracts might be more  toxic than expected and chemi-
cals  might be  added to  the suspect toxicant list errone-
ously. This kind of mistake  should be caught by obtaining
a good toxicity value for the suspect in an appropriate
matrix (more detailed discussion in Section 2.6.1), There-
fore, additional confirmation steps might  be needed  to
eliminate the false suspects.
                                                     6-2

-------
                                           Section 7
                                          References
Amato, J.R., D.i. Mount, E.J. Durban, M.T. Lukasewycz,
    G.T. Ankley, and E.D. Robert. 1992. An Example of
    the Identification of Diazinon as a Primary Toxicant
    in an Effluent. Environ. Toxicol. Chem. 11:209-216

Ankley,  G.T., M.T. Lukasewycz,  G.S. Peterson  and
    D.A.  Jenson. 1990A.  Behavior of Surfactants In
    Toxicity Identification Evaluations. Chemosphere.
    21:3-12.

Ankley, G.T., A. Katko, and J.W. Arthur. 1990B. Identi-
    fication of  Ammonia as an  Important Sediment-
    Associated Toxicant in the Lower Fox River and
    Green Bay, Wisconsin.  Environ. Toxicol. Chem.
    9:313-322.

Ankley,  G.T., J.R. Dierkes,  D.A. Jensen and  G.S.
    Peterson. 1991. Piperonyl Butoxide as a  Tool in
    Aquatic Toxicological Research with Orgahophos-
    phate Insecticides.  Ecotoxicol. Environ.  Safety.
    21:266-274.

Ankley, G.T. and L.B. Burkhard. 1992. Identification of
    Surfactants  as Toxicants  in  a Primary  Effluent.
    Environ. Toxicol. Chem. 11:1235-1248.

APHA, 1989. Standard Methods for the Examination of
    Water and Wastewater, 17th Edition. American Pub-
    lic Health Association, Washington, D.C.

APHA, 1992. Standard Methods for the Examination of
    Water and Wastewater, 18th Edition. American Pub-
    lic Health Association, Washington, D.C.

AQUIRE, 1992. Aquatic Toxicity Information Retrieval
    Database, Technical Support Document. Prepared
    for Environmental Research  Laboratory,  Duluth,
    MN.

Beigger, T. 1990. Interactions of Ammonia and Chlorine
    on Fathead Minnows and Japanese Medaka. The-
    sis for University of  South-Western Louisiana,
    Lafayette, LA.
Burkhard, L.P., E.J. Durhan, and M.T. Lukasewycz. 1991.
    Identification of Non-Polar Toxicants in Effluents us-
    ing Toxicity Based Fractionation with  Gas Chroma-
    tography/Mass  Spectrometry.  Anal.  Chem.
    63:277-283.

Burkhard, L.P., J.J. Jenson. 1993. Identification of Ammo-
    nia, Chlorine, and Diazinon as Toxicants in a Munici-
    pal Effluent. Arch. Environ. Contam. Toxicol., In Press.

DeGraeve, G.M., J.D.  Cooney,  T.L. Pollock, N.G.
    Reichenbach,  J.H. Dean,  M.D. Marcus, and D.O.
    Mclntyre.  1988. Fathead Minnow 7-day test: Round
    Robin Study.  Intra- and Interlaboratory Study to De-
    termine the Reproducibility of the Seven-day Fathead
    Minnow Larval Survival  and Growth Test. Battelle,
    Columbus, OH. Available from: American Petroleum
    Institute, 1220 L Street, NW, Washington, DC 20005,
    Report Number 4486.

Doi, J. and D.R.  Grothe. 1989. Use of  Fractionation/
    Chemical Analysis Schemes for Plant Effluent Toxic-
    ity  Evaluation. In: G.W. Suter II (Editor), Aquatic
    Toxicology and Environmental  Fate. 11:123 ASTM
    STP 1007, American Society for Testing and Materi-
    als, Philadelphia, PA.

Durhan, E.J.,  M.T. Lukasewycz, and  J.R.  Amato.  1990.
    Extraction  and Concentration of  Nonpolar Organic
    Toxicants  From Effluents Using Solid Phase Extrac-
    tion. Environ. Toxicol. Chem. 9:463-466.

Durhan, E.J.,  M.T. Lukasewycz, and S.  Baker.  1993.
    Alternatives to Methanol-Water Elution of Solid-Phase
    Extraction Columns for the  Fractionation of High Log
    Kow Organic Compounds in Aqueous Environmental
    Samples. J. Chromatogr. 629:67-74.

EPA. 1979. Aqueous  Ammonia Equilibrium - Tabulation
    of Percent Un-ionized  Ammonia. EPA/600/3-79/091.
    Environmental Research Laboratory, Duluth, MN.
                                                  7-1

-------
EPA.  1980.  Ambient Water Quality Criteria for Silver.
    EPA-440/5-80-071.  Environmental Research Labo-
    ratory, Duluth, MN.

EPA.  1982. Methods for Organic Chemical Analysis of
    Municipal and Industrial Wastewater. EPA-600/4-82/
    057. Environmental Monitoring and Support Labora-
    tory, Cincinnati, OH.

EPA. 1983. Methods for Chemical Analysis of Water and
    Wastes.  EPA-600/4-79-020. Environmental Monitor-
    ing and Support Laboratory, Cincinnati, OH.

EPA.  1985A. Ambient Water Quality Criteria for Ammo-
    nia. EPA-440/5-85-001.  Environmental Research
    Laboratory, Duluth, MN.

EPA.  1985B. Ambient Water Quality Criteria for Cad-
    mium. EPA-440/5-84-032.  Environmental Research
    Laboratory, Duluth, MN.

EPA. 1985C. Ambient Water Quality Criteria for Chlorine.
    EPA-440/5-84-030. Environmental Research Labora-
    tory, Duluth, MN.

EPA.  1985D. Ambient Water Quality Criteria for Chro-
    mium. EPA-440/5-84-029.  Environmental Research
    Laboratory, Duluth, MN.

EPA.  1985E. Ambient Water Quality Criteria for Copper.
    EPA-440/5-84-031. Environmental Research Labora-
    tory, Duluth, MN.

EPA.  1985F. Ambient Water Quality Criteria for Lead.
    EPA-440/5-84-027. Environmental Research Labora-
    tory, Duluth, MN.

EPA.  1986.  Ambient Water Quality Criteria for Nickel.
    EPA-440/5-86-004. Environmental Research Labora-
    tory, Duluth, MN.

EPA.  1987. Ambient Water Quality Criteria for Zinc. EPA-
    440/5-87-003. Environmental Research Laboratory,
    Duluth, MN.

EPA.  1988A. Methods for Aquatic Toxicity Identification
    Evaluations: Phase I Toxicity Characterization Proce-
    dures. EPA/600/3-88/034.  Environmental Research
    Laboratory, Duluth, MN.

EPA.  1988B. Ambient Water Quality Criteria for Alumi-
    num.  EPA-440/5-86-008. Environmental Research
    Laboratory, Duluth, MN.

EPA.  1989A. Methods for Aquatic Toxicity Identification
    Evaluations:  Phase II Toxicity Identification Proce-
    dures. EPA/600/3-88/035. Environmental Research
    Laboratory, Duluth, MN.
EPA. 1989B. Methods for Aquatic Toxicity Identification
    Evaluations: Phase  III Toxicity Confirmation Proce-
    dures. EPA-600/3-88/036.  Environmental Research
    Laboratory, Duluth, MN.

EPA. 1989C. Short-Term Methods for Estimating the
    Chronic Toxicity of Effluents and Receiving Waters to
    Freshwater Organisms. Second Edition. EPA/600/4-
    89/001  and  Supplement EPA/600/4-89/001 A. Envi-
    ronmental Monitoring and Support  Laboratory,
    Cincinnati, OH.

EPA. 1991 A. Methods for Aquatic Toxicity Identification
    Evaluations: Phase I Toxicity Characterization Proce-
    dures. Second Edition. EPA/600/6-91/003. Environ-
    mental Research Laboratory, Duluth, MN.

EPA. 1991B. Sediment Toxicity Identification Evaluation:
    Phase I (Characterization), Phase II (Identification),
    Phase III (Confirmation) Modifications of Effluent Pro-
    cedures. EPA-600/6-91/007. Environmental Research
    Laboratory, Duluth, MN.

EPA. 1991C. Methods for Measuring the Acute Toxicity of
    Effluents to Freshwater and Marine Organisms. Fourth
    Edition. EPA-600/4-90/027. Environmental Monitor-
    ing and Support Laboratory, Cincinnati, OH.

EPA. 1991D. Methods for the Determination of Metals in
    Environmental Samples. EPA-600/4-91/010. Environ-
    mental  Monitoring and Support Laboratory,  Cincin-
    nati, OH.

EPA. 1992. Toxicity Identification Evaluations: Character-
    ization of Chronically Toxic Effluents, Phase I. EPA-
    600/6-91/005F.  Environmental Research Laboratory,
    Duluth,  MN.

EPA. 1993A. Methods for Aquatic Toxicity  Identification
    Evaluations: Phase  III Toxicity Confirmation  Proce-
    dures for Samples Exhibiting Acute and Chronic Tox-
    icity.  EPA-600/R-92/081. Environmental Research
    Laboratory, Duluth, MN.

EPA.  1993B. Short-term Methods for Estimating the
    Chronic Toxicity of Effluents and Receiving Waters to
    Freshwater Organisms. Third Edition. EPA-600/4-91/
    002.  Environmental  Monitoring and Support Labora-
    tory,  Cincinnati, OH.

EPA.  1993C. Short-term Methods for Estimating the
    Chronic Toxicity of Effluents and Receiving Waters to
    Marine  and Estuarine Organisms. Second Edition,
    EPA-600/4-91/021.  Environmental Monitoring and
    Support Laboratory, Cincinnati, OH.

Fickiin, W.H.. 1983. Separation of Arsenic (III) and Ar-
    senic (V) in Ground Waters by Ion-exchange. Talanta.
    30:371-373.
                                                   7-2

-------
 Ferguson,  W.J.,   K.I.   Braunschweiger,   W.R.
    , B,raunschweiger, J.R. Smith, J.J.  McCormick, C.C.
,>.'.-. Wasmann, N.P.  Jarvis,  D.H. Bell, and N.E.  Good.
    1980. Hydrogen  Ion Buffers for Biological Research.
    Anal. Biochem. 104:300-310.

 Flaschka, H.A. and A.J. Barnard, Jr. (Eds.). 1967. Che-
....... lates in Analytical  Chemistry. Marcel  Dekker, Inc.,
.•',  New York, NY. 418 p:

 Giger, W., C. Stephanou, and C. Schaffner. 1981. Persis-
    tent Organic Chemicals in Sewage Effluents: I. Identi-
 ,   ficationsofNonylphenols and Nonlyphenol Ethoxylates
   , by Glass Capillary Gas Chromatography/Mass Spec-
   ". trorrietry. Chemosphere. 10:1253-1263.

 Giles, M.A. and R. Danell. 1983. Water Dechlorination by
 t.  Activated Carbon, Ultraviolet Radiation and Sodium
    'Sulphite. Water Res. 17:667-676.

 Jpp,  K,M,, T.Z.  Kendall, A.M.  Askew, and R.B. Foster.
    1991. Use of Fractionation Procedures and Extensive
    Chemical Analysis  for  Toxicity Identification of a
    Chemical Plant  Effluent.  Environ. Toxicol. Chem.
.-;, .: iO'981-990.   .','..

 Lukasewycz, M.T. and EJ. Durhan. 1992.  Strategies for
    the  Identification of Non-Polar Toxicants in Aqueous
   ...: Environmental. Samples using  Toxicity-Based Frac-
    tionation and Gas Chromatography/Mass Spectrom-
    etry. J._Chromatogr. 580:215-228.

 Mount, D.R. 1991. A Toxicity-Based Approach to Pollut-
 •.,-, ant  Identification. In:, Proceedings of the Thirtieth
    Annual EPA Conference on Analysis of Pollutants in
  v the:Environment, May 9 and 10,  1990. 21W-7005.
    Office of Water,  Washington, D.C.

 Neilson, A.J., A.S; •Allard, S. Fischer, M. Malmberg, and
   , T. Viktor. 1990, Incorporation of a Subacute Test with
...'.- Zebra Fish into a Hierarchical System for Evaluating
    the  Effect of Toxicants in  the Aquatic Environment.
    Ecotox. and Environ. Safety. 20:82-97.

..Norberg-King,  T.J.,  E.J.  Durhan,  G.T. Ankley, and  E.
     Robert.  1991. Application of Toxicity Identification
   i  Evaluation Procedures to the Ambient Waters of the
,    , Colusa Basin Drain. Environ. Toxicol. Chem. 10:891-
    901.

- Nprberg-King, T.J. 1993. A Linear Interpolation Method to
     Estimate Sublethal Toxicityr The Inhibition Concen-
    tration (ICp) Approach. Release 2.0. National Effluent
     Toxicity Assessment Center Technical Report 03-93.
     Environmental Research Laboratory, Duluth, MN.

 Nriagu, J.O., G. Lawson, H.K.T. Wong, and J.M. Azcue.
 '   v 1993. A Protocol for Minimizing Contamination in the
     Analysis of Trace Metals in Great Lakes  Waters. J.
     Great Lakes Res. 19:175-182.
Oyamada, N. and M. Ishizaki. 1986. Fractional Determi-
    nation  of Dissolved  Selenium Compounds of
 .   Trimethylselenonium Ion, Selenium (IV) and Selium
    (VI) in Environmental Water Samples. Analyt. Sci.
    2:365-369.

Patterson, C.C. and D.M. Settle. 1976. The Reduction of
    Orders of Magnitude Errors in Lead Analysis of Bio-
    logical Materials and Natural Waters by Evaluating
    and Controlling the Extent and Sources of Industrial
    Lead Contamination Introduced During Sample Col-
    lection, Handling, and Analysis. In: Accuracy in Trace
    Analysis: Sampling, Sample Handling, Analysis. P.O.
    LaFleur  (Ed.). National Bureau of Standards Spec.
    Publ. 422. UvS.  Government Printing Office, Wash-
    ington D.C.

Skarheim, H.P. 1973. Tables of the Fraction of Ammonia
    in the Undissociated Form for pH 6 to 9, Temperature
    0 to 30'C, TDS 0-3000 mg/l, and Salinity 5-35 g/kg.
    Sanitary Engineering  Research Laboratory (SERL)
    Report No. 73-5. University of California-Berkeley,
    Berkeley, CA.

Schubauer-Berigan, M.K., G.T. Ankley, and J.R. Dierkes.
    1990. Toxicity Identification Evaluations of Contami-
    nated Sediments in the Buffalo  River, NY and the
    Saginaw River, Ml. Final Report to the Great Lakes
    National  Program Office ARCS Program.  NETAC
    Technical Report 20-90.

Schubauer-Berigan, M.K. and  G.T. Ankley.  1991. The
    Contribution of Ammonia, Metals, and Nonpolar Or-
    ganic Compounds to the Toxicity of Sediment Intersti-
    tial Water from  an Illinois River Tributary. Environ.
    Toxicol.  Chem. 10:925-940.

Schubauer-Berigan, M.K., J.R. Dierkes, P.O. Monson,
    and G.T. Ankley. 1993A. The pH-dependent toxicity
    of Cd, Cu, Ni, Pb, and Zn to Ceriodaphnia dubia,
    Pimephales promelas,  Hyalella azteca,  and
    Lumbriculus variegatus. Environ.  Toxicol. Chem.,
    12:1261-1266.

Schubauer-Berigan, M.K., J.R. Amato, G.T. Ankley, S.E.
    Baker, L.P. Burkhard, J.R. Dierkes, J.J. Jenson, M.T.
    Lukasewycz, and T.J. Nprberg-King. 1993B. The Be-
    havior and Identification of Toxic Metals in Complex
    Mixtures: Examples from Effluent and Sediment Pore
    Water Toxicity  Identification Evaluations.  Arch.
    Environ. Contam. Toxicol. 24:298-306.

Smith, R.M. and A.E Martelh 1981. Critical Stability Con-
    stants. Volume 4: Inorganic Complexes. Plenum Press,
    NY.  87 p.

Stary, J. 1964. The Solvent Extraction of Metal Chelates.
    Pergamon Press Ltd., Oxford,  England. 240 p.
                                                     7-3

-------
Stumm, W. and JJ. Morgan. 1981. Aquatic Chemistry -
    An Introduction Emphasizing Chemical  Equilibria in
    Natural Waters. John Wiley & Sons, Inc. New York,
    NY. 583 p.

Walsh, G.E., and R.L Gamas. 1983. Determination of
    Bfoactrvfty of Chemical Fractions of Liquid Wastes
    using Freshwater and Saltwater Algae and Crusta-
    ceans. Environ. Sci. Technol. 17:180-182.
Windholz, M., S. Budavari, R.F. Blumetti and E.S. Otterbein
    (Eds.). 1983. The Merck Index: An Encyclopedia of
    Chemicals, Drugs, and Biologicals.  Tenth Edition.
    Merck & Co., Inc., Rahway, NJ.

Zief, M., and J.W. Mitchell.  1976. Contamination Control
    in Trace Element Analysis. Chemical Analysis Series,
    Vol. 47. John Wiley & Sons, Inc., New York, NY.
                                                  7-4

-------
             Appendix A
Effluent Volume Calculation Worksheets
                   A-1

-------
 Table A-1.  Effluent Volume Calculation Worksheets

 SPE Fractlonatlon of the Effluent
 1)  Volume of effluent:                                                              ve              ml
        See Table 2-6 for initial suggestions
        for the volume of effluent.

 2) SPEfractionation:
        Eluate volume from the SPE column:                                           a      _ ml
               See Table 2-1 for approximate eluate volume
               or measure volume.
        Concentration factor for eluate: bt = ve •*- a                                      b      _ x

 3) Testing organism and conditions:
        Toxicity test volume/replicate:                          .                       c      _ ml
               C.dubia      10-15 ml/replicate (acute/chronic)
               D.magna     10-1 5 ml/replicate (acute)
               D.pulex      10-1 5 ml/replicate (acute)
               P. promelas   1 0-200 ml/replicate (acute)
               P. promelas   50-250 ml/replicate (chronic)
        Number of replicates:                                                        d      _
        Initial sample + number of renewals                                            e      _
        Highest test concentration:                                                    f              x
        Is the methanol concentration okay?1
           ml eluate = f x c +• bn                                   .    ,
           %methanol » ml eluate x 100 *c

4) Volume of eluate needed for toxicity testing:
        If no dilutions:        g^cxdxexf-i-b,                                      g      __ _ ml
        If using 0.5 dilution factor:
           h = 2xcxdxexf^-b1                                                   h             ml
        If using dilutions by spiking each concentration2 directly:
           J-ixcxdxe + b,                                                      j      _ ml

        Total volume of eluate used:  k = g, h, or j                                      k      _ ml

5) Volume of eluate remaining after toxicity testing:
                                       n>! = a - k                                   m     _ ml
'Acceptable levels of methanol for C. dubia and fathead minnows are <0.6% and 1%, respectively.
2An example of using four test concentrations, the number of dilutions may vary.
                                                  A-2

-------
Table A-1.  Continued

Toxlclty Testing and GC/MS Analysis of the SPE Concentrate
1) SPE Concentration of the SPE fraction:
       Eluate volume from the SPE column:                                         a       —	ml
              See Table 2-3 for approximate eluate volume
              or measure volume.
       Concentration factor for the eluate: b2 = fy x m1 + a                             b2      	x

2) Testing organism and conditions:                   :
       Toxicity test volume/replicate:                                               c       	ml
              C.dubia      10-15 ml/replicate (acute/chronic)
              D.magna     10-25 ml/replicate (acute)
              D.pulex      10-25 ml/replicate (acute)
              P.promelas   10-200 ml/replicate (acute)
              P. promelas   50-250 ml/replicate (chronic)
       Number of replicates:                                                       d       	
       Initial sample + number of renewals:                                         e       	
       Highest test concentration:                                                  *       	x

3) Volume of eluate needed for toxicity testing:
       If no dilutions:         g = cxdxexf-s-b2                                   9       	ml

       If using 0.5 dilution factor:
              h = 2xcxdxexf*b2                                              n      	m

       If using dilutions by spiking each concentration directly:

              j = ixcxdxe*b2                                                  I       	ml

       Total volume of eluate used: k = g,h, or j                                     k      	ml

 4) Amount of eluate used for GC/MS analysis:                                        I       	ml

 5) Volume of eluate remaining after toxicity testing:
                            mz =  a - k -1                                          m2      	ml
                                                   A-3

-------
 Table A-1. Continued

 HPLC Fractlonatlon of the SPE Concentrate
 1) HPLC Fractfonation of the SPE concentrate:
        HPLC Fraction volume:                                                     a               ml
               See Sections 2.2.10 and 2.3.10                                               —	
        Concentration factor for the eluate: b, = b,xm,-s- a                              b               Y
                                       32    2                                 **g      __        A

 2) Testing organism and conditions:
        Toxicity test volume/replicate:                                                c               m(
               C.dubia      10-15 ml/replicate (acute/chronic)                                 ~~	
               D.magna     10-25 ml/replicate (acute)
               D.pulex      10-25 ml/replicate (acute)
               P.promelas   10-200 ml/replicate (acute)
               P.promelas   50-250 ml/replicate (chronic)
        Number of replicates:                                                       $
        Initial sample + number of renewals:                                           e       	
        Highest test concentration:                                                   f	x

3) Volume of eluate needed for toxicity testing:
        If no dilutions:         g = cxdxexf-3-b3                                    g              m(
If using 0.5 dilution factor:
       h-2xcxdxex

If using dilutions by spiking each concentration directly:
              h-2xcxdxexf-s-b3                                              h              ml
                                                                                j       _ m,

       Total volume of eluate used:  k = g, h, or j                                     k       _ ml
5) Volume of eluate remaining after toxicity testing:
                                                                                m3     _ ml
                                                 A-4

-------
Table A-1. Continued

Concentration of the HPLC Fraction for Toxicity Testing and GC/MS Analysis



1) SPE Concentration of the SPE fraction:                                                              .
       Eluate volume from the SPE column:                                          a       	
              See Table 2-3 for approximate eluate volume                      -
              or measure volume.
       Concentration factor for the eluate: b4 = b3xm3 - a                              D4      	*

2) Testing organism and conditions:                                                                   ,
       Toxicity test volume/replicate:                                                c       	
              C.dubia      10-15 ml/replicate (acute/chronic)
              D. magna     10-25 ml/replicate (acute)
              D.pulex      10-25 ml/replicate (acute)
              P.promelas   10-200 ml/replicate (acute)
              P. promelas   50-250 ml/replicate (chronic)
       Number of replicates:                                                       o       	
       Initial sample + number of renewals:                                          ®       	
       Highest test concentration:                                                  T       	

 3) Volume of eluate needed for toxicity testing:
        If no dilutions:        g = cxdxexf *b4                                   9       	

        If using 0.5 dilution factor:                                     *                                .
               h = 2xcxdxexf*b4                                             n      	ml

        If using dilutions by spiking each concentration directly:

               • 1 i xr/xriVe^b'                                                 J       	m'

        Total volume of eluate used:  k = g,h, or j                                      k      	ml

 4) Amount of eluate used for GC/MS analysis:                                         '       	ml

 5) Volume of eluate remaining after toxicity testing:
                            m4 = a-k-l                                           m4      	ml
                                                    A-5

-------

-------